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1.
A STUDY OP IMMUNE MECHANISMS IN THE MOUTH 
______ IN RELATION TO ORAL DISEASE.________
SUMMARY
The evidence to date, from clinical, epidemiological 
and laboratory investigations, underlines the causal role 
of bacterial plaque in two of the most prevalent oral 
diseases i.e. periodontal disease and dental caries. The 
possibility of controlling plaque formation or of inhibiting 
its harmful effects on the teeth and gingivae by the pro­
duction of salivary and/or tissue antibodies was investigated.
Saliva is a more difficult and variable substance with 
which to work than serum, and although extensive research 
has been carried out on the nature of the salivary immune 
system, with especial reference to Secretory IgA, gingival 
flu'ld and gingival tissue immune reactions, there seems to 
be little correlation of the methodology, the results and 
their interpretation.
A number of related problems in connection with saliva 
and gingivae and the possible roles of their components in 
relation to oral disease were investigated in both humans 
and small laboratory animals.
Little data exists 011 the increase in salivary immuno­
globulin levels following the concentration of saliva by 
volume reduction. Lyophilisation, ultrafiltration and 
polyacrylamide gel were compared as to their efficiency in 
concentrating stimulated, mixed, human saliva, the total 
protein and individual immunoglobulins being determined and 
compared. Reliability and feasability of method were
evaluated using solutions of human gamma globulin and 
chymotrypsinogen. It was found that neither total protein 
nor individual immunoglobulin concentration increased 
linearly with reduction in volume, therefore volume 
reduction alone cannot be taken as a reliable indication of 
concentration of immunoglobulins or total protein in saliva.
Although Secretory IgA is known to differ from serum 
IgA in that it contains a secretory piece, it has always 
been assumed that salivary albumin is identical to plasma 
albumin. The results reported in this thesis suggest the 
contrary. Immunoelectrophoresis has confirmed the presence 
of an albumin-like component in mixed saliva. However, 
although a precipitin arc occurs in the albumin region of 
mixed saliva against rabbit anti-mixed saliva serum, the 
arc shows a reaction of non-identity with the plasma albumin 
anti-plasma albumin arc; this arc is still present after 
adsorption of mixed saliva with anti-human plasma albumin. 
Thus it appears that the mixed saliva:anti-mixed saliva arc 
in the albumin region does not result from plasma-like 
albumin.- Double-diffusion results in a reaction of identity 
between salivary and plasma albumins, suggesting antigenic 
similarities between them; this does not exclude the’ 
possibility of a secretory piece. Furthermore, after intra­
venous injection of human plasma albumin into rabbits, the 
human albumin appearing in the saliva seems to be a single 
entity. These results suggest the existence of both a 
serum-type and salivary-type albumin in saliva, with at 
least one identical antigenic component, the concentration 
of the serum—type, being related to the degree of periodontal
5.
disease and therefore tissue destruction.
. A comparison of salivary and serum IgA levels of patieats 
presenting with different periodontal diseases, with a clinically 
healthy control group, closely matched for age, sex, medical 
histories and caries rates was made. Little regard has been 
taken of the amount of caries or systemic disease in previous 
similar studies,' with subsequent difficulty in relating the 
results purely to the type of periodontal disease under- 
investigation ( and. vice-versa). Classification by longevity 
of the inf lamina t ory lesions resulted in more significant 
differences between the male salivas and the controls, than
the females. On sub-division, trends to definite differences
c
between health and specific diseases appeared. Significant 
differences in salivary values were recorded in the acute 
grouping with Acute Ulcerative Gingivitis, Herpes plus Acute 
Ulcerative Gingivitis, Aphthous Ulceration (in agreement with 
1EHUSR, 1969,b) and acute Herpes plus chronic Gingivitis; 
serum levels differed in ’convalescent’ groups of Acute 
Ulcerative Gingivitis, chronic Gingivitis and Rheumatoid 
patients. All values were calculated on the basis of the 
World Health Organization standards to enable correlation with 
any future results reported from other laboratories. The 
study discusses the value of immunoglobulin measurements and 
emphasises the need for maximum control and correlation of 
all variables apart from the disease under study to obtain 
fully meaningful results.
Implantation of cariogenic bacteria in the mouths of 
rabbits fed a cariogenic diet resulted not in caries, but in 
gingivitis v/ith a marked inflammatory cell infiltration.
iTo salivary antibody was detected to these organisms (which 
adhered to the oral tissues) not normally present in the 
rabbit mouthy These results were compared to those of 
humans, by estimating if salivary antibodies were present 
in control and diseased mouths to an organism implicated in 
the pathogenesis of periodontal disease; the control group 
have a higher level than the latter. The role of salivary 
antibodies compared to tissue immune mechanisms is discussed 
in relation to these results.
The ultimate investigation on local immunization out­
lined the difficulties of producing sufficient quantities of 
salivary immunoglobulin to overcome accumulated bacteria and 
their products; also the strict control necessary over 
type and quantity of antigen, route and timing of injections. 
The highest response was obtained by local immunization 
after primary systemic challenge. ’Passive’ immunization 
resulted in the appearance in the saliva of the immunogen 
within a short time (confirming and extending the work of 
SCHSIh and TurTG-, 1962), the amount produced varying v/ith the 
molecular weight, implying there may only be secretion into 
the saliva of molecules below a certain molecular weight, in 
health. Further investigations into local immunization 
appear warranted.
The possible interrelationships of salivary and tissue 
immune mechanisms and their relevance to, and roles in, oral 
disease are discussed, with reference to the results obtained 
throughout the investigations.
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A STUDY OP IMMUNE MECHAEISMS IE THE MOUTH 
______ IN RELATION TO ORAL DISEASE.
SUMMARY (Preface) '
The evidence to date, from clinical, epidemiological 
and laboratory investigations, underlines the causal role 
of bacterial plaque in two of the most prevalent oral 
diseases, i.e. periodontal disease and dental caries. The 
possibility of controlling plaque formation or of inhibiting 
its harmful effects on the teeth and gingivae by the 
production of salivary and/or tissue antibodies was 
investigated.
Saliva is a more difficult and variable substance with 
which to work than serum, and although extensive research 
has been carried out on the nature of the salivary immune 
system, with especial reference to Secretory IgA, gingival 
fluid, and gingival tissue immune reactions, there seems 
to be little correlation of the methodology, the results 
and their interpretation.
A number of related problems in connection with saliva 
and gingivae and the possible roles of their components in 
relation to oral disease were investigated in both humans 
and small laboratory animals.
Little data exists on the increase in salivary immuno­
globulin levels following the concentration of" saliva by 
volume reduction. Lyophilisation, ultrafiltration and 
polyacrylamide gel were compared as to their efficiency in 
concentrating stimulated, mixed, human saliva, the total 
protein and individual immunoglobulins being determined and
compared. Reliability and feasability of method were 
evaluated using solutions of human gamma globulin and 
chymotrypsinogen. It was found that neither total protein 
nor individual immunoglobulin concentration increased 
linearly with reduction in volume, therefore volume 
reduction alone cannot be taken as a reliable indication of 
concentration of immunoglobulins or total protein in saliva.
Although Secretory IgA is known to differ from serum 
IgA in that it contains a secretory piece, it has always
been assumed that salivary albumin is identical to plasma
)
albumin. The results reported in this thesis suggest the 
contrary. Immunoelectrophoresis has confirmed the presence 
of an albumin-like component in mixed saliva. However, 
although a precipitin arc occurs in the albumin region, of 
mixed saliva against rabbit anti-mixed saliva serum, the arc 
shows a reaction of non-identity with the plasma albumin: 
anti-plasma albumin arc; this arc is still present after 
adsorption of mixed saliva v/ith anti-human plasma albumin. 
Thus it appears that the mixed saliva:anti-mixed saliva arc 
in the albumin region does not result from plasma-like 
albumin. Double-diffusion results in a reaction of identity 
between salivary and plasma albumins suggesting antigenic 
similarities between them; this does not exclude the 
possibility of a secretory piece. Furthermore., after intra­
venous injection of human plasma albumin into rabbits, the 
human albumin appearing in the saliva seems to be a single 
entity. These results suggest the existence of both a serum- 
type and salivary-type albumin in saliva, with at least one 
identical antigenic component, the concentration of the
serum-type being related to the degree of periodontal 
disease and therefore tissue destruction.
A comparison of salivary and serum IgA levels of patients 
presenting with different periodontal diseases with, a clinically 
healthy control group, closely matched for age, sex, medical 
histories and caries rates was made. Little regard has been 
taken of the amount of caries or systemic disease in previous 
similar studies, with subsequent difficulty in relating the 
results purely to the type of periodontal disease under 
investigation (and vice-versa). Classification by longevity 
of the inflammatory lesions resulted in more significant 
differences between the male salivas and the controls, than 
the females. On sub-division, trends to definite differences 
between health and specific diseases appeared. Significant 
differences in salivary values were recorded in the acute 
grouping with Acute Ulcerative Gingivitis, Herpes plus Acute 
Ulcerative Gingivitis, Aphthous Ulceration (in agreement with 
LLIUTHR, 1969,b) and acute Herpes plus chronic Gingivitis; 
serum levels differed in Tconvalescent1 groups of Acute 
Ulcerative Gingivitis, chronic Gingivitis and Rheumatoid 
patients-. All values were calculated on the basis of the 
V/orld Health Organization standards to enable correlation with 
any future results reported from other laboratories. The 
study discusses the value of immunoglobulin measurements and 
emphasises the need for maximum control and correlation of 
all variables apart from the disease under study to obtain 
fully meaningful results.
Implantation of cariogenic bacteria in the mouths of 
rabbits fed a cariogenic diet resulted not in caries, but in 
gingivitis with a marked inflammatory cell infiltration.
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No salivary antibody was detected to these organisms 
(which adhered to the oral tissues) not normally present 
in the rabbit mouth* These results were compared to those 
of humans, by estimating if salivary antibodies were 
present in control and diseased mouths to an organism 
implicated in the pathogenesis of periodontal disease; the 
control group have a higher level than the latter. The role 
of salivary antibodies compared to tissue immune mechanisms 
is discussed in relation to these results.
The ultimate investigation on local immunization out­
lined the difficulties of producing sufficient quantities 
of salivary immunoglobulin to overcome accumulated bacteria 
and their products; also the strict control necessary over 
type and quantity of antigen, route and timing of injections. 
The highest response was obtained by local immunization 
after primary systemic challenge. 'Passive* immunization 
resulted in the appearance in the saliva of the immunogen 
within a short time (-.confirming and extending the work of 
SCHEIN and TUNG-, 1962), the amount produced varying-with the 
molecular weight, implying there may only be secretion into 
the saliva of molecules below a certain molecular weight, in 
health. Further investigations into local immunization 
appear warranted.
The possible interrelationships of salivary and tissue 
immune mechanisms and their relevance to, and roles in, oral 
disease are discussed, with reference to the results obtained 
throughout the investigations.
1.
A STUDY OF IMMUNE MECHANISMS IN THE 
MOUTH IN RELATION TO ORAL DISEASE
CHAPTER 1 .
INTRODUCTION.
Saliva, as defined by 1 The Concise Oxford Dictionaryf 
is a "colourless liquid given by mixed secretions of salivary 
and mucous glands discharged into the mouth and assisting 
mastication." Immunity, defined by the same source, means 
"being proof against contagion."
In the following thesis, it is proposed to expand the 
definition of saliva especially with respect to some of its 
protein constituents and to investigate immunity as a 
property of saliva, in addition to analysing to what extent 
the functions and properties of saliva are interrelated with 
other oral immune mechanisms in connection v/ith oral diseases. -
Considerable clinical, epidemiological and laboratory 
evidence has demonstrated the casual role of microbial plaque 
in both dental caries and periodontal disease (IOE, THEILADE 
and JENSEN, 1965; GIBBONS et al., 1966; ALEXANDER, 1970; 
KELSTRUP-and GIBBONS, 1970 and SHEIHAM, 1970). The possibility 
of inhibiting plaque formation or of altering plaque metabol­
ism, as a means of preventing these diseases, by the production 
of specific antibodies in salivary secretions or in the 
gingival tissues, through vaccination, is thus attractive.
It was felt that successful immunization procedures 
could only be achieved, if adequate methods of analysis of 
salivary constituents were defined, and small laboratory 
animals used, to study the mechanisms of initiation of oral
2.
disease.
The aims of the thesis will he to determine the 
immunoglobulin content of the saliva and serum of patients 
who presented suffering from periodontal diseases of 
varying severity and to compare them with that of control 
subjects having clinically healthy mouths (i.e. no active 
dental caries and a low Plaque Index value). Before this 
project was undertaken it was realized that basic work on 
the manipulation and examination of saliva (from both humans 
and experimental animals) was necessary before a meaningful 
patient survey could be carried out. This resulted in 
interesting observations in connection with the concentration 
of saliva and also with the immunochemical properties of the 
albumin in human saliva.
Animal experiments in relation to the production of 
local immunity in the oral cavity were felt to be important. 
Consequently, rabbits were used for experiments on the use 
of bacteria in inducing oral disease and for broadly-based 
investigations on the production of salivary and tissue 
antibodies in the mouth after active and passive immunization. 
It was felt that these results could act as a comparison 
and guide-line for future human studies on immunization 1 
against oral disease.
CHAPTER 2.
CRITICAL REVIEW OP THE LITERATURE.
Two of the principal diseases of the mouth are 
periodontal disease and dental caries. Although, in some 
areas of dental research there is a larger volume of 
literature related to the latter than to the former, and 
this has been included in the review where relevant, the 
investigations reported in this thesis were principally 
concerned v/ith periodontal disease. However, their 
application to dental caries was also considered.
THE MOUTH
A number of microbial ecosystems exist and interact 
within the oral environment as a whole. The tongue, teeth, 
hard and soft palates, gingivae and gingival crevice are 
colonised by, and the gingival fluid and saliva, contain, 
many different microorganisms, a number being common to 
some, or all, of these different parts of the mouth. The 
interaction of these organisms, the factors that affect 
their proliferation, production of metabolites and their 
capacity to induce harmful effects, the constituents of the 
oral tissues and fluids, are all important in influencing 
the reaction of the host to their presence. The general 
health of an individual and the capacity of his immune 
system, at any given time, to cope with the constant change 
in the oral ecosystems, governs his response to adverse 
changes in these systems and also his susceptibility to, and 
recovery from, oral disease.
SALIVA
Saliva is the substance secreted by the parotid, sub- 
T&andibular, sub-lingual and many minor glands, into the 
mouth, where it bathes the tongue, teeth and mucous 
membranes. Its functions, like its contents, are varied.
WHOLE SALIVA
Whole saliva is contaminated by food, desquamated 
epithelial cells, bacteria, gingival fluid and leukocytes 
emanating from the gingival crevice. Its protein content 
including enzymes and immunoglobulins varies with diet and 
length of time after eating (DAWES, 1970), flow rate 
(MANDEL and KHURANA, 1969), stimulation and the type of 
stimulation used (JENKINS, 1970) and the general oral health 
of the subject. (See Table 1.)
It has been shown to contain numerous ions, albumin, 
salivary^,- globulin, double component, m u c o s a l g l o b u l i n  
salivary0^2 globulin, Xactoferrin, salivary ^ globulin,
^ globulin, preamylase, amylase, post amylase, CC-cathodic 
component, salivary mucins, lysozyme and blood group 
substances along with various growth factors (reviewed by 
ELLISON, I960). STOEEER et al. (1962) have reported the 
presence of orosmucoid (°^ ]_ globulin), caeruloplasmin 
( 06 2 globulin), /3 2 macroglobulin ( 2 globulin), 
lipoprotein ( ^  globulin), transferrin ( 1 globulin) and
fibrinogen. Immunoglobulins were identified by MASSON et al 
(1965) while BRANDTZAEG (1965) confirmed the presence of 
IgO and IgM (in very small amounts) and IgA plus Secretory 
IgA in parotid, submandibular and whole saliva.
To identify these proteins, a number of antisera were 
used and at least 11 precipitin arcs; were obtained on 
immunoelectro phoresis (ELLISON, I960); even with uncon­
centrated whole saliva, precipitin bands could still be 
obtained. The subsequent work has resulted in varying 
numbers of precipitin lines against unconcentrated and 
concentrated whole, parotid and sub-mandibular saliva, but 
it must be emphasised that NO standard antiserum has been 
used.
Pooling of samples is often necessary to obtain sufficient 
amounts for analysis and care must be taken to mix only those 
saliva samples from subjects similar in as many respects as 
possible. It is not possible to obtain two or more people 
with exactly the same biological and immunological 
characteristics, so natural variation must be taken into 
account, along v/ith variation in estimation of oral health 
and disease, when examining these saliva samples.
SALIVARY GLAND STIMULATION
Stimulation by different agents results in different 
flow rates, but subjects with a slow reaction to one stimulus 
exhibit the same reaction to others and vice-versa 
(JENKINS, 1970). Chewing of paraffin wax is unpleasant and 
causes denaturation of salivary proteins; Citric Acid may 
act as a chelating agent but is a good stimulant. After 
prolonged stimulation salivary production is reduced and the 
rate of constituent production can no longer parallel flow 
rate with concomitant dilution. MANDEL and KHURANA (1969)
TABLE 1 . Variability in salivary IgA levels in the 
same person.
IgA level in parotid saliva (mg$).
Maximal stimulation.
Continuously over 2 hours 
10 ml samples collected.
1.14
0.93
1.10
1.17
0.95
0.80
0.95
Mean = 1.01
Standard deviation = 0.12. Standard deviation = 0.13
Unstimulated = 8.9mg$ 
Submaximally stimulated =
+ = Maximal stimulation to salivation, produced by sour 
fruit candy allowed the most reproducible levels of 
IgA to be attained. Thus variations due to time of 
day, relation to meals and prolonged stimulation, 
were eliminated. Variability approximates the 
standard error of the IgA determination. (- 10$).
Different days.
1.0
1.04
1.04 
lvO 
1.03 
0.70 
0.95 
0.84
Mean = 0.95
(Erom SOUTH et al., 1968)
reported a decrease in Albumin and IgA concentration on 
increased flow rate; H A M E L  and KATZ also reported, in 1970, 
that pilocarpine stimulation of human saliva gave a twofold 
increase in all components with the exception of Ca++ and 
IgA, which varied inversely in this case, Eig.l illustrates 
the decrease in salivary IgA content on increased stimulation 
of whole saliva.
Whole saliva is therefore a heterogeneous "biochemical 
mixture with a wide variation of properties, depending on 
the environment and state of the subject at the time of 
collection.
GLAND SALIVA
Saliva from canulated ducts should he a sterile, clear 
fluid. Because of canulation it is more difficult to obtain 
and must be stimulated to collect sufficient amounts with 
which to work.
Electrophoresis on cellulose acetate membranes, agar gel 
and polyacrylamide gel (MEYER and LAMBERTS, 1965, a,b;
BEELEY, 1972) results in fewer bands compared to whole 
saliva. This may be because of contamination of the latter 
with bacterial substances, epithelial cells and crevicular 
fluid plus the additional secretion from the minor glands.
SALIVARY IMMUNOGLOBULINS
With the discovery that the IgG/lgA ratio in whole 
saliva is l/l (BRANDTZAEG-, 1965) compared to 5/1 in serum, 
interest turned to the function of IgA in mucosal secretions
20----------------------------- 3 IgA mg/o.
0 o2 0 c/o antiserum.
Pig.l* Decrease in IgA concentration on increased 
saliva stimulation, measured Toy the 
Electroimmunodiffusion technique of 
MERRI1 et a h  (1967)*
i.e« IgA concentration is inversely related 
to flow rate.
IgA was measured in parotid saliva, 
stimulated by fruit gums and collected over 
10 minutes.
Slide by the courtesy of IRA SHANNON, 1972*
N.B. In this, and subsequent immunoelectrophonesis figures,
+ represents the anode,
- represents the cathode.
as it was also found to be the predominant immunoglobulin 
in nasal, bronchial and gastro-intestinal secretions 
(20URVILLE et al., 1969; JOHI'ISOlf, 1970 and ROGERS, 1970).
There is a great range of variation in the previously- 
reported values of salivary immunoglobulins because of 
differences in the methods used for collection, concentration 
and the use of different standards for comparison. This is 
illustrated in Tables 2a, b, c and d, in which BRANDTZAEG 
et al. (1970) tabulated concentration values.
There is doubt as to the origin of salivary immuno­
globulins. Many workers including ELLISON et al. (i960), 
STOPPER et al. (1962) and MASSON et al. (1965) referred to 
the demonstration of serum proteins in saliva. This implies 
a basic sameness in serum and salivary immunoglobulins; 
also that there is diffusion of immunoglobulins from the 
serum, through the gingival tissue into saliva.
Later studies by TOMASI and ZIEGELBAUM (1963), TOMASI 
et al. (1964), SOUTH et al. (1966), BRANDTZAEG-, (1970) and 
STROBER et al., (1970) proved the existence of a secretory 
mechanism for IgA into the saliva, apart from the normal 
production of IgG and IgM. Thus although a small proportion 
of salivary IgA may originate from the serum, it is thought 
that 96$ is synthesised within the salivary glands. (Reported 
by HURLIMANN and ZUBER, 1968; STROBER et al. 1970).
BRANDTZAEG et al. (1968,a) described the selective secretion 
of IgM in IgA deficiency. Normally IgM (BRANDTZAEG et al. 
1968; BRANDTZAEG 1971,e) and possibly IgG (STROBER et al.
1970; BRANDTZAEG, 1971,e) are selectively transmitted.
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Tables 2a and b.
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Tables 2c and d .
REPORTED VALUES OP SALIVARY IMMUNOGLOBULINS. 
(after BRAUDTZAEG- et al., 1970)
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LACHMANN and THOMSON (1970) have demonstrated that 
IgA is the antibody in most normal human salivas that gives 
high titres of immuno-conglutinin activity, i.e. antibody 
to bound complement components. This may be important in 
intra-crevicular reactions. BRANDTZAEG et al. (I968,b) 
noted the 1 in vivo1 adsorption of IgA onto oral bacteria, 
and IgA was the antibody in saliva attributed by SIRISHINA
(1970), to be produced against ^  haemolytic streptococci.
The depletion of salivary IgA by adsorption to microorganisms 
may be a protective mechanism in shielding the oral mucous 
membranes and teeth from attack by bacterial products, but 
may also deplete the IgA pool and so lower resistence to 
prolonged attack.
THE SECRETORY IMMUNOGLOBULIN SYSTEM
The structure and function of the principal mucosal 
antibody has been the subject of a number of reviews and 
investigations. (BRAHDTZAEG, 1968; TOMASI and BIENENSTOCK, 
1968; TOURVILLE et al., 1969; BLOTH, 1970; BRAHDTZAEG et al. 
1970; OGRA and KARZOH, 1970; TOMASI, 1970, BRAHDTZAEG,
1971a,b,c,d,e and WALDMAN, 1971).
Salivary IgA was found to have a sedimentation 
coefficient of 11S whereas serum IgA has one of 7S. It has 
a molecular weight of 390,000 as it consists of 2 molecules 
of M.U. 170,000 bound to a Secretory Piece (S.P.) of M.W.
50,000 (TOMASI et al., 1965)o The S.P. has a faster 
electrophoretic mobility than IgA. BRAHDTZAEG (1970) and 
TOMASI (1970) produced work that refuted the earlier results
of HURLIMAHH et al. (1969) who dismissed the idea of non- 
covalent as well as covalent linkage between the IgA 
molecules and S.P. Both linkages are now known to exist 
between the chains of the 7S monomeric units.
BRAHDTZAEG (1968,a; 1970) stated that the increased 
antigenicity of IgA is due to unfolding, not to the removal 
of light chains, and that *in vivo* there is an anzyme- 
catalized process producing inter-unit S-S bonds, with the 
non-covalent- bonds being secondary. Thus secretory IgA has 
unique physical, chemical and antigenic properties conferred 
by this non-immunoglobulin glycoprotein secretory piece 
which appears to stabilise IgA and make it relatively 
resistant to proteolysis (TOMASI and BIEHHSHSI0CM, 1968).
Secretory IgA is unique in that the two components are 
synthesised in two different cells. The dimerised IgA is 
produced in the sub-endothelial plasma cells and the secretory 
component, in the ductal cells (TOURVILLE et al., 1969).
This confirms the mechanism proposed by TOMASI and BIEHHEHSTOCK
(1968). They combine in the inter-cellular spaces and the 
bound form is secreted. Pree S.P. exudes straight out and 
this explains its presence in patients lacking IgA, as found 
by HEREMAHS and CRABBE (1967), SOUTH et al. (1966; 1968) and 
BRAHDTZAEG (1968). ROSSEH et al. (1967) identified IIS IgA 
by immunofluorescence studies in tissues lining the oral and 
respiratory passages in man.
Secretory IgA is also found in trace amounts in the 
blood of normal individuals (THOMPSOH et al. 1969; WALDMAN 
et al. 1970a,b and BRAHDTZAEG, 1971,d). THOMPSOH and ASQUITH
(1970) have stated that about 99$ of healthy adults have 
Secretory IgA in their serum, but their report was on a 
small sample of people and the method of concentration of 
IgA was not stated. BRAHDTZAEG (1971,d) detected it in 59$ 
of normal people with an increase in the IgA myeloma group.
He possibly used more sensitive methods of detection because 
of the hidden antigenic determinant of IgA. The mechanism 
of its formation is unknown but there may be a "spill-over" 
of free S.P. and Secretory IgA from the intercellular spaces 
to serum via the connective tissue ground substance. There 
is no apparent correlation between Secretory IgA and ordinary 
IgA concentrations in serum. Its level is elevated in 
certain conditions eg. liver disease. WALDMAH et al. (I970,b) 
reported high numbers of sera with Secretory IgA in enteric 
cases, therefore possibly the breakdown of mucous membranes 
allows its release into the serum; no study appears to have 
been made as to whether there are elevated levels in the
sera of persons with severe periodontal disease.
Recently HALPERH and KOSHLAHD (1970) and MESTEOHY et al.
(1971) have demonstrated a J chain or SP component in polymeric 
IgA and IgM. It is synthesised along with the corresponding 
heavy chains by immunocytes (O’DALY and CEBRA, 1971) hut its 
role in stabilization or transport of Secretory immuno­
globulins has not yet been established.
Much of the work on Secretory IgA has been carried out 
by Brandtzaeg. The disadvantage of his work is that only 
small numbers of test subjects have been used and the 
secretion is reduced to a minute working volume. However, 
his results have, in the main, been confirmed by others and
the active transport of IgA into saliva appears generally 
accepted.
TAUBMAN and GEHCO (1971) have suggested that many of 
the properties of Secretory IgA antibody could be explained 
(and enhanced) by a preference of this antibody to bind 
most of its combining sites to a single molecule possessing 
multiple identical antigenic determinants as opposed to cross- 
linking two or more such molecules. G-SHCO et al. (1970) 
reported that antibodies to Strep, mutans, which is implicated 
in dental caries, prevent attachment of the organisms to 
the tooth in the absence of complement. Secretory IgA may 
be important in preventing this attachment since it may bind 
by several of its sites to the multiple determinants of a 
single bacterium.
There is difficulty in producing a good antiserum to 
S.P.-IgA because of its low antigenicity. Only about 40$ of 
S.P. in parotid gland becomes complexed and the non- 
spontaneous binding mechanism is unknown. Immunoglobulin 
may stimulate production of the S.P. whose function may be 
to stabilise the quaternary structure of the locally produced 
IgA dimers. Most measurements of salivary IgA have been 
carried out using serum IgA standards, therefore true 
correlation with salivary levels is difficult because 
diffusion takes place at a different rate due to the different 
molecular size and configuration. This must be taken into 
account in interpreting results using agar diffusion 
techniques.
Apart from IgA the majority of the immunoglobulins in
secretions are structurally identical to their counterparts 
in serum and have not yet shown to be complexed with a S.P, 
Their functions appear to be the same eg. IgG fixes 
complement; IgA does not. Elevated serum IgG levels are 
paralleled by a rise in salivary IgG levels (BRAHDTZAEG,
1971,a). Measurement of all secretion components is difficult; 
TOMASI (1968) has stated that no method provides absolute 
values for the total protein content of a secretion, 
especially since preliminary concentration is often necessary.
The specific biological functions of Secretory IgA are, 
as yet, largely unknown, but because of its relatively high 
concentration in saliva, it seems reasonable to assume that 
it plays an important role in relation to oral disease.
CONCENTRATION OP SALIVA AND ITS CONSTITUENTS
Numerous previous studies have utilised concentrated 
saliva, but there is little data on the success of the methods 
employed (ELLISON, I960; STOPPER et al., 1962; SIMONS et al., 
1964; LEHNER et al., 1967 and STROBER et al., 1970).
LEHNER (1969,b) pointed out that although the saliva he used 
had been concentrated twentyfold (20x) the constituent 
concentration might not be to the same level. SHKLAIR et al. 
(1969), used paraffin wax-stimulated saliva and lyophilised 
it to give a concentration of 50mg/ml (wt/vol) but protein 
concentration was not stated.
BRAHDTZAEG et al. (1970) pointed out that concentration 
of saliva results in a loss of protein but this fact does not 
generally seem to have been taken-into account in reporting 
salivary immunoglobulin levels. It is difficult to interpret
results that have been extrapolated back to concentration 
in the original volume when it has been assumed that 
reduction in volume i.e. Concentration1 results in an 
equivalent concentration of protein or immunoglobulin content. 
As the levels of IgA in both stimulated and unstimulated 
whole saliva have been reported to vary between 0.6 and 
49.9 mg/lOOml (tabulated by BRAHDTZAEG et al. 1970; see 
table 2a) with a mean of 12.39 mg/lOOml, it would seem that 
concentration is not linear, with different methods giving 
different results.
SALIVARY ALBUMIN
Salivary albumin has been reported to be passively 
transmitted from serum to salivary secretions (STROBER et al., 
1970; BRAHDTZAEG, 1971,e) and HALPERN: and KOSHLAND (1970) and 
STROBER et al. (1970) have reported some estimations of its 
concentration, assuming, as is generally done, that salivary 
albumin is immunologically identical to serum albumin.
This seems to have resulted largely from the report by 
ELLISON et al. (I960) on the identity of some serum and 
salivary proteins. On Ouchterlony diffusion plates, a 
continuous band was reported between serum albumin and mixed 
saliva when they were diffused against: anti-mixed saliva 
serum although the "number of reacting compounds in saliva 
was so great as to render resolution Of the bands difficult". 
Also, a drawing of the immunoelectrophoretie pattern formed 
by the use of mixed saliva versus anti-mixed saliva serum 
and anti-human normal serum serum,- shows a reaction of identity 
in the albumin region. (The same experiment is reported in
Chapter 4, Results*) Subsequent studies confirming this 
report have been made on salivary albumin, using anti-plasma 
albumin serum, not anti-salivary albumin serum (STOPPER et al. 
1962; LEACH et al. 1963; MASSON et al. 1965; BRANDTZAEG,
1965 and 1971,e; MANDEL and KHURANA, 1969; STROBER et al.
1970; ZENGO et al. 1971 and OPPENHEIM and HAY, 1972).
However, the unexplained results reported by SIMONS 
et al. (1964) that "curiously enough" their anti-saliva serum 
gave no precipitin arc when allowed to diffuse against 
different concentrations of human plasma albumin, appears to 
have received little subsequent notice. There are thus 
discrepancies in the literature as to whether serum and 
salivary albumin are identical in all respects.
GINGIVAL BLUID
There is a seepage of fluid from the gingival tissues
into the crevice in disease or when trauma of the tissues
occurs. The fluid has been analysed by paper electrophoresis
(MANN and STOPPER, 1964), agar diffusion (MANN and STOPPER,
1964; BRANDTZAEG, 1965) and immunoelectrophoresis (BRILL and
BRONNESHAM, I960; BRANDTZAEG, 1965) and the presence of a
number of immunoglobulins was detected, as was lysozyme
(BRANDTZAEG and MANN, 1964). Inflammation of the gingivae
results in an increased flow rate (MANN, 1963) and therefore
the availability of the proteins, but*it may also cause
igf*
dilution. The immunoglobulins present i.e.XYgA and IgM 
appear to be in the approximate ratio of 12:4:1 as found in 
serum (BRANDTZAEG, 1965).
Crevicular fluid may be collected on filter paper strips
or by capillary tube (SHILLITOE and LEHNER, 1972). These 
authors also found high levels of complement in crevicular 
fluid and SHILLITOE (1972) confirmed that the IgA present 
is of the serum, not the secretory type. It has not yet been 
determined whether immunoglobulins and complement (present 
in much lower levels in the crevicular fluid than in serum 
(SHILLITOE and LEHNER, 1972)) are present in normal 
crevicular fluid, as all samples have been collected from 
periodontally diseased subjects, although OPPENHEIM (1970) 
suggested their presence in the clinically normal gingival 
crevice. Unfortunately, methods of collection cause local 
injury, resulting in an inflammatory exudate which appears 
to be coming from healthy tissues.
ORAL BACTERIA AND PLAQUE FORMATION
The normal mouth has a varied flora. The extent of 
colonisation of the different oral tissues such as teeth, 
tongue, gingivae and gingival crevice by these microorganisms, 
depends on the existing conditions.
Plaque is the deposit that adheres to a clean tooth on 
abandoning oral hygiene measures (EGELBERG, 1970). Its 
development is affected by the chemical nature of the 
environment, the number and nature of the bacteria present, 
their biochemical activities and the factors affecting these 
activities. SCHROEDER and de BOSVER (1970) have stated that 
plaque consists of bacteria, an intercellular matrix of 
microbial origin and crystallites,.in mineralised plaques. 
Within a period of 7-14 days, it consists of 70# bacteria 
and 30# intercellular spaces, thus presenting a three­
dimensional picture.
Bacteria do not normally adhere to a clean surface, 
and accummulation is initiated by the deposition of a non­
mineralised cell-free pellicle less than thick on the 
tooth surface. It consists of glycoprotein derived from
u
saliva (LOE, 1969). Bacterial fopportunism* is probably 
important with streptococci forming a large part of the 
initial plaque due to their being the most common organism 
in the mouth. Plaque is consistently added to and modified, 
with the filamentous bacteria adhering perpendicular to the 
tooth surface. Many organisms that compose plaque are 
intermediate forms or are as yet unidentified. Some have a 
definite habitat on the tooth which exist and multiply in 
conjunction with other bacteria, forming a typical ecosystem 
at a given time, on the tooth surface. This continually 
changes, being influenced by the oral conditions during 
growth; see fig.2.
Saliva only appears to aid supragingival plaque formation, 
although conflicting reports have suggested its importance 
also in sub-gingival plaque accumulation, which is a slower 
process (EGELBERG, 1970).
PERIODONTAL DISEASE
Periodontal disease results from an accumulation of 
dental plaque on the dento-gingival junction. The plaque 
results from inadequate oral hygiene. Thus a healthy oral 
condition is altered to a potentially pathogenic one; the 
plaque and host metabolic reactions interacting to influence 
the process of the disease, (MACPHEE and COWLEY, 1969).
Inflammation of the periodontium is caused by physical 
irritation or by the damaging action of substances not 
normally present at this site* The degree of irritation 
influences the amount of inflammation and alteration in the 
tissue which indicates the severity of the disease.
PHYSICAL EMVIROMMENO; TIME PRESENCE OP HUTRIEHIS
Anatomy and position Saliva,
of tooth.
Anatomy of surround: 
tissues.
Priction from diet £ 
surrounding tissues-
Oral hygiene measures*
Structure of tooth 
surface.
Remnants of epithelial 
cells and leukocytes.
Diet
Gingival fluid
Pig*2* The oral conditions that affect plaque 
accumulation*
BACTERIAL PLAQUE IN RELATION TO PERIODONTAL DISEASE
The composition of bacterial plaque changes with time. 
RITZ (1967) studied the composition of plaque over periods 
of 1-9 days. He reported that during the early stages of 
plaque development, streptococci, neisseriae and nocardiae 
predominated, while at the end of the experimental period, 
the bulk of the organisms were streptococci, actinomyces, 
veillonella and corynebacteriae. These results illustrate 
that increasing thickness of plaque with progressively more 
anaerobic conditions, increases the anaerobic bacterial 
count. This correlates with the results of CROWLEY and ASH
(1969) who reported an increase in filamentous organisms 
corresponding to the rate of plaque formation. These Gram 
negative, anaerobic organisms are often, unfortunately, 
resistant to antibiotics (GOLDBERG, 1970).
Difficulty is encountered in growing the organisms from 
plaque because of the specialised growth factors they 
require which are possibly produced by the interaction of 
metabolites from the oral flora. The microbiota also varies 
in different sites in the mouth and the wrong sample may be 
obtained for experimental cultivation of certain organisms 
(SOCRANSKY, 1970); difficulties therefore amount in 
obtaining reliable counts. However, it appears that 
generally, filamentous forms, spirochaetes, fusobacteria, 
vibrios, streptococci, odontomyces sp.'and other anaerobic 
organisms predominate in older plaque with subsequent changes 
in products and the antigenic characteristics of plaque 
(GENCO et al., 1969).
Hie fact that plaque initiates gingivitis has been
established by the studies of hOE, TIIEILADE and JENSEN, 
(1965); THEILADS et al. (1966) and LOE and SCHlOTT. (1970). 
Their experiments have demonstrated that gingivitis was 
initiated within 9-21 days in a group of young adults with 
healthy gingivae who had abandoned all oral hygiene 
measures; the original plaque indices and gingivitis scores 
could be obtained with the re-institution of oral hygiene 
measures. Suppression of the plaque, both mechanically and 
chemically, maintained the plaque index at the low level 
necessary for a clinically healthy mouth* SAXE et al. (1967) 
and COUIIANT et al* (1968) have demonstrated in dogs what has 
been suggested by epidemeology in man, that plaque causes 
periodontal disease, as a progression from the initial 
gingivitis.
This concept has been corroborated by SHEIHAM (1970) in 
his studies on dental cleanliness and chronic periodontal 
disease. Those subjects with less accumulated plaque had 
less severe chronic periodontal disease than persons with 
poor dental cleanliness, as the accumulation of plaque on the 
teeth of-people with healthy gingivae gave gingivitis which 
could be resolved one week after cleaning. Persons who 
brushed frequently, but ineffectively, were found to have 
more destructive periodontal- disease than those with 
effective, but rarer, tooth-brushing. .These results indicate 
that increase, in severity results from increase in plaque 
and calculus and that duration of irritation is related to 
severity.
GENCO (1970) has proposed that any process that plays a 
part in periodontal disease must fulfil three criteria:
1) must represent a distinct immunopathologic process, 
the vehicle(s) for which are in the periodontal 
tissues or surrounding environment.
2) must induce the periodontal disease in experimental 
animals.
5) must he operative in naturally occurring periodontal 
disease.
This is a modification of Kochis Postulates and may not 
necessarily he applicable, especially part 2, as CARLSSON 
and XRASSE (1969) have shown that different organisms are 
cariogenic in different animals; similarly those bacteria 
or their products causing periodontal disease may not. 
manifest themselves in the same way in animals.
Thus, as stated by STAHL (1970), the condition of the 
host, i.e. nutritional status, age, generalised infection and 
hormones, affects and may accelerate the initiation of, or 
accentuate the present inflammatory periodontal disease.
These factors, plus the composition of the saliva which 
greatly influences microbial growth and reproduction 
(BURNETT, 1970) all influence the host!s resistance to 
periodontal disease.
Virulence of parasite x Dosage of 
parasite
i.e. Health or Disease =
Resistance of host.
(BURNETT, 1970)
PATHOLOGY OP THE PERIODONTIUM IN RELATION TO PERIODONTAL 
DISEASE
A human tooth protrudes through the gingiva and mucous
membrane which acts as a seal between the crown and the 
root (MACPHEE and COWLEY, 1969). The periodontal membrane 
of the gingivae consists of collagen tissue, blood vessels, 
lymphatics and nerves. The gingival tissue (mucous membrane) 
adjacent to the crown is detached 1-1*5mm, resulting in the 
gingival crevice (see fig.5)*
Mast cells are present along blood vessel walls,in the 
gingivae, and their action in gingivitis has been described 
by ZACHRISSON and SHULZ-HAUDT (1967), ZACHRISSON (1967;
1968a,b). They contain many biologically active substances 
which, when released into blood and surrounding tissues, act 
as smooth muscle stimulants and can increase membrane and 
vascular permeability, promoting odoema, stimulation of 
phagocytosis and interfere with blood clotting; i.e. they 
play an important role in inflammation. The human gingiva 
is comparatively rich in these cells and they have been found 
by ZACHRISSON (1967) to decrease in number as) gingivitis 
increases in severity. Chronically inflamed gingiva was 
found by ZACHRISSON (1968,a) to be rich in mature and 
immature' mast cells, the great majority of immature cells 
being found in the pocket area.
On inducing experimental gingivitis by abolition of oral 
hygiene-procedures, and examination of biopsies, ZACHRISSON 
(I968,b) observed scant numbers of plasma cells contrary to 
the chronic disease: condition, but a large infiltration of 
polymorphs was present in the sub-epithelial connective 
tissue* It must be noted however, that inflammatory cells 
(immunoblasts) are present; to a small extent- in clinically 
normal tissue (BRANDTZAEG and KRAUS, 1965; COWLEY:, 1966;
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PORTEOUS, (1969).
There is therefore a definite change in the pathology 
of the periodontium in mild to chronic periodontal disease, 
the type of change, depending on the disease incurred.
CARISS
Caries is caused by bacteria growing on the tooth 
surface in the presence of fermentable carbohydrate. The 
resulting fall in pH causes a demineralization and subsequent 
to this the minimal organic skeleton is removed, presumably 
by proteolytic enzymes, resulting in cavities in the teeth.
Rate of dental caries development depends on the circumstances 
that affect bacterial attack, such as salivary flow rate, 
the intrinsic properties and composition of saliva, diet and 
the structure and spacing of the teeth (JERKINS, 1970).
BACTERIAL PLAQUE IN RELATION TO CARIES
Plaque formation allows local colonization by streptococci 
and other acidogenic bacteria such as lactobacilli, which 
multiply in sufficient numbers to produce the substances that 
cause dental caries. GUGGENHEIM (1968) found Strep, mutans 
in deep carious lesions.
The significance of lactobacillus counts in saliva is 
that they indicate the number of stagnation areas in the 
mouth where thick plaque has formed and sufficiently acid 
conditions exist' to allow continued growth of lactobacilli 
(SIMS, 1970). If oral hygiene is improved, a healthy dietary 
followed and conservative treatment.carried out on a carious 
mouth, the number of areas of stagnation fall, as do the
lactobacillus counts. People with, otherwise comparable 
oral conditions, but statistically significant differences 
in mean lactobacillus counts, exhivit different- caries rates. 
No qualitative or quantitative difference in the types of 
streptococci in plaque from 1 caries-active1 (LMF 20) and 
’caries-inactive1 (LMF 5 and no clinically detectable lesions 
for two years previously) mouths was found by ROGERS (1969).
However, as KESTENBAUM (1968) stated, increased plaque 
does not. alone account for dental caries. Sufficient amounts 
of acid must be produced, therefore the type of organism in 
the plaque on the tooth surface, and the diet, are important.
II#mOLOGICAL ASPECTS OP ORAL DISEASE
The interrelationship of the factors involved in oral 
disease is illustrated in fig.4*
It is-known that on primary irritation of the. gingiva 
there is a large infiltration of polumorphonuclear leukocytes 
into the crevice area (TAICHMAN et al., 1965; - FREEMAN et al., 
1967; MERGENHAGEN, 1970 and TAICHMAN, 1970), which have a 
deleterious effect on host tissue. Subsequently, plasma 
cells appear, as the condition becomes chronic (BRAHDTZAEG 
and KRAUS, 1965; PLATT et al., 1970). Therefore, tissue as 
well as oral fluid, immune mechanisms are implicated in oral 
disease.
a) Gell-mediated: Cell-mediated immunity in oral disease
due to the infiltration by lymphocytes, has been reviewed 
by LEHNER (1972). He classified it into four groups.
I - in which lymphocyte transformation is stimulated by 
plaque bacterial antigens as well as by related organisms. The
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functions of lymphocyte are affected "by serum factors - 
antibodies or immune complexes0 This system may be involved 
in the pathogenesis of periodontal disease*
II - Immunological studies of aphthous ulceration suggest 
there may be auto-immune damage of oral mucosa to give 
ulceration* This could be accounted for by immunological 
tolerance and cytotoxic potential of sensitized lymphocytes* 
The concept of auto-immunity in relation to periodontal 
disease was first discussed by BRANDTZAEG- and KRAUS (1965) 
and Secretory IgA in gastric juice has been shown to be an 
auto-antibody to intrinsic factor (GOLDBERG- et al., 1968).
III - This involves deficiences in the factors involved in 
lymphocyte sensitization and antibody formation i.e. 
cytotoxicity, migration inhibition and sometimes impaired 
delayed hypersensitivity skin reaction to Candida albicans. 
Serum IgG and IgM levels fall but salivary IgA increases and 
lymphocyte transformation remains intact in chronic oral 
hyperplastic candidosis.
IV - In the various histological changes of leukoplakia and 
in carcinoma where there is a?, significant increase in 
lymphocytes with autologous leukoplakic tissue. Cell-mediated 
studies may establish if there is impaired tumour surveillance 
in the leukoplakia-carcinoma relationship.
BARAM and ARNOLD (1970) have stated that there' is no 
known feedback control mechanism to shut down a delayed 
hypersensitivity reaction after initiation*. It is continued 
till all the antigen is degraded or has diffused from the 
oral site.
"b) Humoral: Bacteria provide the antigenic stimulus v/hich
causes the irritation and this effect can he enhanced by- 
adjuvants. As was discovered by STEWART-TULL and WHITE (1964) 
and WHITE (1964) it is the cell wall mucopeptide that has 
adjuvant properties. HOLTON and SCHWAB (1966) extended this 
work and demonstrated that mucopeptide from cell walls of 
j9 -haemolytic streptococci (prevalent in the mouth) can 
also promote the production of antibody. Therefore, the 
initial composition of plaque may play an important role in 
the promotion of an antibody response to the subsequent 
bacterial antigens.
RIZZO (1970) has studied antigen penetration into 
gingiva, using endotoxin and found that it could not penetrate 
unaided; however, low levels gave a local reaction and once 
the tissues were sensitized, very low concentrations only 
were needed for a secondary response. Endotoxin has been 
implicated also by MERGENKAGSN and SNYDERMAN (1971) in oral 
disease, by inducing a humoral response.
NISENGARL and BEUTNER (1970,a) have indicated that 
serum contains antibody to the oral flora. These antibodies 
must only be of importance in relation to oral disease if 
they are demonstrated to be produced against distinct oral 
pathogens and not to related commensals or organisms causing 
a previous systemic infection. NIDENGARD, BEUTNER and HAZEN 
(1968) and NISENGARD and BEUTNER (1970,b) examined the. 
relationship of immediate hypersensitivity to periodontitis 
in animals and man using actinocin from actinomyces in 
plaque. Antibody levels and the percentage of allergic 
individuals increased with increased periodontal inflammation.
In 1971, BERG-IUND detected the presence of immuno­
globulins in gingiva from cells in the tissue, in addition 
to serum antibodies. PLATT et al. (1970) supported this 
and both authors believe that the immunoglobulins produced 
by these plasma cells have specificity for plaque bacteria. 
Immune complexes formed by immunoglobulins and bacterial 
antigens activate the complement system in the gingival 
pocket, where the fact that the fifth component is chemotactic 
(WARD and IE2WMAN, 1969), may be important; the role of 
complement as a mediator of inflammation has been outlined 
by 14ERCE3NHAGEN (1970).
It therefore seems that a number of immunological 
reactions take place in the mouth on the initiation of a 
disease process. Salivary antibodies may be produced against 
cariogenic bacteria as well as those implicated in the 
pathogenesis of periodontal disease. In addition, DICE and 
TROTT (1969,a) have concluded from their investigations on 
rats, that traumatic inflammation increases the effects of 
an immune reaction induced in the oral tissues. Inflammation 
may thus' condition those tissues so that an immune reaction, 
normally fulfilling its intended homeostatic function, is 
overactivated and becomes responsible for tissue injury.
PATIENT SURVEYS IN CONNECTION WITH ORAL DISEASE
A number of surveys have been carried out endeavouring 
to relate patient salivary or serum immunoglobulin levels to 
the degree of dental caries rather than periodontal disease.
An increasing number of investigations are being undertaken 
to investigate-'With.-the role of cell-mediated immune responses
in periodontal disease. In any survey on humans, there is 
the initial and inherent difficulty of finding subjects 
with one OR the other disease; the fact that both caries 
and periodontal disease are likely to be present complicates 
interpretation of the results.
a) Periodontal Disease: Prom a search of the literature it:
appears that salivary immunoglobulin levels have not been 
greatly studied in relation to periodontal disease. SAI10 
et al. (1969) have reported a serum protein analysis by 
irnmunoelecbrophoresis of patients with periodontal disease 
(classified into inflammatory, atrophic and mixed types).
He reported an increase in the gamma globulin fraction 
concentration and a decrease in albumin, from the control 
group values, which contradicted the earlier results of 
SHANNON and GIBSON (1964) and SHANNON et al. (1966) although 
they agreed with those of KARSHOU et al. (1952), MAI SblRJRA 
et al. (I960) and IANIKOTO (i960). NISENC-ARD and BSUTNER
(1970) showed that humoral antibody levels increased 
significantly as periodontal inflammation increase, though 
this might be expected, as with a breakdown of tissue, 
antigen may diffuse inwards more readily, to stimulate anti­
body production.
Serum immunoglobulin levels are of interest, but seem to 
have little relevence to periodontal disease, when they alone 
are measured, as they reflect the general state of health of 
the subject rather than the particular oral condition.
LEHNER (1969a,b) measured serum and salivary immunoglobulin 
levels in subjects presenting with oral disease (excluding 
dental caries) in relation to controls; diagnosis was mainly
on clinical grounds. It is in this type of study that use 
of equivalent indices would he useful for comparison of 
results. He found:
(a) in acute and recurrent ulcerative gingivitis, 
during days 1-4, serum IgA levels decreased and IgM 
increased with a subsequent rise in serum IgG and IgA 
in the first month of onset of acute ulcerative 
gingivitis. These findings suggested an immune defect 
in the pathogenesis of AUG which might account for 
the high rate of recurrence.
(b) in lichen planus, serum IgG fell and IgA rose 
slightly, IgM levels being normal; salivary IgA showed 
little variation. Serum IgG and IgA rose in recurrent 
ulceration.
LEHNER (1967), 17A M I  and LEHNER (1970, 1971a,b) and 
IVANYI et al. (1972) have studied lymphocyte transformation 
by plaque constituents from patients with periodontal disease. 
Their results indicated that lymphocytes from control 
subjects are not sensitized by those bacterial antigens 
which stimulate lymphocytes in subjects with gingivitis and 
periodontitis. These antigens are present in control . 
subjects with normal gingivae and they stimulate lymphocytes 
from patients with gingivitis or mild periodontitis. Loss 
of reactivity in severe periodontitis may be due to the loss 
of feedback inhibition of cell-mediated immune responses 
(AXELRAL and ROWLEY, 1968) or may be due to a serum inhibitory 
factor (IVANYI and LEHNER, 1971,b), thought to be an antibody 
or antigen/antibody complex.
However, the role of salivary immunoglobulins and
cellular responses in periodontal disease, has not yet "been 
fully elucidated.
b) Dental Paries: Apart from the studies implicating
salivary immunoglobulins as an important factor in caries 
development, AITCHISON and CARMICHAEL (1962) reported a 
relationship between the ABO blood mutations and dental 
caries. As the study was confined only to blood grouping 
they state "no attempt was made to list accurately any other 
observations”• There is therefore no indications as to how 
"caries-free" and "caries-rampant" were defined. A greater 
liability to caries in Blood Group A was reported.
GELLER and ROYELSTAD (1959) concluded that a factor 
related either to lysozyme or gamma globulin in parotid 
saliva inhibited lactobacilli and was related to the caries 
resistance of the individual. The DME (Decayed, Missing, 
Pilled, KLEIN et al. 1938) values chosen to indicate the 
degree of caries in. the active and resistant groups were not 
stated. Protein measurements were by UY absorption which is 
inaccurate as uric acid in saliva absorbs at these wavelengths*
Another substance reported to be present in saliva Is 
the salivary anti-bacterial factor (S.A. factor) of IWAMOTO 
and KATSUMURA (1966) which lyses bacteria but is not lysozyme. 
GREEN (1966a,b) also reported this. It was thought that the 
bacteriolysin in caries-immune saliva was an antibody, with 
genetically controlled production. This bacteriolysin has 
since been suggested to be IgA, but as salivary IgA does not 
fix complement and complement is necessary for bacteriolysis, 
it appears to be unlikely. It may lyse bacteria in the 
presence of complement and lysozyme as secretory IgA in human
colostrum is reported to do (ALINOLPI et al. 1965) but this 
might solely be the action of lysozyme. WILSON and GREEN 
(1963) have also reported on differences in salivary gland 
function between "caries-immune" and "caries-active" persons 
which suggested that genetic differences in these groups 
caused differences In immunoglobulin production. GELLES
(1972) failed to demonstrate this bacteriolysin, perhaps 
because it was thought to be bound by susceptible bacteria 
and not released till after cell lysis, its presence may be 
the result of, rather than the cause of low lactobacillus 
counts, as there are too few organisms in "caries-free" saliva 
to remove it completely.
In 1962, KRAUS and SIRISINHA reported no statistical 
difference in gamma globulin levels in parotid saliva 
depending on the carious state of the individual; their 
experimental criteria were not clearly defined. LSHNER et al. 
(1967) found significantly higher serum IgA titres, and 
lower IgA levels and relatively lower clearance rates in the 
saliva of"caries-prone" individuals compared to relatively 
"caries-resistant". Their experimental criteria were clearly 
defined (although "caries-free" LMP values were high) and 
the control and experimental groups were matched for age and 
sex. These results implicated the role of salivary IgA in 
the control of caries-immunity.
SHKLAIR et al. (1969) found no significant differences 
in IgA content of whole and parotid saliva of "caries-free" 
and "caries-active" subjects matched for age and sex. The 
former had no decay or a IMP of 0 and the latter had extensive 
decay with at least 7 open lesions. IgA in "caries-free" gave
increased leukocyte opsonisation of cariogenic streptococci 
* in vitro* and they concluded that this resulted from their 
being more non-specific, and the possibility of an immuno­
globulin causing caries-immunity was mentioned but not 
pursuid. This was an extension of the work of FRIEDMAN and 
TONZSTIGH (1968) who investigated the relationship of oral 
leukocytes to caries incidence, evaluated on the basis of 
leukocye enumeration, disintegration and glucose metabolism. 
The Leukocytes did not significantly enhance rate of glucose 
oxidation or whole saliva or salivary fractions.
In 1968, KENNEDY et al. reported on a controlled trial 
to examine serum antibody levels to cariogenic streptococci 
in humans. They differentiated between "caries-free" and 
"caries-active" by means of very rigid criteria and Included 
a questionnaire on the subjects* oral case history; there 
was no significant difference in this between the two groups. 
Only a slight difference in antibody between "caries-free" 
and "caries-rampant" was found and the protective effect of 
serum antibody only suggested by the data. The resistant 
subjects' must have been previously exposed to the organisms 
because of their existing high circulating antibody titre; 
oral and other streptococci also have cross-reacting antigens, 
which might result in these serum titres.
ZENGrO et al. (1970, 1971) studied saliva in human caries 
resistance; parotid and sub-mandibular saliva were used from 
radiographically and clinically confirmed "caries-resistant" 
adults (no cavities or fillings) and an equal number of 
susceptible individuals (15 or more EDO1). There was a 
statistically significant increase in IgA and albumin .levels
of sub-mandibular saliva of the resistant persons; other­
wise there was no difference and their results throw doubt 
on the sole use of parotid saliva in the study of immunity 
to dental caries in humans, increased ..levels of IgA in whole 
saliva perhaps coming from the sub-mandibular glands,
c) Summary: Due to differences in controls and experimental
methods, evaluation and comparison of results is difficult.
No account of the involvement of caries appears to have been 
made in the study of periodontal disease, and vice versa. 
Patient surveys are only of use if the limits of’ the study 
are clearly defined.
Not all aspects of study on human periodontal disease 
and dental caries can be initially carried out on human 
subjects, eg. immunization, therefore some use must be made 
of laboratory animals..
ANIMAL SALIVARY STUDIES
CEBRA and ROBBINS (1966) studied the rabbit secretory 
system with reference to colostral IgA. Further studies by 
G-ENCO and TAUBMAN (1969) have indicated that IgA, IgG and IgM 
are all present in rabbit saliva, with IgA predominating, 
although by DEAE analysis, IgG appeared first in the 
secretion, in relation to animal age.
VAEREMAN and HEREMANS (1969) have shown that IgA is the 
predominant immunoglobulin in canine milk, saliva, tears, 
hepatic bile and intestinal fluid, whilst BISTANY in his work 
with TOMASI (1970) has reported that rat IgA is the equivalent 
of Human IgA, though a secretory piece could not be identified. 
The method of saliva collection and concentration value were
not stated and the system of measurement may not have been 
sufficiently sensitive to detect secretory piece, therefore 
its existence cannot be discounted.
Hamster immunoglobulins have been studied by BIENENSTOCK 
and BLOCH (1970). They found IgM and IgA in serum, based on 
their physio-chemical characteristics. On studying the 
immunoglobulins of the Syrian golden hamster secretions, 
BIENENSTOCK (1970) could identify IgA in colostrum and saliva 
(it being the only detectable immunoglobulin in the saliva) 
and in urine. The salivary IgA had no detectable antibody 
activity, but this was probably due to its being a local 
secretion and the animals were only immunized parenterally. 
IgA antibody activity was detected in the serum.
BOWEN (1968; 1969a,b) has experimented with monkeys, 
but there has been little reported examination of monkey 
saliva. IgA was demonstrable by acrylamide gel electro­
phoresis (BOWEN and MANNING, 1970).
Measurements have mostly been made of serum antibody 
levels in the study of caries and periodontal disease with 
animals,-and little attention has been' paid to salivary 
antibody levels. There is of course, the difficulty of 
raising antiserum to the animal salivary immunoglobulins, 
once they are isolated in a pure form.
PERIODONTAL DISEASE IN ANIMALS
Both rats and dogs have been used in experimental 
induction of this disease. The organism necessary is not 
so well defined as with cariogenic streptococci but a 
filamentous species eg. Actinomyces sp. has been reported by
KEYES and JORDAN (1 9 6 4 ) to be necessary, along with other 
types of organisms from the subgingival plaque of affected 
animals, for induction in hamsters. A high carbohydrate 
diet is also necessary.
In 1966, ROVIN et al. initiated periodontal disease in 
rats by introducing irritation in the form of silk sutures 
between the teeth of both gnotobiotic and conventional rats. 
These plus the microorganisms caused the disease and 
illustrated the essential role the latter play, for only on 
their retention was the disease initiated. Polymorphs were 
found to be present; in the gingival tissue, but may be a 
normal component of these tissues. A similar experiment was 
conducted by RANNSY and ZANDER (1970) using sensitized 
squirrel monkeys;comparable results, in that both local 
irritation and microorganisms are necessary to produce 
periodontal inflammation, were obtained.
In experimental periodontal disease, inflammation must 
be present, otherwise it differs from that of man.. The 
mongolian gerbil appears to develop an accumulation of plaque 
leading to an inflammatory periodontal disease similar to 
the human type; the pathology of its periodontal tissues 
are also similar to that of the human, although the coronal 
anatomy.is different (MOSKOW et al. 1968). The disadvantage 
is that its immunoglobulins have not been studied like those 
of the other rodents so far experimented with.
DENTAL PARIES IN ANIMALS
It is agreed that to induce dental caries, a cariogenic 
flora must be present and a caries-inducing diet fed, whether
(the animals are conventional, have their indiginous flora 
depressed by tbe administration ox antibiotics, or are 
gnotobiotic (reviewed by KEYES, 1968). Certain animal 
strains are more susceptible than others, but the challenge 
organism must be successfully implanted for meaningful 
results.
GIBBONS et al. (1966) discovered that human cariogenic 
streptococci are similar to rodent strains, several of which 
synthesise large quantities of capsule-like carbohydrate 
from sucrose. Non-cariogenic strains form less, therefore 
capsule formation was implicated as being important in the 
aetiology of dental caries. EELSTRUP and GIBBONS (1970) have 
further studied a cariogenic strain isolated from human 
dental plaque that synthesises large amounts of gelatinous 
plaque deposits, in gnotobiotic rats fed a sucrose-containing 
diet. Alveolar bone loss occurred along with dental caries, 
the site of which depended on the type of diet fed.
BLACKKORE and GREEN (1970) have emphasised that gnoto­
biotic rats are of more use in the study of animal caries, 
because only a short experimental period is necessary to 
produce fissure caries when the rats are mono-contaminated 
with a cariogenic strain; their use also leads to a 
reduction in experimental variation.
BOWEN (1969,a) found that monkeys when implanted with 
cariogenic streptococci, had the highest population of these 
organisms in the animals with the most lesions. Simiiarlj?", 
those with fewest lesions had the lower number of organisms. 
In between, correlation of caries and cariogenic streptococci 
was not found. However, he confirmed earlier demonstrations
- a .
by DCUEi; (1955a,b), COHEN and BONER (1966) and BOY/EH (1968) 
that monheys are useful experimental models; caries could 
be induced rapidly without the need for relative gnotobiosis 
and their results strengthened the hypothesis that dental 
caries nay be a transmissible disease in man.
hamster caries has been discussed by KRA53E and CARL S3 GIT 
(1970); their results on the caries-inducing effects of 
numerous strains of streptococci illustrated the limitations 
of the animal caries models when studying the role of various 
microorganisms in human caries and emphasised that the terms 
"cariogenic” and "non-cariogenic" organisms should only be 
used with reference to specific animal experiments to avoid 
confusion.
BACTERIAL IMPLANTATION Iff ANIMALS
A cariogenic diet is a prerequisite for studies on- 
bacterial implantation in dental caries (KEYES, 1964-;
ERASSE, 1965; SHARAWY and S OCR AN SAY, 1967; KEYES, 1968;
3AHN et al. 1969; BONSN, 1969a,b; BLACKMORE and GREEN, 1970; 
GUGGENHEIM et al. 1970; KELSTRUP and GIBBONS, 1970; ICRA33E 
and CARLSSON,1970; TAKZSR et al. 1970; GAPPAR et al. 1970,
1971, and HAMKCND, 1971) and periodontal disease (KEYES and 
JORDAN, 1964; JORDAN et al. 1963; GIBBONS et al. 1966;
SEARANY and SOCRAI'SKY, 1967; SOCRANSKY et al. 1970, and 
ICELSTRu? and GIBBONS, 1970).
IZRA3SE (1965) studied the diet necessary for implantation 
of cariogenic streptococci in hamsters, concluding that a 
standard powdered caries test diet was necessary for 
implantation and recovery of the organisms. Different
supplements enhance the growth of different organisms eg.
BOV/EE (1969,b) favoured a high sucrose diet for the 
streptococci he implanted in monkeys, whereas ICRASSE (1965) 
favoured either lactose or sucrose for the hamster diet.
It is also an aid to recovery of the implanted bacteria, 
when a particular characteristic for identification is 
employed such as the resistance to Erythromycin exhibited by 
Strep, mutans OMZ 17 6E, used by GUGGENHEIM et al. (1970) in 
their rat studies.
ANIMAL IIHRJNIZATION
NASH et al. (1969) immunised germfree C^H mice (3-4 months 
old) with Perritin, by different routes. Orally stimulated 
mice produced IgA antibodies mainly, by local stimulation 
of the gut, whereas intra-peritoneal and sub-cutaneous 
injections resulted In IgG apart from a little IgM. Repeated 
injections increased immunoglobulin but not necessarily 
specific antibody levels i.e. more non-specific antibody is 
produced on repeated immunization. PAHSY and COOPER (1970a,b) 
attempted oral immunization of Swiss-Albino mice in 
experimental Salmonellosis. Intra-peritonial immunization 
with temperature-sensitive mutants of Sal, enteritidis 
(ISP-19) gave protection against oral challenge of 
Sal, enteritidis; oral immunization also gave protection. 
Therefore local immunization produced secretory antibody at 
sites, other than injection sites, in sufficient quantity to 
protect against lethal doses of related organisms. This may 
well work for other antigens.
LOLEZEL and BIENENSTGCIC (1971) examined the cellular 
and serum antibody response to oral and parenteral 
immunization of hamsters with Bovine Serum Albumin (B.S.A.). 
Their results suggested that the route of immunization and 
antigen distribution" influences the commitment to IgA anti­
body synthesis; also extraintestinal IgA synthesis may 
result from intestinal tissue dissemination.
On immunizing rabbits with Strep, sanguis, CARLSSON and 
KRASSE (1968) found that sucrose intake lowered the tendency 
for plaque formation due to leakage of serum antibodies into 
the mouth via the gingival pocket fluid. BEGLUND et al.
(1969) measured the Immune response to bacterial somatic 
antigen administered to New Zealand Y/hite rabbits via the 
oral mucosa. Low doses of antigen given intra-mucosally 
produced antibody-forming cells in local lymph nodes. The 
cellular infiltrate corresponded with areas of antibody 
activity; control sections were negative. Larger doses 
also gave a systemic response; intra-venous injections gave 
only a systemic response. They concluded that relatively 
large amounts of antigen', locally injected, gave a greater- 
cellular immune response than intra-venous injection; 
smaller doses were more effective in producing this response 
if administered intra-venously.
GENCO and TAUBKAN (1969) executed a number of experiments 
in relation to stimulation of local secretory antibody by 
local immunization. They pointed out that the antigen used 
is important as anti-ferritin antibody was not detectable in 
rabbit colostrum after local immunization (CEBRA and ROBBINS, 
1966). They elecited a local secretory IgA response to
DNP-bovine gamma globulin injected in the mammary gland;
injection in footpads did not produce secretory IgA in
colostrum. They carried out further experiments in 1971, by
immunizing the mammary glands of rabbits with Group A
streptococcal carbohydrate, which resulted in specific IgA
antibody in the colostrum.
BAIL and TROTT (1971) measured humoral antibody after
in rabbits.
intea-gingival injections of B.S.A. and B. coli endotoxin^.
Only serum antibody levels were measured and there were no 
controls. As expected, the initial IgM response was followed 
by IgG (time varied with antigen), and repeated injections 
gave a plateau of immunoglobulin levels (cf. NASH et al. 1969) 
Prom the evidence cited above, it may be concluded that 
local antibody production can be stimulated by the injection 
of a suitable antigen (of correct dose) in a suitable site, 
though time and type of responses vary with the antigen, 
site, and species of animal.
ANIMAL IMI-IUNIZ AT I ON IN RELATION TO ORAL DISEASE
There appears to be no report of attempted immunization 
against periodontal disease, in the literature. There have 
been a number of attempts at immunization against carles in 
laboratory animals.
SWEENEY et al. (1966) gave fortnightly sub-cutaneous 
injections of gamma globulin to caries-susceptible rats 
(Harvard strain). The gamma globulin was from caries- 
resistant Harvard rats, but it was ineffective in inducing 
caries resistance, and this indicated that it is a property 
that may not. be conferred from one rat to another by passive
46.
imrnuni2at ion,
V/AGNER (1967) reported that gnotohiotic rats which had 
been fed a cariogenic diet and immunized against Strep, 
fgeeolis showed decreased caries activity when compared with 
non-immunized controls. It was suggested that this might 
he due to the protective effect of antibodies secreted into 
the saliva and in his thesis conclusion (1966) he stated 
that control of dental caries may be possible through 
imrnuni zat i on,
GUGGENHEIM et al. (1969) used Osborne-Mendel rats* some 
of which had the indiginous flora initially depressed to 
find the effect of immunization against a cariogenic Strep, 
mutans OMZ 176 (the ones with the depressed flora were 
infected with the Erythromycin resistant strain OMZ 176E) or 
glucosyltransferases, on plaque formation and dental caries. 
The vaccinated rats (injected in the tail vein) gave 
precipitating antibodies against the streptococci, but 
antibodies could not be detected against the enzymes. Six 
sera, chosen at random, had complement-fixing antibodies.
The animals kept in relative gnotobiosis had less plaque and 
lower caries incidence, but it could be concluded that intra­
venous immunization does not alter the caries activity of 
rats with indigenous cariogenic flora; there was smooth 
surface caries in all. Salivary antibodies were not studied.
NRI weanling rats were immunized intra-peritoneally by 
3AHN (1969) with an extract of the culture fluid of the 
cariogenic streptococcus strain EA-l, which contained 
dextransucrase activity. ' The rats were prepared for oral 
microbial challenge with antibiotics. The immunized rats 
had significantly less caries than the non-immunized, 112 days
47.
ao.T;er challenge• fAiiZAR et al. (1970) showed an inability 
to immunologically protect Osborne—Mendel rats against 
smooth-surface carles on immunization sub-cutaneously with 
Strep. nutans (Streptomycin-resistant) even though high 
humoral antibody titres were detected* 1AEAH0 and SAIiO 
(1370) pointed out that ix experimental nice were already 
infected there would be an altered response to the immunizing
—  o
agent if different from the infecting agent*
G-AHAR et al. (1970) have worked with weanling golden 
hamsters (HIIS. strain). All hamsters in the experiment were 
partially gnotobiotic and they and the controls were fed a 
Mitchell’s cariogenic diet. Ihose animals immunised with 
formalin-killed streptococcus plus Breunds Complete Adjuvant 
and inoculated with the same organism had a 6Sy reduction in 
caries compared to the non-immunized inoculated group which 
had a 55'^ reduction in caries compared to the non-inoculated, 
conventional hamsters, ihe inoculation site was not stated* 
In 1971, experiments on intra-peritoneal immunization of 
•weanling golden hamsters (hlH strain) with dextransucrase 
and inoculation with Strep, mutans did not result in a 
reduction in caries compared to the non-immunized group.
Both groups were fed the cariogenic diet and had their flora 
depressed before inoculation. Serum and salivary antibodies 
were produced that inhibited the *in vitro* production of 
the polysaccharide by the enzyme, tnerefore anuibodies may 
affect the catalytic site of the enzyme*
301/Eh (1969,b) used monkeys for the induction of 
rampant caries because the carious lesions produced in these 
animals is more similar to that of humans than those produced
in other experimental animals. He (1969,a) infected young 
monkeys with Strep0 ingbritt; they were partially gnoto- 
biotic due to Erythromycin in their drinking water for 12 
months. Other, older monkeys were infected with a dextran- 
producing streptococcus and both groups were fed a diet 
containing 15$ protein and 18$ sucrose. Caries took longer 
to develop in the older monkeys (both fissure and smooth 
surface caries developed) but caries could still be produced 
rapidly without resorting to partial gnotobiosis. He also 
found that after 18 months, those monkeys that had been 
vaccinated prior to infection with a known streptococcus, 
showed 80$ less carious activity than the unprotected monkeys. 
Though only 6 monkeys were used and no salivary antibody 
titres were recorded, it may be concluded that the reduction 
in caries might be due to immunization in this case.
It appears, therefore, that in carefully controlled 
conditions, the local oral immune response may be stimulated 
into antibody production. The role of the antibodies and 
tissue responses is still speculative as is the true success 
of the immunization procedures employed.
CONCLUSION FROM LITERATURE REVIEW AUK SUMMARY 
OP AIMS OP PRESENT THESIS___________________ __
The long term aim of the present research was to 
investigate the feasibility and effectiveness of immunization 
as a preventive measure against oral disease.
Keeping in mind the information gleaned from the survey 
of the literature, a survey of the immunoglobulin levels in
patients suffering from periodontal disease and an investigation 
into the production of local immunity in the mouth using 
small laboratory animals were undertaken. Preliminary work 
was carried out in order that the results of the main 
investigations might be more meaningful, and as a result, 
the report of the experimental v/ork may be classified into 
the five sections stated below*
a) The effects of different methods of concentration on 
immunoglobulin and total protein levels in stimulated, 
mixed, human saliva.
b) Immunological studies on human salivary albumin.
c) An investigation into the salivary and serum IgA levels 
of patients suffering from different types of 
periodontal disease.
d) The effect of implantation of cariogenic streptococci 
in the rabbit mouth.
e) Studies on the local'immunization of rabbits.
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CHAPTER 3.
THE EEBECTS OB DIEEERENT METHODS OP 
C01TCENTRA!ION OH IMMUNOGLOBULIN AMD .
TOTAL PROTEIN LEVELS IN STIMULATED,
_______ MIXED, HUMAN S A L I V A . ________
INTRODUCTION
The comparison of the results of immunoglobulin 
estimations from different laboratories is now generally 
realized to be unsatisfactory (ROBBINS, 1963)c Difficulty 
occurs in salivary immunoglobulin measurements because of 
the small quantities of these substances in the secretion0 
Therefore equivalent methods of collection, concentration and 
estimation compared to a common standard must be used for a 
satisfactory comparison.
As little is known concerning the induction of anti­
bodies in saliva it was felt that data on concentration of 
saliva was an essential prerequisite to the experimental 
programmeo Collection of saliva from experimental animals 
involved stimulation by intra-peritoneal injection of 
pilocarpine hydrochloride with the concomitant disadvantage 
of dilution (MANDEL and XKURANA, 1969); this was necessary 
to collect sufficient amounts for analysis. To obtain basic 
data therefore, stimulated, mixed, human saliva was selected 
for the experiment as it can readily be obtained in 
sufficient quantities to allow adequate experimental design* 
Several problems arise in attempting to obtain a 
homogeneous sample, due to differences in the salivary 
glands of the people from whom the saliva was collected, the 
time lag between eating and saliva collection, the individual 
degree of stimulation necessary to produce a satisfactory
flow rate to collect a sufficient sample within a reasonable 
time and the oral health of the individual. The latter two 
factors are important as with intense stimulation, the flow 
rate increases markedly but the protein and immunoglobulin 
content decrease (MANDEL and KHURANA, -1969), and if the 
gingival tissues are inflamed, immunoglobulins from the 
crevicular fluid leak into the saliva (BRANDTZAEG-, 1966). 
Intense stimulation over a period of time longer than 30 
minutes, ttiresl the glands (JENKINS, 1970). Pooling samples 
should, however, have evened out these differences.
MATERIALS AND METHODS 
Collection of human saliva-
Mixed human saliva was stimulated with Citric Acid 
and the secretion collected over ice. It was stored at 4°C 
until sufficient had been collected and was then pooled and 
centrifuged at 15,000 rpm (27,000g) for 40 minutes at 4°C to 
remove microorganisms and epithelial cells. The supernatant 
fraction to be used was stored at 4°C and that not for 
immediate use was frozen at -20°C.
Dialysis of saliva-
Dialysis tubing (3cm in diameter) was washed overnight 
in distilled water. The saliva supernatant was then dialysed 
against several changes of distilled water at 4 C for 24 
hours•
Concentration of saliva-
A minimum number of 12 aliquots of saliva were concen—
traced oy each, method specified under the different headings.
a ) Lyophilisation: 2x100ml, 1x50ml and 1x10ml amounts of the 
dialysed saliva supernatant were placed in lyophiliser 
flasks and shelled in a mixture of dry ice and acetone. The 
saliva was "then evaporated to dryness under vacuum and 
reconstituted with distilled water to aliquots of 1ml, apart 
from the contents of one flask which were reconstituted to 
the original volume of 100ml.
b) Ultrafiltration: 2x100ml, 1x50ml and 1x10ml amounts of 
saliva supernatant were placed in an Amicon cell (Scientific 
Systems division, Amicon Corporation, 21 Hartwell Avenue, 
Lexington, Massachusetts 02173, USA) with a UM-20membrane 
and concentrated to 1ml under a positive Nitrogen pressure
of 40-50psi at 4°C; as much saliva as possible was recovered 
from the membrane by washing with minimal amounts of distille 
water. The membrane was thoroughly washed with distilled 
water between the concentration of different saliva samples. , 
One 100ml amount reduced to 1ml, was reconstituted to the 
original volume of 100ml.
c) Polyacry1amide gel: The appropriate amounts of Lyophogel 
(Celman Instrument Co:.., packed by Hawksley and Sons, 12 Peter 
Road, Lancing, Sussex), calculated by .determining the volume 
of fluid to be removed and dividing by five to give the 
weight needed, were placed in 1x100ml, 1x50ml and 1x10ml 
aliquots of saliva supernatant, and after 16 hours at 4°C 
the resulting 1ml aliquot in each case, was transferred to a
sterile serum bottle.
Controls of Kabi Gamma globulin (Kabi Pharmaceuticals 
Ltd., Bilton House, Uxbridge Road, Ealing, London, U.5.) and
Chymotrysinogen (Miles-Seravac (Pty.) Ltd., Moneyrow Green, 
Holy-port, Maidenhead, Berks., England) were also 
concentrated as described in a) and b).
Reconstitution of Lyophilised saliva in Lisodium 
Ethylenediamine tetra-acetate, (EDTA) (DAWES, 1965)-
a) O.lg ELLA was added per 100ml of saliva before dialysis 
and lyophilisation.
b) 01.g ELBA was added per 100ml of saliva after dialysis 
and before lyophilisation.
c) The saliva was reconstituted in 0.1M Veronal Buffer, 
pH 8.6, containing 3g or lOg of ELTA/litre.
Quantitation of protein-
This was carried out by the Lowry method (LOWRY et al. 
1951) using Chymotrysinogen in the appropriate range of 
dilutions, as standard. The average of a minimum of two 
values for each estimation was made; those results outwith 
4/£ of the average, were repeated.
Quantitation of immunoglobulin-
The technique of Radial Immunodiffusion (SRID) of MANCINI, 
CARBOHARA and HERMANS (1965) was used to measure the IgA 
and IgG in the saliva and also to measure the IgG in the 
standard Kabi Gamma globulin solution; the diameter of the 
precipitin ring being related to the antigen concentration 
used.
2g Oxoid *Ionagar’ no.2 (Oxiod Ltd., Southwark Bridge 
Road, London, S.E.l) plus 0.1 °/o Thiomersal was dissolved in 
Michaelis diethyl barbiturate buffer, prepared by adding
14.8ml of 0.1N HCI to 100ml of 0.1M Barbitone Sodium, with 
the pH adjusted to 8.6 with 0.1H NaOH or 0 #1N HCI. 0.15ml 
of the appropriate Hyland antiserum (Baxter laboratories Ltd., 
Thetford, Norfolk, England) (tested to check the appropriate 
heavy chain specificity by Immunoelectrophoresis against 
normal human serum) i.e. goat anti-human serum IgA (og chain) 
or goat anti-human serum IgG ( ^ chain) which had been 
brought to 48°C in a water bath was added to 3ml of molten 
agar (cooled to 50°C) and the mixture flooded over a clean 
glass slide. Both 1mm and 2mm wells were punched in the- 
solidified agar. Sensitivity of the 1mm wells was found to 
be poor although they required less antigen, due to difficulty 
in filling the wells and reading the results accurately. A 
wider range of correlating results over more than one 
estimation was obtained from 2mm wells. A mean of at least 
two readings was taken for each sample using a calibrated eye 
piece, after enhancing the rings by the addition of Ifo Tannic 
acid to the plates. Those values that were outwith a yp 
limit of the mean were repeated. Hyland Immunoglobulin 
standards were used to obtain a standard curve and these were 
later calibrated against the MRC Immunoglobulin standards 
(World Health Organization International Laboratory for 
Biological Standards, Division of Biological Standards,
National Institute for Medical Research, Mill Hill, London, 
N.17.7). The standard curves were obtained by plotting 
diameter of the precipitin ring in mm against concentration 
of the reference immunoglobulin in mg/lOOml on semi-logarithmic 
graph paper. The lowest value of standard immunoglobulin 
that could be measured witn a deviation in result no greater 
than Jp was 0.5mg/l00ml. Lower concentrations increased the
inaccuracy of the measurements.
Immunoelectrophoresis-
This was carried out, using Shandon equipment, by the 
method described in the manufacturers manuals (Shandon 
Scientific Company Ltd., 65 Pound Lane, Willesden, London, 
U.W.IO). The electrophoresis gel consisted of 1 °/o Ionagar 
in 0.025M Barbitone/Acetate Buffer, pH 8.6, incorporating 1/ 
Sodium Azide as a preservative. The wells punched in the 
agar with the standard punch were filled with the sample and 
a few grains of Bromophenol blue (G-.l. G-urr Ltd., Coronation 
Road, Cresswick Industrial Estate, High Wycombe, Bucks., 
England) were added to one well to monitor the speed of 
electrophoresis. After electrophoresis (using 0.1M Barbitone/ 
Acetate Buffer, pH 8.6 plus 5ml 5/ Thymol in Isopropanol/ 
litre "as preservative in the tank) at lOV/cm for 1.0-1.5 hours, 
the troughs were filled with antiserum (Hyland) and diffusion 
allowed to take place in a moist atmosphere, at room 
temperature, for 48 hours. Cooled, molten electrophoresis 
gel was poured over the plate to prevent distortion of the 
troughs before the slides were dried at 37°0 and stained by 
triple protein stain (CROWLE, 1961) and mounted in Harlicot 
Synthetic Resin (Kodak Ltd., Kirkby, Liverpool, England).
RESULTS
Estimation of immunoglobulin levels and total protein 
in mixed saliva:_____________     , ------------
Centrifugation caused a drop in protein levels as 
determined by the Lowry technique, from 70 io 67 mg/lOOml,
probably due to the fact that salivary immunoglobulins 
adsorb to the surface of oral bacteria (BRANDTZAEG et al. 
1968). There was a further drop to 52 mg/lOOml on dialysis, 
probably due to a further adsorption to the dialysis membrane.
On measuring total protein concentration, it was noted 
(fig*5) that ultrafiltration and lyophilisation give similar 
increases in concentration up to 50x reduction in volume, 
the former being slightly more effective, until lOOx decrease. 
At this final reduction in volume, lyophilisation appeared 
to be more effective, perhaps due to fine particles of 
undissolved protein being included in the assay, lyophogel 
was ineffective in concentrating the proteins in the salivary 
supernatant but did effectively reduce the volume.
Measurement of IgA in saliva by quantitative immuno­
diffusion gave the results shown in fig.6. Lyophogel did not 
concentrate this immunoglobulin. Ultrafiltration concentrated 
it to a greater extent than lyophilisation at lOOx reduction 
in volume.
Gamma ( ^ ) globulin estimations-
In conjunction with saliva concentration, Y globulin 
solutions of known concentration (5 mg/lOOml physiological 
saline) were reduced in volume by the same methods. This was^ 
carried out to determine whether a protein solution, 
chemically less complex than saliva, would concentrate in a 
linear manner and to give an indication whether other 
constituents of saliva might affect the concentration of
immunoglobulins•
As can be seen in fig.7 ultrafiltration was most
effective, giving greater than 50x increase at the lOOx 
decrease in volume. Lyophogel was not effective.
Pig.8 shows a similar result with the quantitative 
immunodiffusion.
Determination of degree of denaturation-
Rone of the methods concentrated as effectively as had 
been anticipated and to determine whether lyophilisation and 
ultrafiltration actually denatured the proteins in saliva, 
solutions of chymotrypsinogen and Y globulin were reduced 
in volume lOOx and reconstituted to their original volumes, 
as was the saliva supernatant. On full reconstitution after 
lyophilisation, no protein was lost, as shown in fig.9, but 
on reconstitution to a smaller volume and extrapolation back 
to the original volume, the protein values fell. Similar 
results were obtained by ultrafiltration. These results 
v/ere also paralleled using SRID for measuring IgA and IgG in 
the concentrated and reconstituted saliva supernatant and 
the solution of ^ globulin.
The' addition of EDTA to the supernatant either before 
or after dialysis, before lyophilisation or ultrafiltration 
or reconstitution of the freeze-dried material in Veronal 
buffer containing EDTA, did not result in increased concen­
tration. Addition of EDTA after dialysis but before concen­
tration gave the best reconstitution value, being the same 
as that obtained without addition of EDTA whereas the other 
results were lower.
Pinal analyses-
Pinal concentration values for the samples analysed 
and quantitated are shown in Tables 3 and 4.
Pigs. 10a and b demonstrate the normal electrophoretic 
mobility of serum proteins including IgA and IgG. After 
saliva concentration, IgG was checked by Immunoelectro­
phoresis to determine whether it had altered properties 
(fig.11). Apart from a slight increase in intensity of the 
precipitin band, neither concentration by lyophilisation nor 
ultrafiltration appeared to alter the electrophoretic mobility 
of immunoglobulins.
Pigs. 12a, b and c illustrate the proteins detected in 
normal, concentrated human saliva (concentrated by either 
lyophilisation or ultrafiltration) by the immunodiffusion 
technique.
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Pig.5. Concentration of human, mixed saliva supernatant 
(sup) by lyophilisation, Ultrafiltration and 
. Polyacrylamide gel; measurement of total protein 
by Lowry®
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Pig*6* Concentration of human, mixed saliva supernatant
(sup) by lyophilisation, Ultrafiltration and 
Polyacrylamide gel; measurement of IgA by SRID.
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Pig.7. Concentration of Gamma globulin ( # G) by
lyophilisation, Ultrafiltration and Polyacrylamide 
gel; measurement of % G by Lowry.
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F ig .S . Concentration of Gamma g lobulin  ( 16 G) by
L y o p h ilis a tio n , U l t r a f i l t r a t io n  and Polyacrylamide 
g e l; measurement of IgG by SRI3)#
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F ig .9 . P ro te in  loss on ly o p h ilis a tio n . Measurement
o f t o ta l  p ro te in  in  the three samples by lowry 
a f te r  ly o p h ilis a tio n  and p a r t ia l  re co n stitu tio n  
(concentration) and f u l l  reco n stitu tion ^ to  the 
o r ig in a l volume.
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TABLE 3* TOTAL PROTEIN CONCENTRATION-- LOWRY ESTIMATION
Reduction in volume 
Chymotrypsinogen 
Gamma globulin 
Saliva
LYOPHILISATION ULTRAFILTRATION
lOx 50x lOOx lOx 50x lOOx
6x 20x 57x 6x 14x 26x
6x 20x 38x lOx 26x 52x
5.5x 14«3x 3 6 x 7o5x I6x 30x
CONCENTRATION VALUES
TABLE 4. IMMUNOGLOBULIN CONCENTRATION - SRIL
Reduction in volume 
IgG in K abi.Gamma globulin 
Salivary IgA 
Salivary IgG
LYOPHILISATION ULTRAEILTRATION
lOx 50x lOOx lOx 50x lOOx
2.5x 9x 19x 7*5x 27x 50x
2.5x 3«5x 6x 3x 8x 16x
3x 7x 17x 5x 15x 30x
CONCENTRATION VALUES
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Pig.10a.
Normal immunoelectrophoretic pattern of human serum.
All the wells contain normal human serum.
1. Goat anti-human serum; 2. Rabbit anti-human serum
3. Goat anti-IgA; 4. Goat anti-IgG
5. Goat anti-IgM; 6. Goat anti- oC ^
macroglobulin / 2)
I W H p
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Pig #101d .
Normal immunoelectrophoretic pattern of human serum (cont.)
7* Goat anti-plasma 8. Goat anti-complement
albumin;
9. Goat anti-caerulo- 10. Goat anti-transferrin
plasmin;
Antiserum 2 is Wellcome; 1 and 3-10 are Hyland (x2)
+
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Pig.11.
Immunoelectrophoresis of Gamma globulin (#G). x5.
IgG (upper well) = lOOx decrease in volume of 2f G 
by Ultrafiltration.
IgG (middle well) = 5mg/lOOml of X G.
IgG (lower well) = lOOx decrease in volume of #G 
by lyophilisation.
a-G = 1:10 dilution of Goat anti-human serum IgG 
( if chain) (Hyland) •
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Pig.12a.
Immunodiffusion patterns of human saliva, x4.
1. Horse anti-human serum; 2, G-oat anti-human serum
5, G-oat anti-IgA; 4. Goat anti-IgM
5. Goat anti-IgG; 6. Rabbit anti-IgG
j.
7. Human, mixed saliva, reduced in volume lOx by 
lyophilisation,
(All antiserum is Hyland, 1:10 dilution).
6 1
4 3
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Pig.12b.
Immunodiffusion patterns of human saliva. x4.
1. Goat anti-c*' 2. Goat anti-transferrin
macroglobulin;
3. Goat anti-caerulo- 4. Goat anti-rabbit serum
plasmin;
5. Winthrop anti-human 6. Nordic horse anti-IgA
serum;
7. Human, mixed saliva, reduced in volume lOx by 
lyophilisation.
(Antiserum 1-4 is Hyland, 1:10 dilution.)
6 1
5 2
4 3
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Pig.12c.
Immunodiffusion patterns of human saliva. x4*
I® Goat anti-IgA (1:10); 2. Goat anti-IgA (1:3
3. Goat anti-IgM (1:10); 4. Goat anti-IgM (1:3
5. Goat anti-IgG (1:10); 6. Goat anti-IgG (1:3
7. Human, mixed saliva, reduced in volume lOx by
ultrafiltration.
))
)) Hyland.
DISCUSSION
The purpose of th is  series of experiments was to  
evaluate several possible methods of sa liva  concentration  
and, i f  possib le , to develop a reproducible, e ffe c tiv e  
method. An a d d itio n a l objective was to ascerta in  i f  sa liv a ry  
p ro te in  and immunoglobulin concentrated in  a l in e a r  manner 
fo llo w in g  volume reduction. A number of previous workers 
have apparently assumed a p a ra lle l increase in  concentration  
of the p ro te in  w ith  volume reduction (TOMASI and BIENENSTOCK, 
1968; MANDEL and KHURANA, 1969; BRANDTZAEG et a l .  1970 and 
ZENGO et a l .  1970) although LEHNER (1969,b) noted th a t  
concentration might not be l in e a r .
The a c tu a l methods of concentration gave d if fe re n t  
re s u lts  and h ig h lig h ted  d iffe re n t problems w ith  respect to  
each method used.
W ith ly o p h ilis a t io n , d i f f ic u l ty  was encountered in  
removing a l l  the dried  m ateria l from the fla s k  w a ll, and in  
reduction  to  a small volume, not a l l  the dried  m ateria l could 
be re -d is s o lv e d , even a f te r  d ia lysing  before drying to  remove 
s a lts , probably due to  a change in  the re la t iv e  s o lu b ili ty  
of the p ro te in s . With u l t r a f i l t r a t io n ,  the g lyco-proteins  
seemed to  adhere to the membrane although there was no actua l 
s o lid  m a te r ia l, as w ith  the freeze -d ry ing , therefore  a large  
proportion  of the to ta l  p ro te in  was presumably lo s t due to  
i t s  being l e f t  behind on removal of the concentrate.
Repeated washing w ith  d is t i l le d  water and re co n s titu tio n  in  
both cases increased p ro te in  uptake, but the degree of 
concentration (by volume) was in e v ita b ly  reduced. Repeated 
concentration o f the same sample was very time-consuming,
e s p e c ia lly  i f  a la rg e  number of samples were to be 
concentrated.
lyophogel was discarded as a usefu l method o f concen­
t r a t io n ,  because although the volume was qu ick ly  and 
accurate ly  reduced, the p ro te in  and immunoglobulin constituents  
of the s a liv a  appeared to  be adsorbed g iv ing  no e ffe c t iv e  
increase in  concentration .
Although an increase in  p ro te in  concentration equivalent 
to  the volume reduction was not obtained, the constituents  
did not appear to  be denatured, as f u l l  re c o n s titu tio n  gave 
t o ta l  p ro te in  values almost id e n t ic a l to  the o r ig in a l le v e ls .
I t  was th ere fo re  concluded th a t w ith  both methods of 
concentration, the decrease in  volume probably a ffe c te d  the 
s o lu b i l i ty  of the p ro te in s .
Both methods showed a progressive loss o f s a liv a ry  
p ro te in  on volume reduction , the loss being much g rea te r w ith  
the whole s a liv a  than a p ro te in  so lu tio n  such as gamma 
g lo b u lin . Concentration of immunoglobulins in  s a liv a  th ere fo re  
appears to  be complicated by other s a liv a ry  components.
This was' supported by the fa c t th a t IgG added to  s a liv a  which 
was then concentrated and measured by SRID, did not concentrate 
a t the same ra te  as an IgG so lu tion  alone, concentrated and 
measured by the same methods. The change in  s o lu b il i ty  of 
the immunoglobulins may have a ffe c te d  th e ir  a b i l i t y  to  react 
in  q u a n tita tiv e  immunodiffusion and so may p a r t ly  exp la in  
the low re s u lts  using th is  method o f q u a n tita tio n . I t  was 
noted th a t the chymotrypsinogen did not concentrate  
s a t is fa c to r i ly  by u l t r a f i l t r a t io n  because i t  has a m olecular 
weight o f approxim ately 25,000 and the membrane used, f i l t e r e d
substances of 20,000 m olecular w eigh t.o r less* Fragments 
of the p ro te in  molecules th e re fo re , passed through and an 
e ffe c t iv e  concentration value could not be expected.
A r e l ia b le  reference standard fo r  q u a n tita tio n  of 
s a liv a ry  IgA would seem desirab le  (serum IgA was used in  the  
above experiments and c a lib ra te d  to  the TOO standard fo r  
th is  immunoglobulin, as was also the IgG) as a p ortio n  o f i t  
d if fe r s  from serum IgA by the ad d itio n  o f a Secretory Piece 
(TOMASI et a l .  1965) and th is  a ffe c ts  i t s  m o b ility  in  agar. 
D iffe re n t authors (c ite d  by BRANDTZAEG et a l .  1970) have used 
d if fe re n t  forms o f IgA as a standard and th is  also makes 
comparison of re s u lts  o f the measurement of IgA, the 
predominant s a liv a ry  immunoglobulin and th ere fo re  presumably 
the most im portant one in  combating o ra l disease, d i f f i c u l t .
Apart from the observations of LEHNER (1969 ,b ) ,  
previously published work on the concentration o f s a liv a ry  
proteins appears to  depend on reduction o f volume as being 
d ir e c t ly  p ro po rtion a l to  concentration of immunoglobulins; 
as is  shown above, reduction in  volume is  not an in d ic a tio n  
of s a liv a ry  immunoglobulin concentration, th e re fo re  care must 
be taken in  in te rp re tin g  re s u lts  stated  as "concentration” 
value and not ”reduction in  volume” va lu e . N e ith er o f the 
above methods was found to  give a very s a tis fa c to ry  
concentration w ith  increasing  reduction in  volume. However, 
i t  is  u n lik e ly  th a t a lOOx volume reduction w i l l  be 
es s e n tia l fo r  the measurement of a l l  but those substances 
present only in  tra ce  amounts. Smaller volume reductions  
give r e la t iv e ly  b e tte r  p ro te in  concentrations and concentrate  
the immunoglobulins to  e a s ily  detectab le  amounts.
CONCLUSIONS
The choice of method of s a liv a  concentration must 
th e re fo re  depend on the substance under examination and i t s  
o r ig in a l concentration . E x trap o la tio n  back to  the o r ig in a l  
concentration must be avoided as:
a) concentration of in d iv id u a l immunoglobulins does not 
p a r a l le l  e ith e r  t o ta l  p ro te in  concentration or volume 
reduction , and
b) n e ith e r t o ta l  p ro te in  nor in d iv id u a l immunoglobulins 
concentrate l in e a r ly .
CHAPTER 4 .
IllHJNOLOGICAL STUDIES OH HUMAN SALIVARY 
________________ ALBUMIN.__________________
INTRODUCTION
Further investigations into the nature of salivary 
albumin seemed warranted because of some anomalous results 
that were observed Toy the author, on routine electrophoretic 
analysis of human saliva against anti-human serum and anti­
mixed saliva preparations. They emphasised the disparity in 
the reports of earlier investigations, including that of 
ELLISON et al. (I960) and SIMONS et al. (1964), which is 
outlined in Chapter 2, pages 17 and 18.
Although no direct correlation has been previously 
reported between serum and/or salivary albumin and oral 
diseases, this work is included because of the relevance of 
the conclusions that may be drawn from it, to the studies 
on local immunization (Chapter 7).
MATERIALS AND METHODS
Collection, dialysis and concentration of human saliva- 
The saliva used in this series of experiments was 
collected and concentrated in the manner described in the 
previous chapter (with the exception of polyacrylamide gel 
concentration).
Quantitation of albumin and IgA in saliva-
The albumin and IgA contents of the saliva preparations 
were determined by SRID, as described in Chapter 3, p53« The 
antiserum used was Hyland rabbit anti-human plasma albumin 
serum and Hyland goat anti-human IgA.
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Adsorption of s a liv a  w ith  anti-human plasma albumin serum-
A m ixture containing 1 volume of mixed s a liv a  (p ro te in  
concentration 35mg/ml), 1 volume of 0*85$ (w /v ) sa lin e  and 
2 volumes of ra b b it anti-human plasma albumin serum (Hyland) 
was incubated in  a water bath a t 45°C fo r  3 hours* A fte r  
c e n tr ifu g a tio n  a t 13,000rpm (I2 ,0 0 0 g ) fo r  1 hour a t 4°C, the 
supernatant was removed and stored a t -2 0 °0 .
Preparation  of ra b b it antiserum to  concentrated, human, 
mixed s a liv a -_____________________________________________
( i )  0.5m l o f concentrated s a liv a  (p ro te in  concentration, 
lOmg/ml) together w ith  0.5m l 0,85$ (w /v) sa lin e  em uls ified  
in  1ml Freunds Complete Adjuvant, was in je c te d  in t r a ­
m uscularly in to  each of 4 s ite s  in  male C a lifo rn ia n  ra b b its  
once a week fo r  5 weeks. Serum was co lle c te d  1 week a f te r  
the la s t  in je c t io n  of s a liv a  and was termed ra b b it a n t i­
serum 02- 70.
( i i )  This was prepared by D r. J .A . Beeley, Departments
of Oral Biology and Biochem istry, U n iv e rs ity  of Glasgow.
\
The method used was as fo llow s: 1ml o f an emulsion
containing equal volumes o f concentrated s a liv a  (p ro te in  
concentration, 20mg/ml) and Freunds Complete Adjuvant was 
in je c te d  in tra -m u sc u la rly  in to  each hind le g , and 2ml 
d is tr ib u te d  sim ultaneously over the backs of each of 2 male 
Dutch white ra b b its ; a f te r  28 days, 1ml o f concentrated  
s a liv a  (p ro te in  concentration, 5mg/ml) was in je c te d  in t r a -  
p e r ito n e a lly . Serum was co lle c te d  1 week a f te r  the la s t  
in je c t io n  o f s a liv a  and th a t selected fo r  use a f te r  
appropriate te s tin g  was termed ra b b it antiserum n o .552 and 
n o .564*
Determ ination of a n tig e n ic ity  of IgA in -s a liv a -
This was c a rrie d  out by the method of WORK and WORK 
(19 69 ). The s a liv a  used to  develop ra b b it antiserum 02-70  
was d iffu sed  against th is  antiserum in  conjunction w ith  a 
7S Hyland IgA standard (c a lib ra te d  w ith  the WHO standard) 
on standard immunodiffusion p la te s . The t i t r e  o f a n ti- Ig A  
in  antiserum 02-70 was ca lcu la ted  as the la s t  d ilu t io n  of 
antiserum th a t produced a p re c ip it in  arc w ith  the concentrated  
s a liv a ; th a t arc g iv in g  a re ac tio n  o f id e n t ity  w ith  the IgA 
standard.
Immunoelectrophoresis-
This was c a rr ie d  out as described in  Chapter 3 , using 
a liq u o ts  o f the mixed s a liv a  preparations prev iously  employed 
fo r  antiserum production.
Immunodiffusion-
0 .3$  Oxoid 'Ionagar* no«2 (0 .1g /33m l d is t i l le d  w ater) 
was layered  onto alcohol-c leaned  2nx2n glass s lid e s  and 
allowed to  s o lid fy  under cover to  prevent dust s e t t l in g .  
P lex ig lass  tem plates (w ith  s ix  2mm or 1mm w ells  e q u i-d is ta n t 
from each other and a centre w e ll by 4mm or 1mm re s p e c tiv e ly ) 
were placed on the agar surface and the s lid e s  placed on a 
h o tp la te  a t 45°C fo r  a few seconds to  a llow  condensation to  
occur on the undersurface o f the tem plates. Approximately 
lm l o f 1$ 'Io n a g a r1 (O .lg /lO m l 0 .85$ (w /v) s a lin e ) incorpor­
a tin g  a 1:10,000 d ilu t io n  of m erth io la te  as a p res erva tiv e , 
was flooded under the tem plate , care being taken to  avoid the 
production of a i r  bubbles, and the s lid e  removed from the hot
p la te . The w ells  were f i l l e d  w ith  the reagents w ith in  30 
minutes of s o l id if ic a t io n  of the agar and d iffu s io n  allowed  
to  occur fo r  24-28 hours in  a moist atmosphere a t room 
tem perature. The p u r if ie d  human plasma albumin used in  th is  
te s t  was obtained from Hoescht Pharmaceuticals L td . ,  Kew 
Bridge, B ren tford , M iddlesex.
RESULTS
Immunoelectrophoretic analyse.s-
A comparison of the immunoelectrophoretic p a tte rn  
re s u ltin g  from using mixed s a liv a  and anti-p lasm a albumin 
serum w ith  th a t using human normal serum ( f ig .1 3 a )  confirmed 
the presence of plasma albumin, or a t le a s t a p ro te in  bearing  
considerable immunological resemblance to  plasma albumin in  
s a liv a , as prev iously  reported (ELLISON et a l .  I96 0 ;
STOPPER et a l .  1962; LEACH et a l .  1963; SIMONS et a l .  1964; 
BRANDIZAEG, 1965; MASSON et a l .  1965 and STROBER et a l .  1970). 
However, a sharper p re c ip it in  arc was obtained in  the case of 
s a liv a ry  albumin than plasma albumin, an observation also  
made elsewhere (BRANDIZAEG, 1965 and MASSON et a l .  1965), 
but th is  might have re su lted  simply from d iffe ren ces  in . 
concentration of the albumin.
Immunoelectrophoresis of mixed s a liv a  w ith  anti-m ixed  
s a liv a  serum, re su lted  in  the appearance of several arcs, 
inc lud ing  a s ing le  arc in  the albumin region ( f ig .1 3 b ) .  On 
immunoelectrophoresis of normal human serum w ith  anti-m ixed  
s a liv a  serum however, no arc in  the albumin region was 
observed ( f ig .1 3 b ) .  2, 10, 50 and 100 fo ld  d ilu tio n s  o f
normal human serum gave the same r e s u lt .  Accordingly, th is
anomaly was in v es tig a te d  fu r th e r . Pig.-13c shows the 
immunoelectrophoretic p a tte rn  which re su lted  from reac tin g  
mixed s a liv a  w ith  an ti-m ixed  s a liv a  serum and anti-p lasm a  
albumin serum. The arcs produced in  the albumin region  
c le a r ly  cross each other in  a re ac tio n  of n o n -id e n tity .
Mixed s a liv a  was then adsorbed w ith  anti-p lasm a albumin 
serum in  order to  remove the component which produced a 
p re c ip it in  arc on immunoelectrophoresis w ith  anti-p lasm a  
albumin serum. P ig.13d shows the p a tte rn  produced w ith  
mixed s a liv a  before and a f te r  adsorption w ith  anti-p lasm a  
albumin serum, and shows th a t removal of the albumin was 
complete. However, on immunoelectrophoresis o f the adsorbed 
mixed s a liv a  w ith  an ti-m ixed  s a liv a  serum, the p a tte rn  was 
unchanged (Tf ig . l 3 e ) ,  the arc in  the albumin region s t i l l  
being present. These re s u lts  are in  agreement w ith  those of 
SIMONS et a l .  (1964)•
V
Examination of s a liv a ry  albumin by d o u b le -d iffu s io n -
Imraunodiffusion was used as an a d d itio n a l method of 
in v e s tig a tin g  s a liv a ry  albumin because c e llu lo s e  acetate  
electrophoresis  of s a liv a ry  pro teins also produced a component 
w ith  the same m o b ility  as plasma albumin, w h ils t the 
component corresponding to  plasma albumin on is o e le c tr ic  
focussing in  polyacrylam ide gels appears as a sharp band 
ra th e r than the heterogeneous group of bands c h a ra c te r is tic  
of plasma albumin (BEELEY, 1972). This l a t t e r  point warrants 
fu r th e r  analysis  because of d i f f ic u l t ie s  in  th is  in v e s tig a tiv e  
technique, due to  the d iffe rences in  the m olecular s ize o f 
plasma albumin and anti-p lasm a albumin. However, re s u lts
$Pig.13.
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Immunoelectrophoresis slides. The photographs are 
orientated so that the anode is to the left and the 
cathode is to the right, (a) Mixed saliva, 35mg/ml(MS) 
and human normal serum (HITS) in wells; anti-serum to 
human plasma albumin (A-ALB) in trough. (b) MS and 
HITS in wells; anti-serum to mixed saliva (A-MS) from
rabbit no.552 in trough, (c) MS in wells; A-MS from
rabbit no.564 and A-ALB in troughs, (d) MS and MS 
adsorbed with A-ALB (MS1) in wells; A-ALB in trough,
(e) MS and M S 1 in wells; A-MS from rabbit no.02-70 in
trough.
A-ALB
MS
i  A-MS
O
:A-MS
A-ALB
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MS
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Pig. 14.
Double-diffusion. A-ALB, anti-serum to human plasma 
albumin; MSI, mixed saliva used for the preparation 
of antisera in rabbit no.552; MS2, mixed saliva used 
for the preparation of antisera in rabbit no.02-70; 
PA, human plasma albumin.
of a d ou b le -d iffus io n  experiment showed-a re ac tio n  of 
p a r t ia l ,  i f  not to ta l  id e n t ity  between plasma albumin and 
the album in-lilce component of s a liv a ry  albumin ( f i g . 1 4 ), 
although a number o f a d d itio n a l bands appeared between plasma 
albumin and anti-p lasm a albumin serum. This in d ica tes  th a t 
s a liv a ry  albumin has one id e n tic a l an tigen ic  determinant 
w ith  th a t o f plasma albumin.
These re s u lts  are reproducible and independent of the 
method of concentration of s a liv a  or o f antiserum production  
and a l l  preparations correspond to  those used in  s im ila r  
experiments by other workers (in c lu d in g  those o f BEELEY, 1972).
DISCUSSION
The find ings reported by SIMONS et a l .  (1964) have been 
confirmed by the re s u lts  o f the experiments described in  th is  
study, by.showing th a t anti-m ixed s a liv a  serum gives no 
p re c ip it in  arc corresponding to  plasma albumin on immuno- 
electrophoresis w ith  human normal serum. Furthermore, in  
contrast to  the conclusion of ELLISON et a l .  ( i9 6 0 ) ,  the arc  
appearing in  the albumin region on immunoelectrophoresis of 
mixed sa liv a  w ith  anti-m ixed  s a liv a  serum shows a re ac tio n  of 
n o n -id e n tity  w ith  the arc formed between mixed s a liv a  and 
anti-p lasm a albumin serum.
From th is  observation i t  may be concluded-.that e ith e r  
the arc formed in  the albumin region between mixed s a liv a  and 
anti-m ixed s a liv a  serum does not in  fa c t re s u lt  from plasma 
albumin or th a t s a liv a ry  and serum albumins are immunologically 
d if fe r e n t .  Adsorption o f mixed s a liv a  w ith  anti-p lasm a albumin 
fo llow ed by immunoelectrophoresis w ith  an ti-m ixed  s a liv a  serum
fa i le d  to  e lim in ate  the arc in  the albumin reg ion , th ere fo re  
i t  may be concluded th a t the arc does not result" from the 
presence of plasma albumin.
I t  thus appears th a t antiserum to mixed s a liv a  does not 
contain antibody to  whole plasma albumin. Although determin­
ants o f plasma albumin are c le a r ly  present in  mixed s a liv a  
( f ig .1 3 a )  they do not appear to  be an tigen ic  under the  
conditions used here . At present, the reason fo r  th is  anomaly 
is  uncerta in , as i t  is  u n lik e ly  th a t s a liv a ry  albumin, 
although in te ra c tin g  w ith  anti-serum  to  plasma albumin, is  in  
i t s e l f  n on -an tig en ic , even i f  i t  were bound to  a non-antigenic  
glycoprote in  secretory p iece . Although s a liv a ry  albumin may 
be less heterogeneous than serum albumin, i t  does have the 
same e le c tro p h o re tic  m o b ility  and double ra d ia l  immunodiffusion  
has confirmed the presence of an id e n t ic a l component in  
s a liv a ry  albumin and plasma albumin ( f i g . 14 )* One p o s s ib il ity  
is  th a t of denaturation  or ageing w ith  an accompanying increase  
in  heterogeneity  o f the albumin in  s a liv a  and/or serum 
albumin (SOGAMI et a l .  1969; NIKKEI, and POSTER, 1971) during  
antigen p reparation , thus com plicating antibody production  
and/or an tigen-antibody in te ra c tio n s .
Another possible cause of these re s u lts  is  th a t the 
plasma albumin concentration of mixed s a liv a  was too low to  
cause production of detectable q u a n titie s  of antibody.
Indeed, the s a liv a  was obtained from vo lunteers w ith  c l in ic a l ly  
healthy gingivae and thus should have contained l i t t l e  
g in g iv a l exudate. In  a d d itio n , the albumin concentration of 
"concentrated sa liva" does not p a r a l le l  the decrease in  volume 
of the secretio n , as was reported in  the previous chapter w ith
s a liv a ry  IgA and IgG; i n i t i a l  small amounts would th ere fo re  
not be increased g re a tly  in  concentration r e la t iv e  to  to ta l  
p ro te in  concentration .
I t  cannot be concluded, however, th a t the pro teins most 
re a d ily  detected by immunoelectrophoresis are the p r in c ip a l 
components o f a m ix tu re . The preparations used in  these 
experiments had an albumin to  IgA r a t io  ranging from about 
0 .9  to  1 .8 .  IgA in  the mixed s a liv a  was found however, to  
be h ig h ly  an tigen ic  ( t i t r e  1 :5 ,1 2 0 ) using an anti-serum  to  
serum IgA (7S) although as no a n t i - I IS  IgA serum was 
a v a ila b le , the t i t r e  o f secretory IgA in  the mixed s a liv a  
could not be c a lc u la te d . Furthermore, the albumin content- of 
the s a liv a  preparations was adequate to  give a d e f in ite  
p re c ip it in  arc w ith  anti-serum  to  human plasma albumin 
( f ig .1 3 a ) .
CONCLUSIONS
Further in v e s tig a tio n s  w i l l  be requ ired  to  c la r i f y  th is  
problem, inc lud ing  an immunological and biochem ical comparison 
of p u r if ie d  s a liv a ry  albumin w ith  plasma albumin, fo r  
although s a liv a ry  and plasma albumin appear to  have an a n t i­
genic determinant in  common, plasma albumin has many more 
than the former and seems more a n tig e n ic . By making a ra b b it  
to le ra n t to  human plasma albumin and ra is in g  anti-serum  to  
mixed s a liv a  any antibody to  Album in* should be to  * s a liv a ry  
albuminT; th is  a rc , i f  produced on immunoelectrophoresis, 
could then be compared to the one a t present found in  the 
albumin region of the mixed s a liv a /a n ti-m ix e d  s a liv a  immuno- 
e lec tro p h o re tic  p a tte rn , which has not yet been id e n t i f ie d .
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Some conclusions drawn from the results in Chapter 7, 
however, aid the clarification of this anomaly a little; 
see pp. 157,-158.
CHAPTER 5.
AH INVESTIGATION INTO THE SALIVARY AND •
• SERUM IgA LEVELS OE PATIENTS SUFFERING
FROM DIFFERENT TYPES OE PERIODONTAL DISEASE,
INTRODUOTION
It appeared necessary to correlate salivary and serum 
immunoglobulin levels in patients presenting with acute and 
chronic inflammatory lesions of the periodontium and oral 
mucosa, in whom the dental•caries state was also recorded 
simultaneously with their medical history. By doing so, 
changes in immunoglobulin levels could be attributed 
importance depending on the caries experience of the patient.
Patient immunoglobulin levels were compared to a control
group matched as closely as possible and all results calculated 
on the basis of the WHO immunoglobulin standards (ROWE et al. 
1970) to enable correlation of the results with those in 
other laboratories.
In addition, the survey was undertaken to define the 
problems and categories required for such an evaluation.
MATERIALS AND METHODS 
Subjects-
The series consisted of 69 individuals who presented 
with different forms of periodontal disease. They were aged 
from 9-65 years (mean, 34 years) and were compared to a 
control group of 23 individuals aged from 21-55 years (mean,
28 years). They were all assessed as shown in fig.15* She 
Modified Greene and Vermillion Oral Hygiene Index (O.H.I.) 
was used for scoring the mouths (GREENE and VERMILLION,1964).
The scores ranged from 0.0-3*0 (mean, 0.950) in the patients 
compared to the values of 0.0-1.0 (mean,0.246) in the control 
group. The average Russell Index (RUSSELL, 1956) for the 
mouth was also calculated to indicate the severity of the 
disease and the 33M3? values were recorded. The latter does 
not indicate the degree of active caries at the time of 
examination hut indicates the overall carious experience of 
the patient. The broad groups into which the subjects were 
classified, the age ranges, oral hygiene indices, the average 
Russell values and the LME values are shown in Table pa and 
the subdivisions into the different types of periodontal 
disease are listed in Table 5b.
The serum and saliva samples from each patient were 
collected at the same time and in the case of those suffering 
from an acute condition, the Convalescent* samples were 
taken 2 weeks after the first visit. The degree of dental 
caries activity was noted when analysing the immunoglobulin 
measurements; none of the controls had active caries 
although some had a high LME score.
Collection of serum-
10ml of blood was withdrawn from the cubital vein into 
a sterile universal bottle, which was placed in a 37°C 
incubator for 30 minutes before transferring it' to the 
refrigerator. When a clot had formed, the blood was centri­
fuges at 4,000 rpm (200g) for 10 minutes. The serum was 
removed and stored in 1ml aliquots at -20°Co
Collection, dialysis and concentration, of saliva-
This was carried out as described in Chapter 3, using
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POEM.
M.M. SURVEY.
SURVEY NUMBER: _ 
SURVEY CATEGORY:
NAME:
ADDRESS:
HOSPITAL NO.: 
SEX:
D.O.B.: 
RACE:
C.O.:
DENTAL HISTORY:
HERPES*
A.U.G.*
. APHTHOUS* 
OTHER ULCERATION* 
CANDIDA* 
EROSIVE LESION* 
CHRONIC GINGIVITIS 
CHRONIC PERIODONTITIS 
PERICORONITIS 
DENTAL ABSCESS 
PERIODONTAL ABSCESS 
SORE TONGUE 
OTHER
Primary
Condition.
*
Degree. Duration.
Secondary
Condition. Degree. Duration.
--------- 1
Prefers to the severity of the condition; number of * indicates degree of severity.
NO. OP TEETH
DECAYED
MISSING
PILLED
RUSSELL 
Total for jar;
■ Ave. RUSSELL
Ave. RUSSELL 
Mouth.
O.H.I.•
RADIOGRAPHS
CLINICAL
PHOTOGRAPHS
Ave.. upper = /
Ave. lower = /
Ave. mouth = /
MEDICAL HISTORY Condition Duration
HEART
CHEST
SKIN
ALLERGY
DIABETES
PERNICIOUS ANAEMIA
G.I
OTHER
DRUGS
' MIXED
SALIVA
• STIMULATED
• UNSTD'IUL A TED • ■
Saliva stimulant used:
BACTERIOLOGY:
A69 FORM
lyophilisation as the method of concentration.. All saliva 
samples were decreased in volume 50 times in this way.
Quantitation of IgA in serum and saliva-
The technique used was that described in Chapter 5.
The values of IgA in the 'concentrated1 saliva could he 
extrapolated hack to their original values in the unconcen­
trated secretion, if necessary, using the conversion factor 
obtained in the RESULTS of Chapter 5 (Table 4). A mean of 
at least 2 correlating results ( 4 1° difference) was taken 
for each sample measured.
Statistical analysis of results-
A Hewlett-Packard Calculator Model T91A (Hewlett-Packard 
Co., Hewlett-Packard Ltd., 224 Bath Road, Slough, Bucks.) was 
used for the following:
1) To calculate the best straight line through the values 
obtained from the known standards by minimising the sum 
of the squares of the deviations of the data points from 
the line (least squares fit) giving a straight line- of 
the equation,
Log concentration = 0.715 x diameter - 0.415, with a 
correlation coefficient- of 0.975*
This was used as the standard curve for the .known 
concentrations of IgA.
2) The student ?t* test which calculates the t value for 
the distributions of 2 sets of samples.
3) The t values were then used to calculate the probability 
that the two distributions were the same.
Table 5a*
Age ranges, O.H.I. values, average Russell 
Indices and IMP scores of control and patient 
groups* The patient sample is broken dov/n 
into its broad constitutent groups*
Group Sex No Age
Range
Mean
Age
O.H.I. Mean
O.H.I.
R.I. Mean
R.I.
DMP Mean
DMP
CONTROL M 13 21-35 26 0.0-1 .0 0.385 0.0-3.08 0 .68 6-23 15
P 10 21-55 30 0.0-0.67 ai67 0 .0 0 .0 7-32 17
PATIENT 
SAMPLE •
ivi 33 17-54 32 0.0-3 .0 0.965 0.30-6.0 2.70 2-32 16
P 34 9-65 38 0.0-0.270.935 0.0-6 .0 2.65 11-32 19
ACUTE M 12 18-43 24 0.0-2 .0 0.917 0.30-3.68 1.78 2-22
•
15
P 10 9-65 24 0.0-2 .0 1.000 0.0-5.95 1.99 17-32 22
ACUTE + 
CHRONIC
M 7 19-41 28 0.0-3 .0 1.286 0.5-6 .0 2.74 9-32 18
P 3 20-38 30 °*172.170.888 1.48-3.67 2.79 11-16 14
CHRONIC M 12 17-43 28 0.0-2 .5 0.693 0.52-6.0 3.57 3-32 14
P 16 17-53 31 0.0-2.67 0.958 0.50-6 .0 3.17 14-28 22
RHEUMATOID M 4 38-54 46 N o t K n o w n
P 5 48-66 61 N o t  K n o w n
KEY: M = Male
. P = Pemale 
Mo Humber
R.I. = average Russell Index score for the mouth 
DMF = Decayedj Missing; Pilled, value 
O.H.I. = Oral hygiene index value
Table 5b.
Groups
ACUTE
ACUTE +
CHRONIC
Numbers and categories of test subjects 
presenting within each group0
Number.
22
male female
12 10
Categories of disease 
in each group._______
AUG (including 1 male 
patient, clinically and 
radiologically confirmed 
to be * caries-free *);
Herpes + AUG; Aphthous 
ulceration (including 1 
female edentulous subject); 
Gingivitis; Other ulceration.
CHRONIC 10
male female
7 3
28
male female
17 11
AUG + Gingivitis; AUG + 
Periodontitis; Herpes + 
Gingivitis; Herpes + 
Periodontitis,
Periodontitis (including 
1 female patient with 
periodontitis + chronic 
herpetic stomatitis); 
Herpes; Gingivitis; 
Aphthous ulceration.
Key: AUG = Acute Ulcerative Gingivitis.
RESULTS
General Oral Health-
None of the patients in the control sample had active 
caries at the time of serum and saliva collection, although 
the mean IMF values were very similar to those of the test 
group; the average Russell Index scores for the mouth was 
much lower for the controls as was expected.
The patients in the 1 Chronic * and 1Acute + Chronic2 
groups had high average Russell Index scores hut the DME 
values for these groups were not higher than those of the 
2Acute2 group. The average Russell Index scores showed the 
greatest variation in the 2Acute2 group.
The O.H.I. scores of the control subjects was also 
much lower than those of the test subjects, whose values did 
not show much variation between the broadly classified groups.
The oral state of the Rheumatoid patients was not 
precisely evaluated as it was felt that it would cause too 
much distress to the patients, many of them being quite ill. 
However,' none could be said to have healthy mouths and. all 
had gingival inflammation to a certain extent.
The control and patient groups were quite evenly matched 
for age and sex.
Results of the statistical evaluation of the salivary and 
serum IgA levels-____________________________________________
The initial results of the immunoglobulin level 
estimations carried out by SRIL (see fig.16) in the concen­
trated saliva and serum are shown in Tables 6a,b and c. The 
conversion factor to change from MRC units of the WHO standard
to mg/lOOml was IgA, 1 unit = l*2mg. The IgA values for 
saliva were based on the serum IgA standard.
The serum IgA values are very high. This is due to 
the fact that the diameter of .the precipitin rings in some 
of the samples was greater than that of the highest standard 
used. However, the same 1least squares fit2 line was used 
for all estimations and therefore the probabilities will not 
be affected by the high values.
Because within each group, some of the samples were very 
high and some very low, the saliva and serum levels of 
individual diseases within each group were.calculated giving 
the results in Tables 7a and b.
The male saliva values showed more deviation from the 
control values than did the female saliva; similar results 
were obtained with the serum values (Tables 6a and b). With 
male saliva, quite a high salivary IgA value was recorded in 
the first sample which showed a return to normal as the 
condition improved, as did the female in the Acute and Acute + 
Chronic conditions. With the serum samples, this result was 
paralleled in the male values, but the female values 
continued to fall.
As shown in Table 6 c, those values that gave a 
significant difference with the male saliva were Acute (l) 
with a decrease in IgA, and Chronic, with-elevated IgA levels. 
The Acute male 1 caries-free! salivary IgA was very high in 
the first sample but it had returned to a value within normal 
limits on recovery. Female salivary IgA values showed no 
significant differences. Male serum showed a significant 
increase in IgA in Acute (l); female serum showed a very
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(CABLE 6a,
IgA values in the 5Ox lyophilised saliva of the 
different subject groups.
MALE SALIVA
SUBJECT f 
GROUPS |No Mean Range S.D. No Mean Range S.D.
I
Control j 13 11.79 2.77-31.43 7.08 12 12.02 2.77-31.44 8.23
Acute(l) j11 22.59 6.29-38.96 11.63 7 15.73 4.56-37.59 14.2.0
Acute(2) 10 19.40 3.95-91.88 26.58 8 13.16 4.71-27.25 9.24
Acute+Chronic(1) 7 24.23 7.52-74.13 23.76 3 17.64 3.95-25.37 11.89
Acute+Chronic(2) 5 7.70 3.69-11.55 2 .89 3 9.81 7.52-11.55 2.07
Chronic 12 18.58 11.15-34.99 7.26 16 10.23 4.09-27.25 7.13
Rheumatoid 4 17.91 4.89-31.44 11.08 5 14.73
| i 
4.09-44.95 j! 17.18]
i !
FEMALE SALIVA
KEY: No = Number of samples in each group
S.D. = Standard deviation of the sample values
(1) = the first lot of samples taken from that group of subjects
(2) = the second lot of samples taken from that group of subjects,
i.e. the 'convalescent* sample 
All IgA values are in mg/lOOmlo
TABLE 6b
IgA values in the serum of the different subject groups.
MALE SERUM REMADE SERUM
SUBJECT | 
SROUPS Uo Mean Range S.D. No Mean Range jS.D.
Control 13 549.73 113.86- 
1122.. 15
297.78 12 690.15 288.44-
1044.71
232.30
Acute(1) 11 969.87 216.69-
1851.03
608.46 10 534.69 91.69-
2293.88
667.70
Acute(2) 12 539.67 232.75- 
. 972.62
!
211112 j 
j
10 343.90 71.54-
680.27
201.88
Acute+Chronic(1) 7 593.96 232.75-
905.51
I
285.47j 
' ' I
3 387.52 113.86- 
' . ;'539v63
245.82
Acute+Chronic(2 ) 4 442.58 151.56-
843.02
j
292.74!
I.
2
■
374.13 91.88 & 
656.38
399.16
Chronic 12 595.67 91.88-
873.71
256 .25 j 16 502.29 4 . 5 6 -  
1786.02
i
433.77
I
Rheumatoid 4 647.55 873.71-.
730.67
69.98 5 1309.15 268.54-
2646.51
1049.91\
i
KEY: No = Number of. samples in each group
S.D. = Standard deviation of the sample values
(1) = the first lot of samples taken from that group of subjects
(2 ) = the second lot of samples taken from that group of subjects,
i.e. the 'convalescent1 sample 
All IgA values are in mg/lOOml.
TABLE 6c«
Probability values of the means of the different subject 
groups compared to the mean of controls. The values are 
given for both 5Ox lyophilised saliva and for serum IgA 
values.
SUBJECT GROUPS Male saliva Eemale saliva Male serum Remale serum
P cf C P cf C P c f C  P cf C
Acute(1) 0.0104 0.4753 0.0384 0.4579
Acute(2 ) 0.3334 0.7759 0.9244 0.0114
Acute+Chronic(1) 0.0920 0.3454 0.7519 . 0.0668
Acute+Chronic(2) 0.2635 0.6615 0.5375 0.1243
Chronic 0.0262 0.5459 ' 0.6849 0.1861
Rheumatoid 0.2034 0.6606 0.5531 0.0625
KEY: (l) = the first set of samples taken from that group of subjects
(2 ) = the second set of samples taken from that group of subjects, 
i.e. the 'convalescent1 sample 
P cf C = the probability that the values of the subject groups 
listed are the same as the values of the control group 
subjects.
A P value of less than 0.0500 is significant.
TABLE 7ao
Combined Male and Female salivary IgA values from 5Ox 
Lyophilised saliva, compared to those of the control 
group, specifying the different types of disease within 
the groups. *The values of IgA are in mg/lOOml.
SUBJECT GROUPS Noj
i
Mean* Range* S.D. P.
Control 25j 11.89 2.76-31.43 7.49 -
ACUTE (l)
AUG 8 19.71 5.26-37.59 10.81 0.028
- Herpes 5 12.03 4.55-31.43 11.43 0.975
'Herpes+AUG 2 33.59 28.24&3S.95 7.57 0.0006
Aphthous ulcers 2 34.51 31.43&37.59 4.35 0.0003
Calculus formation 1 4.55 - - 0.346
ACUTE (2)
AUG 9 20.59 4.89-91.88 28.06 0.157
Herpes 5 13.41 5.26-25.36 7.35 0.6827
Herpes+AUG 2 16.44 5.65&27.24 15.26 0.443
Aphthous ulcers 2 7.10 4.89&9.32 3.13 0.387
ACUTE+CHRONIC (l)
AUG+gingiviti s 4 16.61 7.52-27.24 10.28 0.274
AUG+periodontitis 4 19.44 10.75-29.26 9.24 0.080
Herpes+periodontitis 1 3.95 - - 0.309 ^
Herpes+gingivitis 1 74.14 — — 23x10”y
ACUTE+CHRONIC (2)
AUG+gingivitis 4 8.94 3.68-11.55 3.71 0.451
AUG+periodontitis 2 7.13 6.75&7.52 0.54 0.386
Herpes+periodontitis 1 10.37 - - 0.905
Herpes+gingivitis 1 7.52 — — 0.572
CHRONIC
Periodontitis 17 15.04 4.09-34.99 9 .20 0.230
Herpes 2 13.43 4.89&21.98 12.08 0.788
Gingivitis 7 9 .88 4.27-17.12 4.20 0.504
Aphthous ulcers 2 17.16 11.55-22.78 7.94 0.349
RHEUMATOID 9 16.14 4.56-31.43 14.01 0.261 '
KEY: No = Number of subject samples
S.D. = Standard deviation 
AUG' = Acute ulcerative gingivitis
P. = probability that the means of the patient samples in the 
different groups are the same as the mean of the control 
samples; P less than 0.0500 is significant.
TABLE 7bo
Combined Male and Pemale serum IgA values from the 
different subject groups compared to those of the 
control group, specifying the different types of disease 
within the group. *The values of IgA are in mg/lOOml.
SUBJECT GROUPS No Mean* Range* S.D. P.
Control 25 617;. 23 113.85-1122.14 272.42
ACUTE (1)
AUG 10 772.89 91.88-1851.03 608.09 0.328
Herpes 5 948o19 216.69-2293.88 947.03 0.134
Herpes+AUG 2 575.35 106.0061044.71 663.76 0.849
Aphthous ulcers 3 720.80 459.09-972.62 256.90 0.537
Calculus formation 1 232.75 - . - 0.179
ACUTE (2)
AUG 11 386o47 71.54-633.33 189.88 0.015
Herpes 5 552.51 383.94-843.02 200.47 0.619
Herpes+AUG 2 547.46 122.306972.62 601.26 0.748
Aphthous ulcers - 3 524.56 475.80-548.94 42.22 0.567
Calculus formation 1 232.75 - - 0.179
ACUTE+CHRONIC (l)
AUG+gingivitis 4 642.72 232.75-905.51 305.54 0.865
AUG+periodontitis 4 425.17 113.85-843.02 325.50 0.211
Herpes+periodontitis 1 459.09 - - 0.574
He rp e s+gingivi t i s 1 589.63 — - 0.921
ACUTE+CHRONIC (2.)
AUG+gingivitis 2 497.29 151.566843.02 488.93 0.571
AUG+periodontitis 2 267.42 91.886442.96 248.25 0.091
Herpes+periodontitis 1 656.38 - - 0.889
He rp es+gingivi ti s 1 332.78 — — 0.316
CHRONIC
Periodontitis 17 626.25 4.56-1786.02 440.19 0.934
Herpes 2 403.16 216.696589.63 263.70 0.294
Gingivitis 7 392.94 174.86-548.94, ■ 130.60 0.044
Aphthous ulcers 2 490.66 412.40^568.92 110.67 0.526
RHEUMATOID 9 105.13 268.54-2646.51 821.36 0.038
KEY: No = Number of subject samples
S.D.' = Standard deviation 
AUG = Acute ulcerative gingivitis
P. = probability that the means of the patient samples in the 
different groups are the same as the mean of the control 
samples; P less than 0.0500 is significant.
significant difference in Acute (2) where the IgA value fell 
markedly. The Acute + Chronic male serum values showed a' 
decreasing trend (Table 6b) and the Acute + Chronic IgA 
values were lowered and the Rheumatoid IgA values were 
raised in both male and female serum.
On examining differences within the individual groups, 
compared to the controls, more significant differences were 
obtained. Males and females were grouped together in this 
case. With salivary values (Table *7a), Acute AUG- (l),
Acute Herpes + AUG- (l), Acute Aphthous ulceration (l) and 
Acute Herpes + Chronic gingivitis (l) showed very significant 
differences in their IgA values. The Herpes salivary value 
was raised (not significantly) from the normal, but when 
combined with gingivitis, gave a greatly increased salivary 
IgA value. Herpes periodontitis showed lowered IgA values 
(not significantly).
With the serum IgA values, there were only three 
significant differences recorded. They were in lowered IgA 
in Acute AUG- (2), a lowered IgA in' Chronic gingivitis and a 
greatly increased IgA in the Rheumatoid patients.
This division of the groups into their constituent ; 
diseases, gave a better indication of the changes in salivary 
and serum IgA that occurred as the disease progressed or 
regressed.
DISCUSSION
It was decided to measure IgA levels in serum and saliva 
of patients presenting with a range of periodontal complaints 
compared to control subjects free from such disease on
clinical examination. IgA was estimated because it is the 
predominant immunoglobulin in saliva and overall evidence 
collected by HEREHAES (1968) shows that IgA plays a major 
role in contributing protection to the sero-mucous surfaces 
of the body.
•The discovery on the first statistical analysis of the 
quantitation of serum and salivary IgA, in the control and 
test subjects, v/as interesting, in that there were difference 
in the results between the sexes. If the two groups of male 
and female were assessed together, significant differences 
apart from those of the Acute (1) group, were lost. The 
IMF values and average Russell Index values were similar for 
both sexes in each group and the numbers with each disease 
in both groups were quite evenly matched; there were also 
no outstanding differences in the available medical histories 
of the two groups..
Some differences in immunoglobulin levels may have been 
due to the patients’ susceptibility to caries as raised IgA 
values have been attributed to greater caries-resistance 
than caries-susceptibility (LEHNER et al. 1967; ZENG-0 et al. 
1970, 1971). The total IMF values do not indicate the 
present degree of decay; however, the control group, 
although having no active caries, had varied IMF values and 
the IgA values in relation to susceptibility to' caries should 
have been matched with the test subject groups.
The. salivary values for the groups as a whole, vary 
depending on the type of disease, as already noted by 
IEHEER (I969a,b). An increase in salivary IgA on increasing 
severity of the disease might have been expected; on the
other hand, more of the immunoglobulin might be taken up 
with the attempted control of the disease process and so be 
removed from the saliva, giving lowered values. The type(s) 
of antigen(s) in each disease must therefore be considered, 
especially In a virus-caused disease such as Herpes, where 
it is probably the Secretory IgA levels that are important 
(C-EECO and TAUBMAE, 1971), a rise in titre in the convalescent 
stage indicating a Herpes infection. It is interferon 
production that is initially concerned with the action to 
overcome virus infections, antibody being produced in larger 
quantities in the recovery phase of the illness.
Of the salivary values, both groups show a return to 
normal IgA levels In the convalescent state of Acute and 
Acute + Chronic infections. The Chronic values are raised 
in the males and reduced in the females. However none of the 
values was significant in the saliva apart from the male 
Acute (1) and male Chronic; it may be concluded therefore 
that the values in the other groups remain more or less 
normal in these diseases, when taken as a whole.
The values of IgA in the individual diseases show 
little variation from the normal as 1EHEER (l969,b) reported. 
Herpes + gingivitis has a greatly increased IgA level In the 
acute phase, which returns to normal in the convalescent 
stage, but as this was only in one subject, this change 
cannot be taken as always being the case. The results of- 
increased IgA in major Aphthous Ulceration in both serum and 
saliva, corroborated those of LEHEER (1969,b) as did the 
increased serum values in Herpes, although not signij.leantly. 
LEHEER (1969,b) did not take into account the caries state
or the amount of gingival or periodontal disease when 
examining Herpes and Aphthous Ulceration.
The presence of an acute plus a chronic condition makes 
analysis of the results more difficult as either raised or 
lowered levels may result from one or the other condition 
or both.
The amount of endotoxin produced by the plaque can have 
an inhibitory effect on antibody production (ERAEZL and 
McKASTER, 1968; Mcl-IASTER and ERAEZL, 1968) depending on the 
route, dosage and time of injection compared to other 
antigens. Poor oral hygiene resiilts in the accumulation of 
plaque which contains more Gram negative organisms and 
subsequently increased amounts of endotoxin, as the plaque 
ages (GIBBOUS, 1963; RITZ, 1964; GEECO et al. 1969; LYNCH 
et al. 1969 and GOLDBERG, 1970). Those Gram negative 
organisms may thus prevent immunoglobulin synthesis, 
resulting in lowered IgA levels in both saliva and serum.
This may in part account for the fact that serum IgA 
levels fall in the Acute (2) measurements, where some of the 
patients may not have been convalescent but in a more acute 
phase, with their excessively lowered immunoglobulin values 
affecting the results as a whole; those immunoglobulins 
normally produced, being used in the immune reaction and 
then being catabolised as normal with no subsequent stimulus 
for increased production.
An additional fact is that IIS IgA plus Complement 
(which is present in crevicular fluid) plus Lysosyme (which 
is a constituent of saliva) lyse Gram negative bacteria 
(ADIEOLEI et al. 1966), releasing additional bacterial
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substances which, may be harmful to the host. Increased 
values of IgA in serum and saliva, on the other hand, 
especially in the acute phase of eg. AUG plus periodontitis 
or Aphthous Ulceration, may be the natural result of the 
defence mechanisms of the body to the antigen in these cases.
Increased levels in Rheumatoid Arthritis are commonly 
found and apart from the'usual secretory mechanisms into 
the saliva IgA is especially synthesised by the, labial 
salivary glands in Sjogren’s syndrome (TALAL et al. 1970).
50x lyophilised saliva was used throughout the complete 
patient survey. Because there were so many samples to be 
concentrated within a short space of time, it was felt that 
both time-wise and financially, lyophilisation would be best.
At this level of ’reduction in volume’ there is little 
difference in the final degree of concentration (see Tables 
3 and 4). As all samples were processed in an identical 
manner before immunoglobulin estimation, the results should 
be comparable.
CONCLUSIONS
An accurate measurement of salivary IgA is difficult 
because of the presence of both 7S and 11S molecules, and 
measuring total IgA assumes that both types are involved in 
specific antibody production in oral disease. - HOBBS (1970) 
recommends multiplication by 1.4 as 11S diffuses 70$ of 7S 
but this, assumes that salivary IgA is all the 11S type and 
this is not so (BRANDTZAEG et al. 1970). Presumably, the 
most efficient method would be to measure it against both a 
7S and an 11S standard so as to gauge the full IgA concentration
in the saliva. Other immunoglobulins may be important in 
conjunction with IgA (LEHRER, 1969a,b), depending on the 
disease.
Serum levels may be confusing as they mirror the general 
health of the individual and are influenced by minor as well 
as major ailments. Antibodies may be present in serum to 
organisms related to (and therefore exhibiting some antigenic 
characteristics in common with) the organisms implicated in 
oral diseases. Thus their measurement may not give the 
correct serum antibody level to the oral disease-causing 
organisms.
The use of different; standards and methods in different 
laboratories leads to confusion in the comparison of results, 
therefore experimental limits and data must be well-defined 
and detailed, To enable as much correlation as possible,
a) choice of groups into which test subjects are divided,
b) standard methods of analysis, and
c) comparison of immunoglobulin levels with universal 
immunoglobulin measurements and standards, would be an 
advancement in the elucidation of the connection of salivary 
immunoglobulin levels with defined oral diseases.
The fact that other oral disease eg. dental caries, and 
systemic disease, are bound to play a role in determining the 
overall•immunoglobulin levels in serum and saliva must be 
taken into account. LEH1TER and SHILLITOE (1972) reported 
that they chose not to examine caries but only chose those 
subjects who had no other oral or systemic diseases, when 
examining immunoglobulins in crevicular fluid; there are few 
reports where it is even mentioned whether these other
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factors are taken into account or not.' A rise in serum 
immunoglobulin in systemic disease may cause a concomitant 
rise in salivary levels by leakage into the oral cavity if 
there is tissue destruction due to periodontal disease.
These factors confuse the issue, and the results indicate 
that salivary immunoglobulin levels may be only really 
relevant and informative where a single disease state may be 
examined, although trends towards a change in immunoglobulin 
levels could be observed in the categories listed above.
However, in conclusion, it must be noted that measure­
ment of immunoglobulin levels in both the serum and saliva 
by SRIH is HOT a measure of the antibody levels to the 
antigen(s) causing the different forms of oral disease. 
Variation in immunglobulin levels may be due to an increased 
or decreased rate of catabolism or production of the 
immunoglobulins and is not necessarily an indication of the 
amount of antibody produced in the disease. It may solely 
indicate impaired immune functions in these individuals with 
immunoglobulin levels that vary from the normal, although a 
trend to changes in immunoglobulin levels in groups of 
patients with different- oral diseases is evident: 
particularly when these diseases are analysed singly, rather 
than grouped under the same condition (eg. acute; chronic) 
with a sub-division into male and female.
CHAPTER 6.
THE EEEECT OE IMPLANTATION OE CARIOG-EHIC 
STREPTOCOCCI IN THE RABBIT MOUTH.
INTRODUCTION
Rodents were used for this investigation "because of 
ease of (a) implantation of microorganisms in the oral cavity 
and (b) mixed saliva collection. Tiie response of the oral 
environment to this change in flora, hoth by salivary and 
gingival tissue immune mechanisms was estimated and compared 
to the human response to microorganisms present in the 
mouth, which are implicated in the pathogenesis of oral 
disease.
MATERIALS ARE METHODS 
Cultivation of bacteria-
The cariogeni'c streptococci Strep, mutans OMZ 176 E
were obtained from Dr. B. Guggenheim (Zurich, Switzerland).
They were grown anaerobically on horse blood agar plates on
which they produced a narrow zone of/£haemolysis, or in
Brewers Medium (CRUICKSHANK, 1965). These organisms are
Erythromycin resistant and therefore incorporation of lmg-
Erythromycin (Eli Lilly & Co. Ltd.; supplied by The Lilly
Research Centre Ltd., Erlwood Manor, Windlesham, Surrey)
/ml medium prevented growth of other streptococci.
Laboratory animals-
In each experiment:, three male Californian rabbits 
weighing 2-5 ICg were used. They were 3-4 months old on 
initial implantation.
Cariogenic diet Tor implantation of microorganisms--
The following cariogenic diet was devised by KEYES ■ 
and JORDAN (1 9 6 4 ).
Diet 2,000 Confectioners sugar 56# Powdered alfalfa 5#
Skim milk powder 28# Liver powder 1#
Whole wheat flour 6# Sodium chloride 2#
Brewers yeast 4#
This was fed with a weekly supply of equal parts of apple, 
carrot and kale, blended into a puree; about lOg/animal/week.
lOg of the dry ingredients of the diet was dissolved 
in the drinking water of rabbits 7 and 8 (the test animals) 
each day, while rabbit 1 (the control animal) received the 
normal drinking water. This diet was fed throughout the 
duration of the experiment.
Implantation of microorganisms-
A sterile swab was rubbed over a heavy growth of 
organisms on a blood agar plate. This swab was then rubbed 
over the upper and lower incisors and surrounding gingivae 
of rabbits 7 and 8 , every third day for the duration of'the 
experiment. Rabbit 1 received no organisms.
Determination of the success of implantation- .
Before commencing the experiment, swabs were taken from 
the incisor area of the rabbit mouths and were plated out on 
blood agar plates. The swabs were also placed in Brewers 
medium containing lmg Erythromycin/ml medium. No streptococci 
grew in the latter although some o^haemolytic streptococci
were present in the normal rabbit oral flora and were 
defected on the blood plates. No OMZ 176 E were present' in 
the rabbit mouths. Each day, before swabbing with the 
organisms, swabs were taken to test whether implantation 
had occurred. These swabs were plated on blood agar to test 
for haemolytic colonies and were placed in Brewers medium 
plus Erythromycin (img/ml); growth in this medium indicated 
the implantation of OMZ 176 E in the rabbit mouth.
Collection of rabbit serum-
The ear was shaved and the vein enlarged by swabbing with 
xylene. A 1 ” 20G- B-D Vacutainer needle (Becton-Dickinson, 
Division of Becton, Dickinson & Co., Rutherford, New Jersey) 
was inserted and the blood allowed to flow through the needle 
into a sterile bottle. After cessation of bleeding, the ear 
was thoroughly washed with water to prevent necrosis of the 
tissue by the xylene. The blood was centrifuged at 4,000 rpm 
(2 0 0g) for 10 minutes; the serum was removed and stored in 
lml aliquots at -20°C.
Collection of rabbit saliva-
Kixed saliva was stimulated by an intra-peritoneal 
injection of 5mg Pilocarpin© Hydrochloride (BDH Chemicals Ltd., 
Poole, -Dorset, BH12 4 NN, England) /Kg Body weight of the 
rabbit (after BROWN and QUINTON, 1957)- Increased salivary 
flow was apparent, after about 10 minutes and the fluid was 
collected in a sterile universal bottle as it dripped from 
the rabbit moutho The saliva was stored at 4°0 until centri­
fugation at 15,000 rpm (20,000g) for 40 minutes. The
supernatant fraction was removed and stored at -20°C until 
required.
Concentration of rabbit saliva-
The saliva supernatant was dialysed against distilled 
water for 24- hours at 4 °0 , in a similar manner to human . 
saliva (see Chapter 3). The volume of dialysed saliva was 
decreased lOx or 20x by Lyophilisation, as described in 
Chapter 3. Protein concentration was'measured by the method 
of Lowry (LOWRY et al. 1951). Ultrafiltration, as described 
in Chapter 3, was also carried out.
Immunoelectrophoresis and Immunodiffusion-
The methods used were those described in Chapters 3 and 
4 respectively. The rabbit serum and concentrated rabbit 
saliva were tested for immunoglobulin content using C-oat 
anti-rabbit gamma globulin (Hyland) and goat anti-rabbit IgA, 
IgG- and IgM (Miles-Yeda ltd., distributed by Miles Research 
Products Division, Miles Laboratories, Inc., P.O.Box 272, 
Illinois 60901, USA). The antisera were tested by immuno- 
electrophoresis to check that only specific anti-heavy chain 
activity was present.
Pathology of implantation-
After six months, the three rabbits were killed by intra­
venous injection of Nembutal (Abbot Laboratories Ltd., 
Queenborough, Kent), after the final swabs had been taken and 
serum and saliva collected. The wipper and lower incisors 
including the surrounding gingivae, of all the rabbits were
removed immediately after death, into neutral buffered 
formal saline. The teeth were decalcified and the teeth 
(with the attached tissue) were embedded in wax. The 
sections cut from the upper incisors plus gingivae of rabbit 
1 and rabbits 7 and 8 were stained H and E and Gram.
Examination of rabbit serum and saliva by 
Immuno-fluorescenee methods-______________
I. To estimate if serum and/or salivary antibodies
were produced in rabbits 7 and 8 against the implanted
organisms, the following immuno-fluorescence techniques were
employed.
1« Smears of OMZ 176 S were made on cleaned glass slides
and allowed to air dry before fixing in neutral 
buffered formal saline for 10 minutes at 4 °C.
2. The slides were washed in isotonic Phosphate Buffered 
Saline (PBS), pH 7.1 for 2-3 minutes.
3. The experimental rabbit serum or lOx Lyophilised rabbit 
saliva was layered onto the slides which.were left in
a dark, moist atmosphere for 30 minutes.
4 . The slides were washed in PBS for 10 minutes.
5. Goat anti-rabbit gamma globulin (fluorescent) (Hyland
or Pluoroscan, Winthrop Biologicals Ltd., V/inthrop House, 
Surbiton-on-Thames, Surrey) was layered onto each slide 
and left in a dark, moist atmosphere for 30 minutes.
6 . The slides were washed in PBS for 10 minutes.
7. The slides were mounted in neutral buffered glycerol, 
pH 7.1, using ultra-thin coverslips before examination 
under the UV microscope.
Negative controls were set up in the following ways.
a. Smears were heated in boiling water for 10 minutes before 
processing as in 2.-7 above.
b. The technique was carried out as in 1.-7 above, 
substituting 0.857-' (w/v) saline in 3. Human serum was 
not used to block the reaction because ’of the reported 
cross-reactivity between rabbit and human serum proteins 
(JOHNSON and YODER, 1970).(illustrated in fig.12b, 4 vs 7).
II. To estimate the class of immunoglobulin (if any) 
producing immunoglobulin antibody, the technique was as 
follows:
1. As in 1.-4 above.
2. Goat anti-rabbit IgG, IgA and IgM (Miles-Yeda ltd.) were 
layered onto each slide and left in a dark, moist 
atmosphere for 30 minutes.
3. The slides were washed in PBS for 10 minutes.
4. Rabbit anti-goat gamma globulin (fluorescent) (Difco,
Difco Laboratories, Detroit 1, Michigan, USA) was 
layered onto each slide which were left in a dark, moist 
atmosphere for 30 minutes.
5o As in 6 . and 7. above.
Negative controls were set up as above, with the additional 
control of substituting physiological saline at part 2 . of 
II, above.
Immuno-fluo-reseence studies on human oral streptococci, 
human serum and saliva as a comparison with the implanted 
animal model-_______________________________________________
A strain of Strep, sanguis was obtained.from the 
Bacteriology Department, Glasgow Dental Hospital and School,
which had oeen isolated on blood agar, from a patient oral 
swab. Serum and saliva (50x Lyophilised) were collected.in 
the usual way from both patients and controls; some patients 
and controls were selected from the Patient Survey samples 
(Chapter 5).
The immuno-fluorescence studies were carried out as 
described in I. of the previous section, substituting human 
serum and saliva in 3., and Hyland fluorescent anti-human
IgM and IgA (goat) in 5. Negative controls were set 
up as described before.
RESULTS
I-Iacroscopic and microscopic examination of the oral 
state on implantation-_______________________________
A fortnight after commencing implantation, the organisms 
OKZ 176 E were recovered from the swabs of the incisal area 
of rabbits 7 and 8 . Gram stains were made of the implanted 
organisms and those recovered from the Brewers medium 
containing Erythromycin (fig.17). Prom then until the 
rabbits were hilled, these organisms formed part of their 
oral flora.
Whilst being fed the cariogenic diet, the rabbits 
developed a redness in the gingivae (which may have been 
caused by the trauma of swabbing) and a film over the 
incisors which was not evident in control rabbit 1.
The teeth and gingival tissues were examined micro­
scopically following sacrifice.
(i) Gram stain: The control rabbit had a few bacteria on 
the tooth surface which stained Gram positive and had
the appearance of cocci. .The experimental rabbits 
had large numbers of bacteria on the teeth. These 
were mostly Gram positive Cocci; the high carbohydrate 
diet had caused a thin pellicle to be laid down on 
the tooth surface to which the bacteria could adhere 
more easily than when fed normally. This mimics the 
early stages of human plaque formation. Pig.18 
illustrates this observation.
(ii) H and 5 stain: The gingivae of rabbit 1 appeared
normal (figs.19 a and b). That of rabbits 7 and 8 
showed an inflammatory cell infiltrate (figs.20 a and b) 
which could have resulted from the bacterial build-up 
at the gingival margin.
ho dental caries was evident on the incisors of either the 
control or experimental animals.
Concentration of rabbit saliva-
Rabbit saliva total protein concentration when measured 
by Lowry, after reduction in volume, gave good corresponding 
concentration values compared to that of human saliva. 
Pilocarpine stimulation probably resulted in a more dilute 
secretion that was more easily concentrated as reduced 
viscosity results in less loss of protein. The results are 
recorded in Table 8. The estimates were carried out a 
minimum of twice on each sample.
As with human saliva, protein appeared to adhere to the 
Uri-20 membrane on Ultrafiltration, causing loss of protein. 
Concentration by Lyophilisation resulted in good concentration 
and this method was subsequently employed.
115.
Pig.17* Strep, mutans OMZ 176 S (xl520).
116.
j?i£.13. Strep, mutans OMZ 176 3 on the surface of the 
urjper incisor of rabbit 7« (xl5l6.8).
117.
Pig.19a. Gingivae of rabbit 1 (control) adjacent to 
upper incisors. (x41.44)»
118.
Pig. 19b. High, power of gingivae of rahhit 1
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to upper inci
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Pig. 20b. High power of gingivae of rabbit 7. (x360).
Examination of rabbit serum, and saliva by immunoelectro- 
phoresis and immunodiffusion--__________________________
On analysis of rabbit serum by immunodiffusion (fig.21) 
when it was diffused against anti-rabbit gamma globulin, a 
number of precipitin lines developed. Hot as many were 
produced as on 'immunodiffusion or normal human serum against 
anti-human normal serum.
Immunoelectrophoretic analysis using antiserum specific 
for the individual rabbit serum gamma globulin fractions 
produced precipitin arcs indicating the presence of IgG,
IgA and IgM in the rabbit serum (fig.22). On immunoelectro- 
phoresis of unconcentrated saliva, no immunoglobulins were 
detected. When the secretion was concentrated lOx by 
Lyophilisation, an IgC- arc appeared and on 20x reduction 
in volume by lyophilisation, all three immunoglobulins were 
seen to be present, the IgM arc appearing as a very faint 
band (fig.23). The appearance of IgG- as the immunoglobulin 
in greatest concentration in rabbit saliva corroborates the 
report of TAUBMAM and C-EHCO (1969) that this is the 
predominant immunoglobulin in rabbit saliva.
Estimation of antibody production to the implanted 
streptococci by immune fluorescence.______________
After applying the serum and concentrated saliva of the 
control rabbit 1 and test rabbits 7 and 8, plus' the specific 
fluorescent anti-serum, the slides were examined for the 
presence of fluorescing organisms. The controls were 
negative as were the experimental slides; no fluorescence 
was apparent from either the serum or saliva of any of the 
rabbits.
Table 3« Concentration of rabbit, mixed saliva supernatant 
by Lyophilisation and Ultrafiltration; 
measurement of total protein by Lowry.
Saliva and methods of 
concentration
Protein coneeh. 
mg/lOOml.
C one ent rat i on 
factor.
Rabbit saliva 114.0 -
Rabbit saliva after 
centrifugation and 
dialysis
95.0 -
R. saliva after volume 
decreased 20x by 
Ultrafiltration
840.0 8x
R. saliva after volume 
decreasedlOx by 
Lyophilisation 891.0 9x
R. saliva after volume 
decreased 20x by 
Lyophilisation 1140.0 15x
Results of analyses on pooled saliva samples from six healthy 
rabbits. This was used to correspond as closely as possible 
to the human situation.
123.
Pig.21. Normal immunodiffusion pattern of rabbit serum. (x4)
1. 1:10 Plow rabbit serum; 2. 1:10 rabbit 1 serum
3. 1:10 rabbit 7 serum 4. 1:10 rabbit 8 serum
5. 1:10 rabbit anti-lruman serum
6. 1:10 normal human serum
7. 1:3 goat anti-rabbit serum (Hyland)
6 1
124.
Pig,22. Formal immunoelectrophoretic pattern of rabbit 
serum. (x2).
The anode is to the right and the cathode to the 
left. All the wells contain normal rabbit serum,
1. Hyland goat anti-rabbit gamma globulin
2. Miles-Yeda goat anti-rabbit IgA
3. Miles-Yeda goat anti-rabbit IgM
4. Miles-Yeda goat anti-rabbit IgG
1
2
125.
Pig.23. Normal immunoelectrophoretic pattern of 20x 
Lyophilised rahhit saliva (x2)
The anode is to the right and the cathode to the 
left. All the wells contain rabbit saliva.
1. Hyland goat anti-rabbit gamma globulin
2. Miles-Yeda goat anti-rabbit IgA
3. Miles-Yeda goat anti-rabbit IgG-
4. Miles-Yeda goat anti-rabbit IgM
To increase the sensitivity of the reaction, antiserum 
specific for the individual rabbit immunoglobulins was 
applied. Again, all the smears were negative.
These tests were repeated a number of times and on all 
occasions they proved negative. Positive controls demon­
strated that the system was working, as fluorescent-labelled 
antiserum applied to a smear that had already had specific 
streptococcal grouping antiserum applied in an identical 
manner to the above, gave positive fluorescence. It was 
therefore concluded that if any serum or salivary antibodies 
had been produced to the implanted OMZ 176 E in rabbits 7 
and 8, they were in insufficient quantity to be detected by 
this method.
Immuno-fluorescence studies on human oral streptococci, 
human serum and saliva as a comparison with the 
implanted animal model-_______________________________
All the tests were repeated at least twice on the three 
patient and three control samples. The results, recorded 
in Table 9, followed the same pattern that had been observed 
in previous, trial immuno-fluorescent studies.
Both patient and control groups had antibodies, 
especially IgC- class in their serum, to the isolated organism, 
The control subjects, who were free from periodontal disease 
and had no active caries, although one had a history of a 
previously high caries rate, had salivary IgA antibodies.
The presence of antibodies in the saliva of the test subjects, 
one of whom had no active caries, was doubtful, as fluorescence 
was very low. The fluorescence produced by the IgA anti­
bodies in saliva was positive when compared to the positive
Table 9 > Results of fluorescence studies on human serum 
and saliva (concentrated 50x by Lyophilisation) 
from individuals estimated to have clinically 
healthy gingivae and those with some form of 
periodontal disease. The diseased subjects 
were taken from the patient sample (reported 011 
in Chapter 5) as were the controls taken from 
that control sample.
SUBJECT' SERUM ANTIBODIES SALIYARY ANTIBODIES
IgG IgA IgG IgA
Patient with A. TIG-. ++ + - +
Patient with Herpes 
and Pericoronitis. ++ + - +
Patient with 
aphthous ulcers. ++ + - +
Control 1. ++ + - +
Control 2. ++ + - +
Control 3. ++ + - + ,
Number of + indicates the degree of fluorescence. 
- indicates negative fluorescence.
+ indicates doubtful fluorescence.
The organism used was Strep, mutans OMZ 176 E.
and negative controls, but did not fluoresce as brightly 
as the antibody in the positive sera.
The fluorescent antibody technique is not a precise 
quantitative test, but it appeared from the amount of 
fluorescence that:
1) Patients and controls had high serum IgG and good serum 
IgA antibody titres to the streptococci.
2) Neither patients nor controls had salivary IgG- antibody 
to the streptococci.
3) Controls showed the presence of more IgA antibody to 
the streptococci than test subjects whose saliva 
resulted in a low level of fluorescence.
DISCUSSION
The aim of this series of experiments was to discover 
what effect an implanted organism, that was foreign to the 
normal flora of the rabbit mouth, would have on the appearance 
of the teeth and gingivae, both macroscopically and micro­
scopically and also to assess its effect on serum and 
salivary antibody production.
It was proved relatively easy to implant the cariogenic 
streptococci, swabbing the rabbit mouths in the same way as 
Guggenheim et al. (1970) whilst they were being fed the 
cariogenic diet. The organisms could be identified in the 
plates (fig.24a) and in the medium containing Erythromycin 
(fig.24b), thus preventing growth of other streptococci.
Both types of media were used for isolating the organisms 
from the swabs used for testing for implantation.
It was obvious on macroscopic appearance, that a film was
129.
Pig.24a. Blood agar plates showing growth of Strep. 
mutans OHZ 176 E.
10 shov/s the original culture with// haemolysis
2. shov/s the culture of implanted and recovered 
organisms with fainter ft haemolysis.
1 2
130.
Pig.241. Brewers medium containing Erythromycin (lmg/ml).
1. shows the clear medium indicating no 
growth from the swah of control rabbit 1.
2. shows the cloudiness indicating growth 
from the swab of test rabbit 7»
I
developing over the incisors of the implanted rabbits that 
did not appear in the non-implanted, therefore Diet 2,000 
of KEYES and J0RDA1T (1964) was instrumental in allowing 
implantation. The diet was stopped for a fortnight with 
rabbit 8 and 0I1Z 176 E disappeared but was reimplanted on 
readministration of the diet. Therefore it may be concluded 
that a high sucrose diet was responsible for implantation in 
this case.
As reported in the results, those rabbits with implanted 
organisms ’foreign’ to their normal flora, developed a 
surface layer on their incisors and at the dento-gingival 
margin, resulting in the appearance of inflamed gingivae.
The bacteria that adhered in this area had not penetrated the 
intact epithelium to invade the tissue at all. This fact 
that bacteria do not invade the intact tissue has been 
observed at Electron Microscope level by EREEDMAK et al. 
(1968) and SUSSMAE et al. (1969), but it does not exclude 
the possible penetration of bacterial metabolites and/or 
toxins into this area.
In agreement with this, it was observed that the normal 
appearance of the rabbit gingiva at the labial mucosal- 
gingival site exhibited few inflammatory cells, whereas in 
the implanted animals, there was a large inflammatory cell 
infiltrate (figs.20a and b). Either bacterial- products were 
acting as antigens and causing an immunological response in 
the gingiva, and/or the accumulation of debris (including 
bacteria and the diet deposit) on the dento-gingival margin, 
was causing trauma of the tissue, resulting in inflammation 
and gingivitis. This immunological response demonstrates the
aoility of the tissue at the site of irritation to initiate 
a protective response to overcome the irritation. It 
appears that in this case, as well as in the human situation, 
the protective immune mechanism results in the release of 
substances including eg. lysosomal substances, pharmacological 
reagents and antibody with the capacity to bind to tissue, 
that are detrimental to the host during the process of 
combating local infection.
Examination of the rabbit serum and saliva by immuno- 
electrophoresis and immunodiffusion revealed the presence of 
immunoglobulins, as has already been described by CEBRA and 
ROBBIES (1966); CEBRA and SMALL (1967); CEBRA et al. (1968); 
GEECO and TAUBMAE (1969) and TAUBMAE and GEECO (1971) • The 
fact that these IgO, IgA and IgM immunoglobulins are present 
in both serum and saliva, though in different proportions 
from the human situation, indicates that the animals are 
capable of producing antibodies to foreign proteins, as has 
already been reported by BERGLUET) et al. (1969), GEECO and 
’TAUBMAE (1969) and TAUBMAE and GEECO (1971).
The immuno-fluorescence studies were carried out to 
determine if either serum or salivary antibodies had been 
produced, but none were detected. This means that either 
none were produced or that any that were produced in a 
nrimary response were immediately combined with the antigen 
before it could effectively provide enough antigenic 
stimulation to elicit a high titre of antibody in a secondary 
response. Alternatively, it could mean there was a lymphocyte-
mediated immune response.
In comparison, in the human situation, antibodies to a
streptococcus that is thought to play a causative role in 
the initiation of periodontal disease were present in the 
serum of "both periodontally diseased patients and control 
subjects. Salivary antibodies appeared to a greater extent 
in the healthy controls than in the diseased. Serum antibody 
levels may not be important in this case. Salivary antibodies 
could have some significance in that they might possibly be 
adsorbed to the greater numbers of accumulated bacteria in 
the diseased mouth and therefore be unable to carry out a 
protective role at the surface of the oral tissue although 
they are protecting the mouth from further bacterial attack.
It seems that possibly tissue mechanisms might play a more 
important role in combating oral disease than salivary 
mechanisms, although those people with periodontal involvement 
may have impaired secretory immunoglobulin mechanisms.
DICE and IROTT (l969,b and 1971) have demonstrated that 
antigen penetration of the gingiva cannot always be 
demonstrated due to efficient ingestion and inactivation by 
the host defence cells, which thus prevent the activation of 
antibody-forming cells. Any antibody formed as a result of 
minor leakage would enhance the phagocytic activity of the 
polymorphonuclear leukocytes (PMEs) (HAKP and POLKE, 1968) 
in the irritated gingival tissue. However, the bacteria 
themselves did not appear to penetrate the gingivae in this 
experiment, therefore it was concluded that the bacterial 
products caused the production of an inflammatory cell 
infiltrate in this case, to overcome the noxious agents.
Any salivary antibody produced due to their accumulation on 
the surface of the teeth on adsorption to the surface of the
bacteria (BRAILDTZAECr et al. 1968,b) would render nil, the 
possibility of its detection by the method used.
COEOLUSIOES
It appears that the continued presence of an organism 
in persons with a more competent immune system enables 
health to be maintained; implantation of a new organism 
does not result in sufficient quantities of salivary anti­
body to overcome its effect.
It seems probable from these results that it is 
necessary to implant the antigen into the pocket as did 
RIZZO and MITCHELL (1966) and R A MEY (1970) or to cause 
irritation with an inert substance such as cervical 
ligature (ROVIM et al. 1966) in order to allow sufficient 
antigen penetration to stimulate the production of detectable 
amounts of antibody in the serum or saliva and in the tissue 
locally. In the human situation, the PMH infiltration is 
followed by antibody-producing plasma cells, on continued 
irritation of the gingiva (ZACCHRISSON, 1968; PORTEOUS, 1969; 
PLATT et al. 1970 and BSRGLUED, 1971).
In animals, previously sensitized with the antigen, 
the tissue antibody response would be much greater, and 
the antibody would combine with the antigen and the 
resulting complexes would attract PMHs. Their'action, 
although removing the antigen, would lead to tissue 
destruction.
This might be the case in the human mouth, with continual 
sensitization of the gingiva by bacteria and their meta­
bolites, some of which might have adjuvant activity, and
micro-ulceration of the gingival epithelium, leading 
eventually to tissue destruction by the body’s endeavour 
to overcome this infection locally.
CHAPTER 7.
STUDIES OH THE LOCAL IMMUNIZATION 
__________ OP RABBITS.
INTRODUCTION
Immunization against periodontal disease and/or dental 
caries is attractive. Results of immunization studies to 
date (WAGNER, 1966; 1967 and BOWEN, 1969,a) are encouraging 
even if the mechanisms cannot yet he fully explained.
Rodents were chosen for this investigation because of 
ease of examination of the oral cavity; the possibility of 
producing antibody in rabbit saliva against a single antigen 
was studied.
Dental plaque is so complex and the oral microflora so 
varied, that no single antigen has so far been identified as 
the causative agent of the different oral diseases. Any 
plaque antigen chosen would be removed from its usual 
environment and could well have a different effect from that 
exerted normally in the human mouth and might not necessarily 
be antigenic in the rabbit mouth (cf. CEBRA and ROBBINS (1966) 
who failed to elicit antibody in colostrum to Perritin 
injected in the rabbitmammary gland). Active immunization 
was therefore attempted with a single solution of human 
gamma globulin to investigate the best route of inoculation 
that would give maximum local antibody production. Immun­
ization passively, with human plasma albumin, human serum 
and horse anti—human IgG was also attempted.
MATERIALS AND METHODS 
Laboratory animals-
Six male Californian rabbits weighing 2-3 Kg. were used
in each, series of immunization experiments. They were fed 
their normal diet.
Collection of rabbit serum and saliva-
Serum and saliva samples were collected as described 
in Chapter 6.
Concentration of rabbit saliva-
The rabbit saliva was concentrated as outlined in 
Chapter 6.
Immunoelectrophoresis and Immunodiffusion-
The same techniques were employed as described in 
Chapter 6.
Active immunization schedules-
sham-
A control rabbit that was not immunized or was^immunized 
with physiological saline was included in each series of 
immunization experiments. The injection schedules are out­
lined in Tables 10a,b,c. Kabi gamma globulin was the antigen 
(Ag) used. Immunoelectrophoretic examination of the serum 
and saliva from the rabbits before injection, revealed that 
they had no natural antibodies to this antigen; haemagglut- 
ination was also used to confirm this fact (Vide infra).
’Passive1 immunization schedules-
A minimum of two rabbits was used in each test.
1. 1.0ml of normal human serum was injected intra-venously.
2. 0.65ml of Horse anti-human IgG (Nordic Pharmaceuticals
and Diagnostics, 91 Amhurst Park, London N16) was 
injected intra-venously.
3* 0.2g of Human plasma albumin (Behringwerke AG, Hoecbst
Pharmaceuticals, Hoechst House, Salisbury Hoad,
Hounslow, Middlesex, England) in 0.6ml sterile, distilled 
water, was injected intra-venously.
4. 0.2g of Human plasma albumin (Behringwerke AG) in 0.6ml
sterile, distilled water, was injected intra-peritoneally.
2 uninjected rabbits were used as controls; the saliva of 
the animals used for injection was tested beforehand for the 
presence of antibodies to the antigens used, by immunoelectro- 
phoresis and haemagglutination. If antibodies were already 
present, they would combine with the substance being 
injected and prevent any transport into the saliva.
Haemagglutination-
The method in ’Handbook of Experimental Immunology'
(edited by'WEIR, 1967)was followed; see fig.25.
(i) This test was used to determine the serum and salivary 
antibody titres produced in response to active immunization 
with gamma globulin. 20mg of gamma globulin was coated onto 
the red blood cells. All tests were repeated to check the 
results obtained.
(ii) This test was also used to check for the presence in 
saliva of the proteins it was proposed to administer 
parenterally. 20mg of each of the following proteins was 
coated onto the tanned red cells to determine whether any of 
the substances to be injected as outlined in the previous
Table 10a. Active Immunization schedule 1.
Rabbit
number
1.
2.
3.
4.
5.
6.
1 st 
injection
8mg Ag+FCA 
i-m
As in 1 •
As in 1.
5mg Ag/Kg 
body weight 
i-gingiva
As in 4.
As in 4-
-28days- 2ndinjection
5mg Ag 
i-v
1.Omg Ag 
i-lymph node
10mg Ag/day 
in drinking 
water
1.Omg Ag 
i-right cheek
1Omg Ag/day 
in drinking 
water
I.Qmg Ag 
i-lymph node
-10days-
The antigen (Ag) used was Kabi gamma globulin; serum 
collected 10 days after injection in each case.
Key: FCA = Freunds Complete Adjuvant
i = intra
i-v = intra-venously 
i-m = intra-muscularly
3rd
injection
2mg Ag
i-left cheek 
As in 1.
As in 1. 
rabbit died
1.Omg Ag 
i-left cheek
2mg Ag
i-left cheek
and saliva were
Table 10b> Active Immunization schedule 2
Kabbit 1st Q 2nd 3rd 4th
number injection injection ^^injection” a^S*”injection
1.
2.
3.
4.
5.
6.
5mg Ag/Kg 
body weight 
i-left S-M 
gland
As in 1.
As in 1.
As in 1.
4 i-m 
injections 
of lOmg Ag 
+ PCA
As in 5.
2mg Ag
i-left cheek
1Omg Ag/day 
in drinking 
water
2mg Ag . 
i-left cheek
10mg Ag/day 
in drinking 
water
5 mg Ag 
i-left S-M 
gland
5mg Ag 
i-v
2mg Ag
i-left cheek
As in 1•
As in 1.
As in 1.
As in 1•
No
injection
2mg Ag 
i-left cheek
As in 1.
As in 1.
As in 1.
As in 1.
0o2ml NaCl 
(physiological) 
i-left cheek
The antigen (Ag) used was Kabi gamma globulin; serum and saliva were 
collected 10 days after injection In each case.
Key: FCA = Freunds Complete Adjuvant
i = intra
i-v = intra-venously 
i-m = intra-muscular 
S-M = sub-mandibular
Table 10c. Active immunization schedule 3
Rabbit 1st
number injection-28days-
2nd 
injection-14days-
3rd 
injection-14days-.
4th
injection
1.
2.
3.
4.
5.
6.
16mg Ag + 
FCA
i-m in 2 
sites
As in 1.
As in 1
As in 1 
As in 1
I2mg Ag + 
FCA
i-m in 2 
sites
5mg Ag 
i-v
5mg Ag 
i-left
parotid gland
As in 2. +
1.Omg Ag 
i-left cheek
As in 3.
5mg Ag 
i-left
parotid gland 
+ 1.Omg Ag 
i-m
As in 5.
0.2ml NaCl Ro
(physiological) injection 
i-left
parotid gland
2mg Ag 
i-left
parotid gland 
As in 2.
As in 2. 
As in 2.
As in 2.
2mg Ag 
i-left
parotid gland 
As in 2.
As in 2. 
As in 2.
As in 2.
The antigen (Ag) used was Kabi gamma globulin; serum and saliva were 
collected 10 days after injection in each case.
Key: FCA = Freunds Complete Adjuvant
i = intra
i-v = intra-venously 
i-m = intra-muscularly
section was already present in the rabbit saliva.
1. Hyland goat anti-human normal serum.
2. Kabi gamma globulin.
3. and 4* Hyland goat anti-human plasma albumin.
All tests were repeated to check the results obtained.
In (i) and (ii) the dilute or concentrated saliva, and 
serum, collected from the rabbits was termed the 1 antiserum1 
in these experiments and was absorbed with tanned red cells 
to remove non-specific organisms. Positive and negative 
controls were always set up concurrently with the tests. The 
negative control consisted of tanned red cells plus the 
antiserum used in the test; the positive control consisted 
of red cells coated with a substance known to react with the 
test antiserum. Other controls were set up as follows:
a. Washed red blood cells (RBCs) plus antigen.
b. Washed RBCs plus rabbit serum (absorbed and inactivated
with sheep red blood cells).
c. Washed RBCs plus saline (PBS).
d. Washed RBCs plus 1°/ rabbit serum*/PBS.
e. Tanned RBCs plus PBS.
f. Tanned RBCs plus rabbit serum* (not absorbed and
inactivated).
g. Tanned RBCs plus rabbit serum* (absorbed).-
h. Tanned RBCs plus lc/o rabbit serum*/PBS.
i. Tanned RBCs plus antigen (absorbed),
j. Coated RBCs plus PBS.
k. Coated RBCs plus rabbit serum* (not absorbed and
inactivated).
1. Coated RBCs plus 1$ rabbit serum*/PBS.
HAEMAG-G-LUTINAT ION.
Sheep red blood cells, washed 3x in PBS,pH 7.2.
2x 0.6ml red blood cells + 10ml Ufa Tannic acid in PBS 
Incubated for 15 minutes at 37°C in water bath.
Wash red blood cells 2x in PBS.
lx 0.6ml red blood cells 1x^0.6ml red blood cells.
CONTROL. Add 2 Omg of absorbed antigen
10ml PBS and incubate in
31°0 water bath for 50 
minutes-.
Wash 3x in PBS + 1 inactivated and absorbed (commercial)* 
rabbit serum; serum added to prevent spontaneous agglutination.
iRed blood cells suspended in 50ml PBS/Rabbit serum (1%) to 
give a Vfo suspension for the haemagglutination test.
CONTROL - TANNED. TEST, - COATED.
Pig.25 Plow diagram to outline the method used in the 
haemagglutination reaction, to prepare"the red 
blood cells.
ICey: *!he rabbit serum was obtained from Plow Laboratories
Ltd., Victoria Park, -Heatherhouse Road, Irvine, 
Ayrshire, Scotland.
PBS = Phosphate Buffered Saline, pH 7.1.
The haemagglutination reactions were carried out in 
plastic agglutination plates, with wells 1.5cm in diameter 
(Plow Laboratories Ltd.). 0.1ml of a 1$ suspension of 
sensitized (i.e. coated) cells was added to 0.1ml of a 
doubling dilution of the absorbed 1 antiserum1; the doubling 
dilutions were made in physiological saline. The results 
were read after overnight incubation at room temperature, in 
a moist atmosphere to prevent drying out. The end point 
(i.e. titre) was estimated as that dilution of fantiserum* 
causing the formation of a pellet of red blood cells with a 
surrounding ring.
The haemagglutination test was used because rabbit 
saliva is rich in IgG- (unlike human saliva) (TAUBMAN and 
GENCO, 1969) and should therefore be a sensitive test for 
any antibody produced, being more specific for IgG- antibodies 
than IgA.
Immuno-fluorescence studies on rabbit sub-mandibular 
salivary g l a n d - _________________________________
The left sub-mandibular gland was removed from a rabbit 
with a salivary anti-human gamma globulin titre of 1:10 
after local administration of antigen in the oral cavity. 
Prozen sections were cut at -20°C in the cryostat, fixed in 
neutral buffered formal saline for 15 minutes at 4°C and then 
washed in PBS, pH 7.1 for 10 minutes.
The presence of anti-human gamma globulin producing 
cells was tested using the method outlined in Chapter 6, pill, 
section I, using the gamma globulin in the concentration in 
which it was injected, on the section, as in stage 3; Hyland 
goat anti-human IgG (fluorescent) was added at stage 5.
The class of rabbit immunoglobulin that might produce 
antibody in the salivary gland was determined by the method 
outlined in Chapter 6, pill, section I, using goat anti- 
rabbit IgG and IgA (liiles-Yeda Ltd.) at stage 3> and rabbit 
anti-goat gamma globulin (fluorescent) (Difco), at stage 5.
Negative controls were set up as before to eliminate 
the possibility of non-specific fluorescence.
RESULTS
A. ACTIVE IMMUNIZATION.
Examination of serum and saliva by immunodiffusion-
On analysis by immunodiffusion, it was observed that 
there were no serum or salivary titres to the Kabi gamma 
globulin, used as antigen, before injection, as no precipitin 
lines appeared in the agar.
Examination of serum and saliva by haemagglutination-
The serum and salivary titres obtained in the three 
active immunization schedules are. shown in Table 11. Eairly 
high serum titres were obtained in agreement with BERGLUND 
et al. (1969) who induced serum antibody to the lipopoly- 
saccharide somatic antigen of E. coli on intra-mucosal 
injection; they did not however, report salivary titres.
None of the injection schedules used was successful in 
producing high salivary antibody titres although low titres
were achieved.
The best salivary antibody titre was obtained with an 
intra-muscular injection to prime the animal followed by 
local immunization (schedule l); purely local immunization
Table 11. Serum and salivary antibody titres-on 
measurement by haemagglutination after 
active immunization.
Rabbit
number
Serum
titre
Salivary
titre
Serum
titre
Salivary
titre
SCHEDULE 1. After 2nd injection After 3rd injection
1. 1/1 280 - > 1/5120 1/20
2. 1/5120 - >1/5120 1/20
3. >1/5120 - >  1/5120 1/10
4. 1/1280 - Rabbit died
5. 1/20 - 1/160 -
6 c 1/1280 - >1/5120 1/10
SCHEDULE 2. After 3rd injection After 4th injection
1. 1/10 - 1/640 -
2o 1/40 - 1/640 -
3. 1/160 - 1/640
4. - - - -
5. 1/160 1/10 1/640 1/10
6. 1/640 - 1/640 -
SCHEDULE 3. After 3rd injection After 4th injection
1. 1/20 - 1/40 -
2. 1/10 1/40 1/2
3. 1/160 - 1/320 1/4
4. 1/40 4/4 1/40 1/2
5. 1/160 - 1/160 -
6. 1/160 - 1/160 1/2
Key: >  = greater than
did not result in the presence of any measurable titre of 
salivary antibody with the techniques presently employed 
(scnedule 2). Schedule 3 was difficult to carry out as the 
parotid gland is in a very inaccessible site in the rabbit 
mouth.
Examination of serum and saliva by immunoelectrophoresis-
The serum and saliva (lOx Lyophilised) of rabbits 1-6 
on injection schedule 3 after the 3nd injection were examined 
immunoelectrophoretically for the presence of antibodies to 
the gamma globulin, used in the quantities in which it was 
injected. Por example, rabbit 3 had a serum titre of 1:160 
and rabbit 4 had one of 1:40; precipitin arcs appeared in 
the gamma globulin region, indicative of antibody production 
(fig.26a). On examination of the concentrated saliva, it 
was noted that although rabbit 4 had a 1:4 titre by haemagglut 
ination, no precipitin arcs appeared in the gamma globulin 
region. None appeared, as expected with rabbit 3 as it had 
a zero haemagglutination titre (fig.26b). Therefore it was 
confirmed that haemagglutination was a more sensitive method 
than immunoelectrophoresis for the detection of antibody 
production in the serum and saliva of rabbits.
Immuno-fluorescence studies on rabbit sub-mandibular 
salivary gland after active immunization-___________
Immuno-fluorescent antibody pictures obtained on 
examination of the injected sub-mandibular salivary gland 
indicated that antibody to the injected gamma globulin was 
produced by the inner cells of the intra—lobular salivary 
ducts in which some brightly fluorescing cells were observed.
Cells producing both rabbit IgA and IgG were present in 
this- site.
B. 1 PASSIVE» IHMUN IZ AT I ON.
Examination of rabbit saliva by haemagglutination-
This test was used, before passive immunization was 
commenced, as the most sensitive test to determine if anti­
bodies were already present to the substances to be injected 
parenterally. All tests proved negative using lOx lyophilised 
saliva.
Examination of rabbit saliva by immunoelectrophoresis
and immunodiffusion-_______________________ _____ _
It appears that after injection of 1. Human serum,
2. anti-human IgG and 3. plasma albumin, intra-venously, and 
examination of the 20x Lyophilised saliva collected after 
injection, that some of the substances when administered 
parenterally do appear in the saliva, which is collected for
1 - It hours after immunization. This confirms the report of 
SCHEIN and TUNG (1962) who detected parenterally injected 
albumin in pilocarpine—stimulated raobit saliva, by immuno­
diffusion analysis.
Examination of the patterns obtained on immunodiffusion 
and immunoelectrophoresis of the saliva against the antiserum 
to the injected substances, led to the following observations.
a) Some of the human serum protein appeared in the saliva,
as a precipitin arc appeared between the rabbit saliva
and the anti-human serum, although not all the human 
serum protein components did (fig.27)«
b) There was a faint precipitin arc between the saliva of
149.
Pig.26a. Immunoelectrophoretic examination of rabbit
serum containing antibodies to gamma globulin 
after active immunization (x2).
Wells contain Kabi gamma globulin 
1. Rabbit 3 serum; 2. Rabbit 4 serum.
150.
Pigo26b. Immunoelectrophoretic examination of rabbit 
saliva with and without antibodies to gamma 
globulin after active immunization (x2).
Wells contain Kabi gamma globulin
3. Rabbit 3 saliva. 4. Rabbit 4 saliva.
In both cases, the anode is to the left and the cathode is 
to the right.
11
the rabbit injected parenterally with anti-IgG, and 
the IgG itself on examination of the rabbit saliva by 
immunodiffusion and immunoelectrophoresis. This result 
was not convincing,
c) Human plasma albumin appeared in the saliva of the
rabbits intra-venously injected; it was readily detected 
by immunoelectrophoresis and immunodiffusion of the 
rabbit saliva against anti-human plasma albumin and a 
line of identity was produced between the albumin in the 
rabbit saliva and the albumin injected into the rabbit 
(fig.28). No albumin was detected in the saliva of the 
rabbits injected intra-peritoneally.
DISCUSSION
As stated before, the ultimate aim of this work was to 
endeavour to produce a satisfactory form of injection schedule 
as a means of inducing immunity to, and thus preventing oral 
disease•
A. ACTIVE IMMUNIZATION.
As can be seen from the results obtained, none of the 
injection schedules employed, using gamma globulin as antigen, 
was highly successful in producing salivary antibody, as even 
titres of 1:10 and 1:20 do not seem sufficiently high to 
overcome a challenging agent, except as an ancillary mechanism 
to other protective immune processes. Quite high serum 
titres were obtained in some cases however. High titres were 
not recorded either by RAMEY and ZANDER (1970) on measurement 
of serum antibody after sensitization of squirrel monkeys.
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Pigo27 Immunodiffusion of rabbit saliva, after 
parenteral immunization with human serum, 
against anti-human serum. (x4)•
1. 1:10 human serum;
3. 20x Lyophilised
saliva;
2. 1:10 human serum
4. 20x Lyophilised 
saliva;
5. 1:20 human serum
7. Hyland goat anti-human serum
6. Unconcentrated rabbit 
saliva
4
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Figo28. Immunodiffusion of rabbit saliva, after
parenteral (i-v) immunization with human
plasma albumin, against anti-albumin (x4).
1. Human plasma albumin; 2. rabbit serum from
immunized animal.
3. unconcentrated rabbit saliva
4. 20x lyophilised saliva after i-v immunization.
5. 20x lyophilised saliva before i-v immunization
6. Hyland goat anti-human plasma albumin
Key: i-v = intra-venous„
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Haemagglutination was used to measure the antibody 
titres because, unlike human saliva, IgG- is the predominant 
immunoglobulin in rabbit saliva (G-EHCO and TAUBMAN, 1969) 
whilst IgG- is the predominant immunoglobulin in both human 
and rabbit serum. It was therefore felt that this should 
be a sensitive test. As mentioned in the results, neither 
immunoelectrophoresis nor immunodiffusion was considered to 
be as sensitive a method for the detection of antibody, even 
in ’concentrated1 saliva. This is not surprising as it is 
not a quantitative test and is not sensitive enough to 
detect minute quantities of an antigen.
The greatest salivary titre was obtained by injecting 
into the local lymph node after either systemic or local 
challenge by the antigen. This would seem to be in accordance 
with the results of G-OUDIE et al. (1966) who recommended 
injection of very small amounts of antigen into the lymph 
node to produce a high antibody response. The second best 
salivary titre v/as obtained by injection of the antigen into 
the sub-mandibular gland (supported by the results of the 
immuno-fluorescent studies on rabbit sub-mandibular gland) 
or by administering it in sufficient quantities in the 
drinking water after primary systemic challenge, or by 
injecting the antigen into the local lymph node after local 
challenge. However, it may not be feasible to administer 
antigen in this way in the human situation because of the 
possible atrophy or allergic response of the glands or lymph 
node when directly injected.
EMMING-S and G-EHCO (1972) have reported that they 
obtained a response after injecting dinitrophenylated bovine
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serum albumin directly into surgically exposed sub­
mandibular glands of rabbits with and without adjuvant and 
also with and without intra-peritoneal pre-immunization.
They detected the antibody formed as a result, by immuno­
fluorescence techniques. Serum titres to this antigen were 
measured but salivary titres were not recorded. The fluor­
escence results obtained as mentioned on page 147 also 
showed that antibody was produced to the injected gamma 
globulin, indicating that a mechanism for antibody production 
may exist in the gland on direct stimulation after initial 
systemic challenge. The antibody that was produced was not 
predominately of a specific class, as compared to the results 
of the above-mentioned authors who found that injection of 
the antigen in saline resulted in a 30-90$ IgA response; 
pre-immunization, or antigen injected in adjuvant, resulted 
in a predominance of I g G r .  All results show that route of 
injection determines the response. It is not yet known if 
the parotid gland reacts in the same way after direct 
injection.
COHCLirSXOHS (A.)
It is concluded at this stage that although serum titres 
can be obtained to a simple antigen, it is difficult to 
produce a parallel salivary titre using the above methods of 
immunization and detection. There could be a number of 
reasons for this failure:
i) The wrong antigen might be being used, as CEBRA and 
ROBBINS (1966) discovered when they failed to elicit an anti­
body response to Ferritin in rabbit colostrum even though
their secretory
mechanism may be identical to that of the human salivary glands which 
are unable to produce high concentrations of salivary antibody,
5 ) Antibodies do not readily enter saliva because they may be too 
large to pass through the salivary gland, gingival fluid perhaps being 
the source of these substances in the mouth.' _
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serum titres were obtained, after local injections of the 
antigen into the mammary gland.
2) Eon-optimal routes of injection might have been employed.
3) Eon-optimal detection methods might be employed, even 
though the haemagglutination test measures 0.003 yug of anti­
body Mtrogen.
4) The rabbit may not be able to produce large amounts of 
salivary antibodyjX
If it is the secretory IgA that is important in protect­
ing the rabbit mucous membranes as it seems to be in humans, 
then even though it is produced in increased amounts on local 
immunization, it would possibly not be detected by 
haemagglutination as this is not a very specific test for 
this immunoglobulin, especially as it is not the predominant 
immunoglobulin in either rabbit saliva or serum.
It must be remembered that an antigen must be-non-toxic 
and a disadvantage of active immunization is that if. any 
active principle was found that contained streptococcal 
components, there would be a danger in producing sub-acute 
bacterial endocarditis. Plaque is so complex and although 
it has been shown to contain at least two toxins (LEVINS,
1972), it will be difficult to produce a non-toxic, active 
antigenic principle from it.
B. 1 PASSIVE’ IKTIUEI Z AT I ON.
The ’passive’ immunization schedules were more successful. 
On examination of the rabbit saliva after intra-venous 
injection it was discovered that some component of human 
serum, and definitely human plasma albumin (when injected
singly) appeared in the rabbit saliva, collected shortly 
after injection. Horse anti-human IgG was not so evident 
in the saliva after it was injected intra-venously and human 
plasma albumin, after intra-peritoneal injection did not 
appear at all in the saliva.
There therefore appears to be a diffusion from the serum 
into the saliva of certain substances, depending on their 
molecular weight. That of albumin is 69,000; other human 
serum components have molecular weights of under 100,000 
(Spl=Table 2) but the antibody molecules such as Horse anti­
human IgG- have a molecular weight of at least 160,000. 
Therefore the smaller molecular' weight substances can appear 
in the saliva, and also fragments of larger molecules which 
may still be detected immunochemically in this case, if the 
antigenic part of the antibody molecule i.e. the :FQ piece 
(Spl fig.l 0 diffuses through. This would explain the 
presence of albumin, some of the serum components and the 
variable presence of anti-IgG in the saliva. In addition, 
in disease and the resulting tissue breakdown, more serum 
components will pass into saliva, than when the glands and 
tissue are intact.
The immunodiffusion results of the passively injected 
human plasma albumin proved interesting in connection with 
the immunological investigation of human salivary albumin 
(Chapter 4-).
In these experiments, salivary albumin against anti­
human plasma albumin (fig.14) gave an arc whereas plasma 
albumin against anti-human plasma albumin gave a number of 
arcs. A similar result was obtained on immunodiffusion of'
*Spl = Supplement
the albumin which was injected intra-venously in the rabbit, 
which appeared in the rabbit saliva. This albumin gave one 
band with anti-plasma albumin and a line of identity with 
human plasma albumin, indicating that it was the injected 
albumin that appeared in the saliva. However, a number of 
other bands (faintly-staining because of the low concentration 
of albumin in the well) also appeared in this diffusion of 
control albumin against anti-human plasma albumin (fig.28) 
giving the same picture as in fig.14, and emphasising the 
greater heterogeneity of plasma albumin.
CONCLUSIONS (B).
It may be concluded from these results that although 
there is salivary albumin in saliva, giving an arc in the 
albumin region on immunoelectrophoresis of mixed saliva 
against anti-mixed saliva (fig.13c) there is also a diffusion 
of one antigenic component, or a modified antigenic component, 
of plasma albumin into human saliva. This is probably more 
evident in the saliva of patients with periodontal disease.
As the anti-mixed saliva used in Chapter 4 was prepared from 
saliva from volunteers with clinically healthy mouths, little 
plasma albumin would be present in it and so result in the 
pictures obtained there.
Finally, it appears that passive immunization might be 
successful if the antibody to the toxic substances in plaque 
that cause the most harm could be digested with pepsin, to, 
allow the P ^ fragment (the antigen-binding part of the 
molecule) to diffuse into saliva after intra-venous injection. 
The main disadvantage is that continual passive immunization
can result in serum sickness (see Supplement, p. 15 ).
Final analyses-
From the results of this study, it would appear that 
continued experimental work in both active and passive 
immunization would be valuable, especially if the ’active' 
toxin(s) of plaque (once characterized) could be utilized, 
eg. in the form of a toxoid. The toxoid could be used for 
the production of an antiserum or as the antigen in active 
immuni zat i on.
Active immunization studies in animals on the route of 
injection to stimulate maximal local antibody production is 
important. As only smaller molecules appear to infiltrate into 
saliva from serum, this is more important than producing high 
systemic antibody titres.
Passive immunization studies with the ’Active’ principle 
of an antiserum for short-term immediate protection must also 
be pursued. Therefore studies on the production of an anti­
serum to toxic plaque antigens, with subsequent fractionation 
of the antiserum to produce the small molecular weight, .• 
antibody-binding fraction (Fa^ part: see Spl. fig. 1) for 
injection, are important.
CHA3-TKR 8 .
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GENERAL DISCUSSION.
Ever since the days of Louis Pasteur and rabies 
vaccination, medical research has been concerned with experi­
mentation on immunization as part of the whole research in 
the science of immunology. The immune system is concerned 
with defence against foreign substances, with discriminating 
between ’self’ and ’non-self1, with inflammation and with 
repair. Some of these reactions, although all have the 
ultimate aim of benefiting the person concerned, may result 
in processes detrimental to the host due to their intrinsic 
properties. They may also malfunction and thus induce auto­
immune disease.
Immunization studies are employed to investigate anti­
body responses and their role in overcoming disease. However, 
in an area as complex as the oral cavity, it cannot be 
assumed that an antibody response is the sole existing immune 
mechanism. However, it was felt that a study of immunization 
in connection with oral disease, to investigate if local 
antibodies could be induced and so enhance one of the existing 
oral immune mechanisms, would be of value.
As stated in the introduction, saliva is a complex 
substance with varied and fascinating properties; the 
complexity of these and the problems arising from their 
investigation is amply illustrated in Chapters 3 to 7.
Saliva contains non-specific immune mechanisms. Its 
viscosity protects the mucous membranes but this very property 
can give rise to experimental difficulty in that it provides 
a base for the deposition of oral debris and growth of
bacteria. It also contains enzymes such as lysosyme, which 
help to combat infection. Bacteria are always present in 
the mouth and when there is a rise in salivary pH, due to 
their action or by loss of COg, there is precipitation of 
salivary constituents resulting in their deposition on the 
teeth. Bacteria adhere to this deposit, and if it is not 
removed, their numbers increase and bacterial plaque is 
formed (see Chapter 2). Also LEACH and MELVILLE (1970) have 
described the mechanism whereby the terminal sialic acid is 
removed by enzyme cleavage from the carbohydrate side chains 
of the glycoprotein; accordingly a bacterial deposit is 
formed.
Bacterial plaque accumulates in the absence of effective 
oral hygiene measures with the potential to cause periodontal 
disease and dental caries. Secretory IgA antibodies to 
Strep, mutans prevent, in the absence of complement, the 
colonising of the teeth (TAUBMAN and GENCO, 1971). However, 
irritation of the gingiva allows exudation of complement- 
containing crevicular fluid, and colonisation of the teeth 
can be initiated. The subsequent build-up of organisms and 
debris causes continual irritation and stimulation of the 
immune system, in order to cope with these ’non-self’ 
substances. This may result in paralysis of the immune 
system. Continual low-level stimulation results in low levels 
of antibody which combines with the antigen thus removing the 
stimulation of the competent cells. New antigens can then 
leak in from plaque and the process is repeated to induce 
tolerance.
Alternatively, large amounts of antigen overload the
system, which cannot cope with the continual onslaught of 
concentrated antigen, and this results in immune-paralysis. 
From work outlined by COHEN (1970), on low zone and high 
zone paralysis of immune reactions, it appears that there 
are low affinity and high affinity competent antibody- 
producing cells, the former having higher site numbers for 
the attachment of antigen than the latter. Cells with high 
affinity have more chance of capturing antigen and being 
stimulated to proliferate and produce antibody. With high 
doses of antigen, such as from large amounts of plaque, even 
low affinity cells combine and give antibodies of low 
average affinity. COHEN (1970) believes that the antigen is 
processed to make it immunogenic, all competent cells having 
receptors enabling this immune reaction to take place.
Interaction of a single molecule of antigen with 1 
receptor leads to paralysis; interaction with more than one 
antigen molecule induces antibody production. Higher doses 
of antigen saturate the cells with low site numbers first 
and then leave them in their tolerant state. As antigen 
concentration increases, there is a fall below the activation 
threshold of low affinity cells first (higher site numbers) 
and then the activity of the high affinity cells is picked 
up and so the average affinity of the antibodies is increased 
i.e. when the animal or human escapes from high zone 
tolerance or is partially tolerant, the antibody will be of 
low affinity. This could explain the lack of significant 
change in the salivary and serum IgA levels in the different 
periodontal disease states, especially in chronic conditions 
where the immune system is continually overloaded with
Erratum: ppl63 and 176.
TAUB et al (l970,b) should read 
, DRESSER, D.W., TAUB, R.N. and KRANTZ, A.R, 
Immunol. 18 (l970,b) 663-670.
antigens.
Immune paralysis seems a likely explanation for the 
continued presence of periodontal disease as the antigen(s) 
are always present. The paralysis may explain why there is 
no response that overcomes the plaque antigen(s) as there 
is in eg. a streptococcal infection of the throat.
This theory may also account for the low levels of 
antibody produced in the immunization schedules, as the dose 
of antigen required to give maximum response is crucial.
X. TAUB et al (1970 a and b) experimented with the 
injection of substances directly into the lymph node (in 
mice). Injection of substances with extrinsic adjuvanticity 
caused paracortical expansion and hyperplasia of the nodes. 
This was partly due to augmented cellular traffic with a net 
flux of recirculating lymphocytes into these areas. 
Substances with intrinsic adjuvanticity led to a marked 
influx of lymphocytes. In both cases, therefore, there was 
an increase in the number of cells in contact with antigen. 
This may be the reason for the higher degree of success in 
producing local antibody on injection into the lymphnode 
and suggests that further studies-on immunization in this 
area would be justified. Injection of substances with 
extrinsic adjuvanticity would be less likely to cause 
irritation of the node. It is apparent therefore, that the 
route of injection, as well as antigen concentration and 
composition, is of the utmost importance.
Induction of high serum titres by active immunization 
might not necessarily be of great value, if the antibody 
molecules are too large to diffuse into the mouth, which
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might he the case as concluded from the results of Chapter 4 
and Chapter 7. As stated in the latter, passive immunization 
with- the active binding part of the antibody molecule would 
be of more value, for immediate treatment of an acute 
condition, as in eg. tetanus or german measles infection, 
although this could be harmful. Serum-sickness can be 
induced if passive immunization is used for long-term 
therapy.
Apart from the variation in serum and salivary anti­
bodies, another notable feature of periodontal disease is 
the change in the pathology of the periodontium. The initial 
rise in polymorphonuclear leukocytes, PMNs, illustrated in 
rabbits in Chapter 6, may indicate an Arthus-type reaction, 
because of the repeated exposure of the gingivae to bacterial 
antigens and plaque deposits in concentrations within those 
levels that may induce immune-tolerance. Arthus activity is 
decreased on depletion of PMNs in rats (WARD and COCHRANE, 
1965) even though complement and immune reactants are present. 
Rats and guinea pigs vary in their response with complement 
present, depending on their complement-fixing capacities 
’in vitro’ but their results outline the importance of 
continued PI-IN presence for the Artlms-type reaction.
An alternative mechanism may be due to the fact that 
antigen in sensitized tissues rapidly combines with any 
antibody produced to it. These complexes attract PMNs and 
lead to phagocytosis and therefore destruction of antigenic 
properties (BOYDEN, 1962). However, tissue destroyed in this 
process would allow further inward leakage of plaque antigens. 
With the resulting rapid introduction of the antigens in
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large numbers, insufficient antibody could be produced in 
sufficient time to complex all the antigen and some of the 
latter would remain free, to promote further immune reactions.
An increase in the number of plasma cells after FMN 
infiltration may result in a further inflammatory response 
of an anaphylactic type. The breakdown of the tissue after 
initial sensitization could result in the second shocking 
dose of plaque antigen(s) being administered. Complement is 
present in the crevicular fluid and serum and a local 
anaphylaxis could occur. Salivary IgA on infiltration into 
the destroyed tissues may aid the anaphylactic reactions.
GREEN et al (1970) outlined an interaction between monovalent 
antigen and antibody at the. mast cell surface, which in the 
absence of complement can provide an anaphylactic reaction. 
Also, if antibody is adsorbed first to the cell surface, 
complement is not necessary. IgA does not fix complement 
and could therefore aid the response in this additional type 
of anaphylactic process. The release of pharmacalogically 
active substances would further destroy the periodontal 
tissues.
IEHMER, in his 1972 'Review of Cell-mediated immune 
responses in connection with oral disease?, provides substan­
tial evidence for the involvement of these mechanisms, to 
varying extents, in connection with the different types of 
disease. The local tissue is capable of eliciting a cellular 
response to the bacterial antigens present in the plaque, 
with a subsequent breakdown of tissue.
From the results obtained in this work reported in this 
thesis, only the surface of the problem has been investigated,
but tlie results obtained can be seen to illustrate several 
of the reactions outlined above. It appears that no single 
mechanism of all those present in the oral cavity, is 
involved. The diversity of the responses the local environ­
ment is capable of making is another factor that causes the 
tissue destruction and inflammation that is representative 
of periodontal disease in its different manifestations. 
Salivary antibodies have a role in these processes but their 
action is perhaps more confined to the dental caries process 
i.e. salivary IgA is removed from the saliva by its adherence 
to oral bacteria (BRANDTZAEG- et al. 1968) i.e. as plaque 
accumulates, the antibodies are less able to cope. It also 
seems to be generally accepted that people less prone to 
caries have more IgA in their saliva than those who are 
caries-susceptible (see Chapter 2). However, they may play 
an important role in the pathogenisis of periodontal disease, 
as is mentioned above.
Thus, from the theories already outlined, the most 
fitting conclusion appears to be that proposed by RANNEY and 
ZANDER (1970): "Thus it may be hypothesised that periodontal
disease may in some instances be a by-product of a successful 
endeavour by the immune system to protect the body as a whole 
from foreign materials, with the periodontium undergoing 
progressive chronic destruction with eventual loss of support 
from the teeth as a result of the local injurious nature of 
the immune reactions". Control of these immune mechanisms 
must be sought to lessen their destructive properties and to 
aid recovery from oral diseases.
CHAPTER 9.
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BASIC CONCEPTS IN IMOJNOIOC-Y.
It was felt that a resume of some basic immunological 
concepts, and the immunological mechanisms pertinent to the 
subject would be of use for reference when dealing with the 
interpretation and discussion of the results and with the 
general conclusionso
Iffi-IUNITY
Vertebrates, excluding the most primitive, when they 
come in contact with a ’foreign’ agent or material, can to 
a varying extent, exhibit an immune reaction which can be 
’non-specific* or ’specific1. Non-specific immune mechanisms 
include innate, which is ratialiy or genetically determined; 
racial differences in susceptibility to disease; age, as 
the old and the very young are more susceptible to disease; 
and hormones, which if inefficient in their job render one 
more susceptible. Skin and mucosae act as both mechanical 
and biochemical barriers to infection. If infective agents 
enter the body, anti-bacterial substances in the blood and 
lymph attack them and polymorphs attempt phagocytosis. The 
specific immune reaction may be mediated through the 
production of soluble proteins (immunoglobulin antibodies) 
or by cells (lymphocytes). It may be aided by ’Cytophidic’ 
antibody which attaches to macrophages and is analagous to 
the ’cytotropic’ antibody that binds to the surface of mast, 
cells and mediates anaphylactic responses.
PROPERTIES OP ANTIBODIES
Antibody is produced in response to the presence of an
antigen (or immunogen) which may he a substance of molecular 
weight greater than 20,000; alternatively it may have a 
smaller molecular weight and act as a hapten by being 
covalently United to a heavier protein* An antibody molecule 
is a glycoprotein, which does not bind to the whole of the 
foreign substance but with the antigenic determinant* These 
determinants may all be different as with proteins, or may be 
common to certain substances, as in bacteria of the same type.
The basic property of antibody molecules is the ability 
to bind individual molecules; or particles of the antigen, 
into large aggregates, which are then more rapidly phagocytosed, 
and destroyed, ’in vivo’. Individual classes of antibodies 
are adapted to perform extra functions apart from binding to 
immunogens* eg. IgGr, in man, has a structural feature 
enabling it to cross the placenta and confer protection on 
the newborn; also, the IgA in man produced in sero-mucous 
secretions, has an additional ’Secretory’ or ’Transport’ 
piece enabling it to be transferred to the surface of the 
mucous membrane where it is probably important in counter­
acting local infection* These different properties can be 
utilised in identifying the class of immunoglobulin the body 
is producing eg. complement fixation identifies IgG* 
Immunoglobulins may be characterised also, by their ability 
to move through a supporting medium with or without an 
electric current; a property useful for their identification. 
Some of their biological activities determined to date, are 
listed in Table l-
These different antibody activities were all named 
according to function eg. one having the ability to effect the
lysis of bacteria was called a bacteriolysin. It is now 
known that antibodies with the same basic structure but 
varying specificity, induce these different effects.
ArTTIBODY G Off CEITTR AT I PIT
Antibody concentration in serum is constant with time 
i.e. is in a steady state. Antibodies of a given specificity 
behave like the total mass of non-specific immunoglobulins and 
break down exponentially. ’In vivo’, IgM and IgA antibodies 
are broken' down more quickly than IgGr and the degradation 
rate is characteristic for a given class of immunoglobulin 
in a particular species.
Antibodies and their functions have been extensively 
studied in serum and their levels measured in a number of 
diseases (HOBBS, 1970). See also Table 2.
ANTIBODY STRUCTURE
The antibodies identified to date have been divided into 
five classes, namely IgGr, IgM, IgA, IgD and IgE. All classes 
have unique heavy chains.but all have either K  or X  
light chains. The basic molecule has a molecular weight of 
150,000, the two heavy chains being 50,000 each and the two 
light chains, 25,000 each. The biological properties other 
than antigen-binding, vary according to class and are 
controlled by structures in the P Pa^t of the molecule 
(fig.l). IgGr exists as a monomer, IgM as a pentamer and IgA 
as a dimer or trimer (in most cases).
PROPHYLAXIS
The main function of an antibody is to protect a host
4.
Table 1 PROPERTIES OP HUMAN IMMUNOGLOBULINS.
(after JEPPERIS, 1972),
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against infection (fig.2), On first exposure, primary 
response, there are no cells callable of making antibody and 
the body takes time to start manufacture. Antibodies can 
be detected 3-4 days after injection of erythrocytes, 5-7 
days after soluble proteins and 10-14 days after bacterial 
cells. The role of lymphocytes and the derivation of 
effector cells in this response is illustrated in fig.3.
There have been a number of selection theories as to 
the production of antibody. The first theory was proposed
•X*
by PAULING (1940) and his predecessors who believed that 
non-specific polypeptide chains were moulded after synthesis 
to assume a specific immune pattern by physical contact with 
the antigen. In 1955, the Natural Selection Theory was put 
forward by JERKS'; 1 natural antibody’ already present in the 
host was thought to unite with antigen and this complex 
then ingested by a phagocytic cell and more antibody then 
produced to the pattern of that ingested. LEDERBERGf (1959) 
proposed the Subcellular Selection Theory by which each cell 
possesses the preexistant capacity to produce large numbers 
of antibody patterns. The entry of antigen would cause the 
selection of the appropriate pattern for the expression of 
antibody. The most favoured theory to date is that of 
BURNETT (1959) which is termed the Clonal Selection Theory 
in which, stem cells by a process of randomized somatic 
genetic change develop different immune patterns, of which 
one only is expressed for each cell and clone. Antibody 
formation or any other specific response is provoked by 
contact with the corresponding antigen.
It is known that many cells rapidly divide in the lymph
^Reference: BURNETT
Table 2. PROPERTIES OP SERUM COMPONENTS INCLUDING ANTIBODIES.
(Behringwerke AG. 1 Table of Proteins of
Human Blood Plasma'.)
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7Fig.1. Sasic Immunoglobulin Structure.
(after STANWOHTH, 1972).
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nodes near the injection or initial site of infection, 
large basophilic cells, full of REA and therefore producing 
vast amounts of protein divide to give intensely basophilic 
progeny - plasma cells; the antibody producers. Generally 
the first immunoglobulin produced is IgK and IgG- is detected 
shortly afterwards. Injection of an adjuvant eg. Freunds 
complete adjuvant, which is a water in oil emulsion of 
extracts of the cell walls of tubercle bacilli, along with 
the antigen gives a better and more prolonged (though 
possibly less specific) response. The antigen molecules are 
slowly released from the emulsified antigen/adjuvant mixture, 
resulting in continual exposure of antigen molecules and more 
prolonged antibody production.
Exposure to the 'antigen for a second time induces a 
very rapid response (secondary response) which is character­
ized by, (a) lowering of the threshold dose, (b) decrease in 
the lag phase, (c) greater rate of synthesis of antibody,
(d) prolonged persistence of the antibody produced and (e) 
greater affinity of the antibody for the immunogen compared 
to that sunthesised at a similar time after the initial 
stimulus.
The amount of antibody produced is also'dependent on 
the host!s innate ability in this system. Several syndromes 
i.e. the combination of defects that influence humoral and/or 
cell-mediated antibody 'production, may be exhibited where 
there are defects in the mechanism of production of gamma 
globulins. These people have little or no resistance to 
infection and are subject to continual bacterial infection 
unless gamma globulin is injected regularly in homoral
Antibody
production
Secondary
response.
Primary
response.
Time (weeks).
Secondary Tertiary 
injection. Injection.
Primary
injection.
Pig.2. Serum antibody response after primary, secondary and 
tertiary Infection or injection*
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responses, from ROITT et al (1969)-
Many stages involve active cell proliferation but this is 
only indicated at two stages, for simplicity.
deficiencies. V/hen cell-mediated responses are also 
affected, treatment is much more difficult and infection 
increases in severity0
Basically, therefore, antibody production occurs after 
(a) natural exposure to a foreign agent or antigen including 
ingestion and inhalation and (b) deliberate injection of 
the antigenic substance i.e. immunization.
II-rUiT I ZAP I PIT
It has been proved beyond doubt, that prophylactic 
immunization is of benefit both to the individual and the 
community as a whole. It can give some manifestations of 
the disease itself but confers partial or total immunity.
Immunity may be classified as follows:
1) hatural acquired immunity - through infection or 
transmission by mother to foetus.
2) Artificial acquired immunity - by injection. Artificial 
can be further subdivided into ACTIVE and PASSIVE.
Active is long-lived as the body itself, manufactures 
antibodies after injection. Passive is short-lived as the 
antibodies (prepared in another host) are themselves injected 
to neutralise the infection.
After prophylactic immunization, the number of people in 
a community susceptible to a disease falls as there are only 
a few left in whom the organism can proliferate, therefore it 
can no longer act as an aggressor. As a result, if prophylaxi 
is continued in ensueing years, the disease may die out due 
to the HERD effect, even though there is not 100^ immunization
If the critical number of 3:1 are immunized, the disease 
can be overcome.
ACTIVE i m m i Z A T I O H
Gome bacteria are better immunogens than others.
Bacterial antigens can be subdivided as follows:
a) organism dependent where the killed or live, attenuated 
organism is injected. The antigenic determinant is 
the same as that of the virulent organism eg. enteric 
organisms and pertussis. The disease process is more 
subtle, therefore less certain and less long-lasting 
immunity is obtained. Bead vaccines need reinjection 
at smaller intervals than live.
b) toxin dependent in which the toxin produced by the 
organism is treated to form a toxoid without change in 
antigenicity. There is a high success rate as the- 
antigen is a soluble, diffusable protein, of which 
larger doses can be administered, eg. tetanus, diphtheria 
and scarlet fever.
In giving multiple injections, it must be taken into 
account that one antigen may affect the other, therefore a 
balance between them must be obtained to induce maximum 
immunity against the different antigens.
FACTORS APPECTIEG RESPONSE IE THE RECIPIENT
There are also a number of factors in the recipient 
that affect the response to the immunogen, eg.
a) the child may he immunologic ally immature, agarnma- 
globulinaemic and/or thymus deficient. Immunologically 
deficient people may get massive infections with the 
organisms used as antigen that give very mild' infections 
to immunologically mature recipients.
b) the recipient may have already been exposed to the 
antigen or had a mild infection. A child may have a 
low titre from his mother. The subsequent secondary 
response, on immunization, will be good.
c) if there already is a high titre of circulating anti­
body, the antigen is mopped up before it reaches the 
antibody-manufacturing cells and therefore continual 
production of antibody is not obtained.
d) continual exposure to low doses of the antigen from an 
early age induces a state of tolerance to that 
antigen.
e) the general state of health of the recipient is 
important.
PASSIVE IH-IUiTI Z ATI OH
In this case, the antibody to the disease agent is 
administered directly. An alcohol or ether fractionation of 
immune serum is carried out and is injected i-m in eg. 
german measles, small pox aiid tetanus, to give immediate 
protection as the antibodies to the antigen would be produced 
with too long a delay to be effective as a cure. Another 
example is that of Rhesus negative mothers who are injected 
with a small dose of antibody to the Rhesus antigen at the 
time of birth to prevent subsequent manufacture of large
closes of antibody to the Rhesus factor.
Thus, the recipient*s immunological mechanism is not 
actively engaged in manufacturing protective antibody and 
the effect is short-lived but very necessary when administered
CBlL-ilhPIATSB IlmiTJITI T Y (delayed hypersensitivity)
Immunological reactions are not always advantageous or 
protective. In specific cell-mediated responses, where 
plasma cells are little concerned, lymphocyte infiltration 
with the ensuing reaction may be dangerous (and unpleasant) 
to the host.
Sensitization of the T lymphocytes takes place as 
illustrated in fig.3* On returning via the blood stream to 
the site of stimulation they are responsible for such 
reactions as contact sensitivity, the homograft rejection 
reaction, tumour immunity and runt disease.
AUDIT I ORAL DETRIMENTAL B11UITS REACT I OHS
These other reactions take place as a result of antigen/ 
antibody interaction.
Anauhyla-xis is the antithesis of prophylaxis in that 
the antibodies produced are not protective. If a shocking 
dose of antigen is administered after a time-lapse has 
occurred since the sensitizing dose, a severe reaction occurs. 
The sensitizing and shocking antigens need only have cross- 
reactivity; the initial dose is administered systemically 
whilst the subsequent dose is given intra-venously or intra- 
peritoneally. The F piece causes attachment of the
15.
circulating antibody peripherally and subsequent antigen 
attaches to the antibody, and the mast cell is lysed in the 
presence of complement* Pharmacological agents such as 
heparin, serotonin (SRS-A) and histamine are released from 
the mast cells.
Serum shock is an analogue of anaphylaxis although 
different pharmacological agents (or their proportions) are 
employed. This can occur, eg. with penicillin, where the 
patient goes into coma, has respiratory difficulty and dies 
in a few seconds* The penicillin or its derivatives combine 
with body protein to give macromoleeular antigens.
Serum sickness develops when large amounts of foreign 
serum are injected, eg. Horse a'^-ti-toxin for diphtheria.
The injection of the foreign serum protein (often i-v) causes, 
in a few days, a rash, temperature increase, enlargement of 
the lymphnodes where injected, damage to the kidneys 
resulting in the execretion of protein and albumin and some 
swelling of the joints to give local arthritis, i.e. it 
leads to the formation of toxic antigen/antibody complexes 
which cause a severe and generalized inflammatory response.
The Arthus Phenomenon occurs when antigen is repeatedly 
injected at a local site, corresponding to local serum 
sickness, giving a severe inflammatory response. The anti­
body differs from that of anaphylaxis as it is the heavy 
chain of the antibody that precipitates with the antigen 
and it therefore does HOT depend on the F piece in this case.
Hay fever and similar allergic reactions occur with 
elevated IgS levels. A severe allergic reaction occurs 
after secondary contact with, the immunogen or allergen in 
persons who, after initial contact have produced the IgE 
tissue-binding class of antibody (reagin), the ?c piece 
having endowed it with a high avidity for mast cells, 
resulting in bronchial spasm and acute hypotension. This 
is a manifestation of anaphylaxis.
The autoimmune response occurs when an individual forms 
demonstrable, antibodies to a self-antigen or exhibits an 
allergic reaction when tested with it, i.e. there is a loss 
of self-tolerance or q h altered distribution of self­
antigen.
There are many other deleterious immune reactions, eg. 
transfusion reactions due to antibody reacting with red 
cells, white cells or platelets, haemolytic disease of the 
nev/born, haemolytic anaemia. These are initiated by the 
antibody reacting with either an antigenic component of a 
tissue cell or an antigen or hapten which has been intimately 
associated with tissue cells. Complement is usually, but 
not always, necessary. These may be termed cytolytic or 
cytotoxic reactions.
0OHCLUSTOH
This brief outline of immunological mechanisms is 
intended to give a general outline of their characteristics 
and functions at serum and tissue levels, where they apply 
to general human disease and the body*s attempt- to combat 
infection*
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